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Chapter 1
An Overview of Asymmetric Additions to Ketones Using Various C-Metal 
Nucleophiles; Including the Additions of Alkynyl, Alkyl, Vinyl and Dienyl, Aryl and 
Allyl Based Nucleophiles
I.  Introduction
A number of catalytic enantioselective additions of organometallic reagents to 
aldehydes resulting in enantiomerically enriched secondary alcohols have been reported.1
However, there are relatively few examples of additions to ketones to afford tertiary 
alcohols.2  Methods developed for additions to aldehydes generally cannot be applied to 
ketones, due to the reduced electrophilicity of the carbonyl carbon, as well as the diminished 
steric difference between the two carbonyl substituents, which makes facial selectivity more 
                                                
1 For methods for catalytic enantioselective additions of organometallic reagents to aldehydes, see: (a) Soai, 
K.; Niwa, S. Chem. Rev. 1992, 92, 833-856. (b) Pu, L.; Yu, H.-B. Chem. Rev. 2001, 101, 757-824. (c) Bolm, 
C.; Hildebrand, J. P.; Muñiz, K.; Hermanns, N. Angew. Chem., Int. Ed. 2001, 40, 3284-3308. (d) Oguni, N.; 
Matsuda, Y.; Kaneko, T. J. Am. Chem. Soc. 1988, 110, 7877-7878. (e) Oguni, N.; Omi, T. Tetrahedron Lett. 
1984, 25, 2823-2824. (f) Kitamura, M.; Suga, S.; Kawai, K.; Noyori, R. J. Am. Chem. Soc. 1986, 108, 
6071-6072. (g) Noyori, R.; Suga, S.; Kawai, K.; Okada, S.; Kitamura, M. Pure Appl. Chem. 1988, 60, 
1597-1606. (h) Kitamura, M.; Okada, S.; Suga, S.; Noyori, R. J. Am. Chem. Soc. 1989, 111, 4028-4036. (i) 
Oppolzer, W.; Radinov, R. N.; Brabander, J. D. Tetrahedron Lett. 1995, 36, 2607-2610. (j) Oppolzer, W.; 
Radinov, R. N. Helv. Chim. Acta 1992, 75, 170-173. (k) Oppolzer, W.; Radinov, R. N. J. Am. Chem. Soc. 
1993, 115, 1593-1594. (l) Wipf, P.; Kendall, C. Chem. Eur. J. 2002, 8, 1778-1784. (m) Wipf, P.; Ribe, S. J. 
Org. Chem. 1998, 63, 6454-6455. (n) Dahmen, S. D.; Braüse, S. Org. Lett. 2001, 3, 4119-4122. (o) Dosa, P. 
I.; Ruble, J. C.; Fu, G. C. J. Org. Chem. 1997, 62, 444-445. (p) Bolm, C.; Hermanns, N.; Hildebrand, J. P.; 
Muñiz, K. Angew. Chem., Int. Ed. 2000, 39, 3465-3467. (q) Rudolph, J.; Rasmussen, T.; Bolm, C.; Norrby, 
P.-O. Angew. Chem., Int. Ed. 2003, 42, 3002-3005. (r) Huang, W.-S.; Pu, L. Tetrahedron Lett. 2000, 41, 
145-148. (s) Zhao, G.; Lib, X.-Z.; Wang, X.-R. Tetrahedron: Asymmetry 2001, 12, 399-403. (t) Ko, D.-H.; 
Kim, K. H.; Ha, D.-C. Org. Lett. 2002, 4, 3759-3762. (u) Pu, L. Tetrahedron 2003, 59, 9873-9886. (v) 
Frantz, D. E.; Fassler, R.; Carreira, E. M. J. Am. Chem. Soc. 2000, 122, 1806-1807.
2 For representative examples of catalytic enantioselective additions of carbon-based nucleophiles to 
ketones, see: (a) Evans, D. A.; Kozlowski, M. C.; Burgey, C. S.; MacMillan, D. W. J. Am. Chem. Soc. 1997, 
119, 7893–7894. (b) Tian, S.-K.; Deng, L. J. Am. Chem. Soc. 2001, 123, 6195–6196. (c) Denmark, S. E.; 
Fan, Y. J. Am. Chem. Soc. 2002, 124, 4233–4235. (d) Fuerst, D. E.; Jacobsen, E. N. J. Am. Chem. Soc. 
2005, 127, 8964–8965. (e) Shintani, R.; Inoue, M.; Hayashi, T. Angew. Chem., Int. Ed. 2006, 45, 3353–
3356. (f) Li, H.; Wang, B.; Deng, L. J. Am. Chem. Soc. 2006, 128, 732–733. (g) Komanduri, V.; Krische, 
M. J. J. Am. Chem. Soc. 2006, 128, 16448–16449. (h) Siewert, J.; Sandmann, R.; von Zezschwitz, P. 
Angew. Chem., Int. Ed. 2007, 46, 7122 –7124.
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difficult. To overcome such reduced reactivity, additions to activated ketones (bearing an 
electron withdrawing group to the carbonyl) have been studied. 
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F igur e 1. Representative Tertiary Alcohol Containing Products Found in Nature or in
the Pharmaceutical Sector
Compounds containing tertiary alcohols are found in many natural products and used 
in the pharmaceutical industry (Figure 1);3 thus, it is important to develop effective catalytic 
systems that allow access to enantiomerically enriched tertiary alcohols from all types of 
ketones. Outlined in this chapter is a critical overview of some catalytic enantioselective 
                                                
3  (a) Chen, S.-T.; Fang, J.-M.; J. Org. Chem. 1997, 62, 4349-4357. (b) Andrews, S. P.; Ball, M.; 
Wierschem, F.; Cleator, E.; Oliver, S.; Hügenauer, K.; Simic, O.; Antonello, A.; Hünger, U.; Smith, M. D.; 
Ley, S. V. Chem. Eur. J. 2007, 13, 5688-5712. (c) List, B.; Shabat, D.; Zhong, G.; Turner, J. M.; Li, A.; 
Bui, T.; Anderson, J.; Lerner, R. A.; Barbas III, C. F.; J. Am. Chem. Soc. 1999, 121, 7283-7291. (d) Seu, 
Y.-B.; Kho, Y.-H. Tetrahedron Lett. 1992, 33, 7015-7016. (e) Ramachandran, P. V.; Liu, H.; Reddy, M. V. 
R.; Brown, H. C. Org. Lett. 2003, 5, 3755-3757. (f) Friesen, R. W.; Ducharme, Y.; Ball, R. G.; Blouin, M.; 
Boulet, L.; Cote, B.; Frenette, R.; Girard, M.; Guay, D.; Huang, Z.; Jones, T. R.; Laliberte, F.; Lynch, J. J.; 
Mancini, J.; Martins, E.; Masson, P.; Muise, E.; Pon, D. J.; Siegl, P. K. S.; Styhler, A.; Tsou, N. N.; Turner, 
M. J.; Young, R. N.; Girard, Y. J. Med. Chem. 2003, 46, 2413-2426. (g) Macías, F. A; Aguilar, J. M.; 
Molinillo, J. M. G.; Rodríguez-Luís, F. ; Collado, I. G.; Massanet, G. M.; Fronczek, F. R. Tetrahedron, 
2000, 56, 3409-3414. (h) Starck, J-P.; Talaga, P.; Quéré, L.; Collart, P.; Christophe, B.; Lo Brutto, P.; Jadot, 
S.; Chimmanada, D.; Zanda, M.; Wagner, A.; Mioskowski, C.; Massingham, R.; Guyaux, M. Bioorg. Med. 
Chem. 2006, 16, 373–377.
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protocols to afford enantiomerically enriched tertiary alcohols, including alkynylide additions, 
alkylations, vinyl- and dienylation, arylations and allylations of ketones.
II. Overview of Alkynylide Additions to Ketones
Catalytic enantioselective alkynylide additions to ketones are one way of affording
enantiomerically enriched tertiary propargylic,4 allylic and alkyl (using reduction protocols) 
substituted alcohols.  Many catalytic procedures have been developed, some of which will be 
discussed here.  For this class of reactions, activated ketones, such as -ketoesters, are the
most studied.
Jiang and coworkers employed amino alcohol 3, in combination with Zn(OTf)2 for
the addition of Zn-alkynlides to -ketoesters, affording a diverse class of propargylic 
alcohols.5  Aliphatic, aromatic and heteroaromatic -ketoesters are efficient substrates for 
this method (Scheme 1). Substrates are thought to be activated by bidentate chelation
(chelation through both carbonyl moieties); thus, the fact that 2-substituted heteroaromatic -
ketoesters are tolerated is impressive. Tertiary alcohol 5 demonstrates the effectiveness of 
the catalytic system.  As this type of substrate offers competitive binding for bidentate 
activation, which could potentially decrease the reactivity and selectivity of the catalytic
process. Furthermore, this method allows for the additions of various alkynyl-nucleophiles
and the ligand can be recovered and reused without loss of selectivity or efficiency.
                                                
4 For catalytic enantioslective additions of C-based nucleophiles to ynones, see: (a) Deng, H.; Isler, M. P.; 
Snapper, M. L.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2001, 41, 1009–1012. (b) Christensen, C.; Juhl, K.; 
Hazell, R. G.; Jørgensen, K. A. J. Org. Chem. 2002, 67, 4875–4881. (c) Tian, S-K.; Deng, L. J. Am. Chem. 
Soc. 2003, 125, 9900–9901.
5 Jiang, B.; Chen, Z.; Tang, X. Org. Lett. 2002, 4, 3451-3453.
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Scheme 1. Jiang's Method for Catalytic Enantioselective Alkynylide Additions to -
Ketoesters
1
2
3
Cozzi and coworkers utilize salen-derived ligand 10 to afford tertiary propargylic 
alcohols through alkynylide additions to unactivated ketones.6  Salen complexes are able 
to act in a cooperative manner by behaving as a bifunctional Lewis acid–Lewis base 
catalyst (Figure 2). The Cozzi laboratories demonstrate the ability to efficiently add three
different Zn-alkynylides to aromatic and sterically demanding aliphatic ketones,
affording tertiary propargylic alcohols in low to moderate enantioselectivities and yields 
(32-81% ee and 40-81% yield, see Scheme 2). For the addition of alkynylides to aliphatic 
ketones affording tertiary alcohol products (11, 12, 13, 15), 36 hours are needed for the 
reaction to reach completion and 96 hours are required for the alkynylation of aryl 
ketones delivering alcohols such as 14.  Despite lengthy reaction times, one major 
advantage for this method is that the chiral ligand is commercially available .7
                                                
6 Cozzi, P. G. Angew. Chem., Int. Ed. 2003, 42, 2895-2898.
7 Commercially available from Aldrich at $20/g or $7100/mol, as of December 2007.
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Scheme 2. Catalytic Enantioselective Alkynylide Additions to Simple Ketones
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Figure 2. Transition State Model for Catalytic
Enantioselective Alkynylide Additions to -
Ketoesters
Lewis acid Lewis base
In 2003, Professor Albert Chan and colleagues identified the combination of the
highly Lewis acidic Cu(OTf)2 and camphor sulfonamide ligands for alkynylide additions 
to aryl-ketones, affording propargyl alcohols with good enantioselectivities and yields
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(71-97% ee and 39-94% yield).8  This cost-efficient, easily attainable class of ligands 
allows for the addition of phenylacetylene to a variety of aromatic ketones, affording 
representative alcohol products 19-22, including alcohols bearing electron-donating (22)
and electron-withdrawing (20) substituents.  Also, ortho-substitution seems to benefit the 
overall reaction (see Scheme 3, alcohol 20).
O
C6H5
+
C6H5
C6H5
C6H5
HO
19
92% yield,
88% ee
3 equiv
Me Me
10 mol %
10 mol % Cu(OTf )2
Me2Zn, CH2Cl2
0 oC, 48 h
SO2NH
OH
C6H5
HO
20
65% yield,
96% ee
Me
C6H5
C6H5
HO
21
57% yield,
71% ee
Et
C6H5
HO
22
75% yield,
85% ee
Me
Br
17
16
18
Scheme 3. Copper-Catalyzed Enantioselective Alkynylide Additions to Aryl
Ketones
Professor Wang and coworkers developed a series of catalytic enantioselective 
methods for the addition of phenylacetylene to aryl ketones.  The first method disclosed
by Wang was the alkynylation of aromatic ketones promoted by (S)-phenylalanine 
derived -amino alcohol ligand 23.9  This method, as illustrated in Scheme 4 provides
tertiary alcohol products with enantioselectivities ranging from 60-80% and moderate to 
good yields (51-90%).  Mild conditions make this method attractive: the reactions are run 
                                                
8 Lu, G.; Li, X.; Jia, X.; Chan, L.; Chan, A. S. C. Angew. Chem., Int. Ed. 2003, 42, 5057-5058.
9 Liu, L.; Kang, Y.-f.; Wang, R.; Zhou, Y.-f.; Chen, C.; Ni, M.; Gong, M.-z. Tetrahedron: Asymmetry 2004, 
15, 3757–3761.
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at room temperature and Et2Zn is both the Lewis acid and nucleophilic precursor.  
Lengthy reaction times are required (30-48 hours), but a range of aromatic substrates are 
tolerated.
O
C6H5
+
C6H5
2 equiv Et2Zn
hexanes, 0 oC, 30 h
C6H5
C6H5
HO
19
7 0% yield,
71% ee
2 equiv
Me
Me
H2N
Ph
OH
PhBn
10 mol %
C6H5
HO
24
88% yield,
60% ee
Me
C6H5
HO
25
58% yield,
80% ee
Me
Br
17
16
23
Scheme 4. Wang's 2004 Method for Catalytic Enantioselective Alkynylide
Additions to Aryl Ketones
A second method was disclosed in 2004 by Wang and coworkers, which used a 
binolate-Ti(Oi-Pr)4 catalyst to produce tertiary alcohols from phenylacetylene addition to 
aryl-ketones.10 This method was developed to extend the substrate scope as well as to
improve upon enantioselectivity. Method 2 (Scheme 5) allows for the alkynylation of 
alkenyl (26, 73% ee, and 88% yield) and alkyl-substrates (28, 63% ee and 91% yield), in 
addition to aromatic substrates, albeit with lower selectivities.  Asymmetric addition of 
phenylacetylene using this method requires that Ti(Oi-Pr)4 be distilled prior to use,
making this protocol slightly less practical then Wang’s previously developed method.11  
                                                
10 Zhou, Y.-f.; Wang, R.; Xu, Z., Yan, W.; Liu, L.; Kang, Y.-f.; Han, Z. Org. Lett. 2004, 6, 4147–4149.
11 No results were reported with undistilled Ti(Oi-Pr)4.
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Scheme 5. Titanium-Catalyzed Enantioselective Alkynylide Additions to
Aryl, Alkyl and Alkenyl Ketones
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HO
25
57% y ield,
88% ee
Me
Br
17
18
29
Scheme 6. Wang's Third Method for Catalytic Enantiselective
Alkynylide Addtions to Aryl Ketones
HN O
MeMe
Wang’s third method for phenylacetylene additions to aromatic ketones does not 
require an additional Lewis acid; only the presence of Et2Zn is necessary.
12   The
oxazolidine ligand 29 is a derivative of amino alcohol ligand (23) used in their 2004 
method.  Some examples are illustrated in Scheme 6 for comparison with the 2004
                                                
12  Kang, Y.-f.; Liu, L.; Wang, R.; Zhou, Y.-f.; Yan, W. J.  Adv. Synth. Catal. 2005, 347, 243–247.
Chapter 1, Page 9
method.  Reaction times are still lengthy (24-48 hours), yet slight improvement in 
enantioselectivity was observed (i.e., 25 increased to 88% from 80% ee).
Another catalytic enantioselective method was disclosed by Wang in 2005, 
catalyzed by commercially available quinine 13 with Et3Al as a Lewis acid, tertiary 
propargylic alcohols are achieved in moderate to good enantioselectivities and yields (70-
86% ee and 60-83% yields, eq 1) for aryl ketones.14 This method proved to be less 
efficient: the reaction requires a catalyst loading of 80 mol % and yields are not reflective 
(61% yield for 19).  Even with high catalyst loadings, longer reaction times are required 
(60 h vs. 24-48 h).
O
C6H5
+
C6H5
0.5-3.75 equiv AlEt3
1.6-3 equiv Et2Zn
Et2O, 0
oC, 60 h
C6H5
C6H5
HO
19
61% y ield,
86% ee
2 equiv
Me
Me
80 mol % quinine
C6H5
HO
30
80% yield,
80% ee
Me
Cl
17
16
(1)
In 2004, Katsuki and colleagues disclosed a method for the alkynylation of aryl 
and sterically bulky alkyl-ketones to afford alcohol products in poor to excellent
enantioselectivities and yields (24-94% ee and 13-98% yield).15  From the representative 
examples in Scheme 7, the nature of the substrate and the nucleophile play a significant
role on the selectivity and yield.  For example, ortho-substitution on aromatic substrates 
shows reduced reactivity (20). The alkyl group of aryl-ketones can be extended without 
detriment to the reaction (see 19a, b, c), yet non-sterically demanding dialkyl ketones,
such as 15, while still efficient are not selective (24% ee).  The ligand molecular weight 
is 827.02 g/mol and it is not mentioned as to whether the catalyst can be recovered or 
                                                
13 Commercially available from Aldrich at $4.00/g or $1300/mol as of December 2007.
14 Liu, L.; Wang, R.; Kang, Y.-f.; Chen, C.; Xu, Z.-Q.; Zhou, Y.-f.; Ni, M.; Cai, H.-Q.; Gong, M.-Z. J. Org. 
Chem. 2005, 70, 1084–1086.
15 Saito, B.; Katsuki, T. Synlett 2004, 9, 1557–1560.
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reused. Also, reactions are performed at room temperature yet two day reaction times are 
required for completion. 
NN
OH HO
(R)
O
t -Bu
+
C6H5 C6H5
t -Bu
HO
11
75% yield,
91% ee
2 equiv
Me Me
Me2Zn,
toluene/CH2Cl2
22 oC, 2 d
8 mol %
Ph Ph
Me
HO
C6H5
15
98% yield,
24% ee
C6H5
C6H5
HO
20
18% yield,
78% ee
Me
Br
t -Bu
HO
32
53% yield,
93% ee
Me
n-C5H11
t -Bu
HO
33
13% yield,
94% ee
Me
31
9
16
Scheme 7. Katsuki's Protocal for Catalytic Enantiselective Alkynylide Addtions to Aryl
and Alkyl Ketones
C6H5
t -Bu
HO
19a R=Me 49% yield, 81%ee
19b R-Et 61% yield, 87%ee
19c R=Pr 34% yield, 86%ee
R
III. Conclusion for the Addition of Alkynyl Groups to Ketones
There are several efficient and selective means for alkyne additions to aryl-, 
sterically bulky, and activated ketones. Many additions can be performed at room 
temperature and in the absence of additional Lewis acids, making these methods practical. 
Nonetheless, methods involving alkyne addition to ketones are limited in substrate and 
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nucleophile scope; phenylalkynylide and aryl ketones are primarily utilized. Methods for 
obtaining highly diverse tertiary propargylic alcohols are still in demand.16,17
IV. Overview of Dialkylzinc Additions to Ketones
C6H5
O
O
OMe
C6H5
OMe
O
EtHO
10 mol %
10 mol % Ti(O i-Pr)4
1.2 equiv. Et2Zn
toluene, –40 oC, 2 h
35
89% yield,
78% ee
NN
N N
OH HOt-Bu t-Bu
OEt
O
EtHO
36
99% conv
52% ee
Me
OEt
O
EtHO
37
92% conv
30% ee
t-Bu
OEt
O
EtHO
38
57% conv
47% ee
MeO
1
34
Scheme 8. Kozlowski's Method for Catalytic Enantioselective Et2Zn Additions to
-Ketoesters
In 2002, the Kozlowski laboratories reported a method for the catalytic 
enantioselective addition of Et2Zn to aryl -ketoesters. 18   This method uses easily 
modifiable salen ligands in combination with Ti(Oi-Pr)4 at -40 
oC.  Strategic modification 
of the ligand structure allowed the Kozlowski group to tune the bifunctional catalyst 
achieving maximize selectivity and efficiency. Salen-ligand 34 was determined to be 
                                                
16  For ketone alkynylations promoted by chiral reagents, see:, Tan, L.; Chen, C.-y.; Tillyer, R. D.; 
Grabowski, E. J. J.; Reider, P. J.  Angew. Chem., Int. Ed. 1999, 38, 711–713 and references sited therein.
17 For review of alkynylzinc additions to aldehydes and ketones, see:  Pu, L. Tetrahedron 2003, 59, 9873–
9886.
18 (a) DiMauro, E. F.; Kozlowski, M. C. Org. Lett. 2002, 4, 3781–3784. (b) DiMauro, E. F.; Kozlowski, M. 
C. J. Am. Chem. Soc. 2002, 124, 12668-12669. (c) Fennie, M. W.; DiMauro, E. F.; O’Brien, E. M.; 
Annamalai, V.; Kozlowski, M. C. Tetrahedron, 2005, 61, 6249-6265.
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optimal.  This catalyst acts in a bifunctional maner; the pendant amine is a Lewis base, 
which activates the nucleophile and Ti(Oi-Pr)4 is the Lewis acid which activates the 
electrophile (Figure 3).
N
N
Ti
O
O
N
O t-Bu
N
Zn
t-Bu
R CO2Me
EtEt
Lewis acid
Lewis base
F igure 3. Proposed Transition State for
Kozlowski's Method for Catalytic
Enantioselective Et2Zn Addtions to -Ketoesters
As illustrated in Scheme 8, the highest enantioselectivity achieved was 78% ee for 
tertiary alcohol 35.  For this method, only Et2Zn can be used as a nucleophile and a 
minimal substrate scope of aryl -ketoesters results in only moderately selective tertiary 
alcohols (35-38). Interestingly, modification of the ester moiety initially indicated the 
methyl ester to be most beneficial; substrates that were screened, however, contained an
ethyl ester.  Competitive reduction of the ketone to the secondary alcohol was observed 
as an uncatalyzed process.19  
A complimentary method, disclosed by Professor Shibasaki in 2003,
demonstrated catalytic enantioselective addition of Me2Zn to -ketoesters.20  Shibasaki
uses a proline derived ligand (39), and proposes a dinuclear zinc complex (similar to 
                                                
19 The resultant secondary alcohol is racemic.
20 (a) Funabashi, F.; Jachmann, M.; Kanai, M; Shibasaki, M. Angew. Chem., Int. Ed. 2003, 42, 5489-5492. 
(b) Wada, R.; Oisaki, K.; Kanai, M.; Shibasaki, M.  J. Am. Chem.  Soc. 2004, 126, 8910-8911.
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Professor Noyori’s proposal for Et2Zn additions to aldehydes)
21 to be the active catalyst.  
Using this dinuclear catalyst (Figure 4), Shibasaki and coworkers are able to produce
methyl-substituted tertiary alcohol esters in moderate to good enantioselectivities (59-
96%) and yields (42-95%, Scheme 9).  
C6H5
O
O
OMe
C6H5
OMe
O
MeHO
40
95% yield,
92% ee
2.5 equiv Me2Zn over 30 h
27 mol % i -PrOH, toluene/hexanes
–20 oC, 42 h
N
HO
Bn
Ph
OH
Ph
10-20 mol %
OMe
O
MeHO
41
42% yield,
92% ee
MeO
OMe
O
MeHO
42
91% y ield,
96% ee
OMe
O
MeHO
6
75% yield ,
59% ee
43
82% yield,
76% ee
NMe
O
HO Me
C6H5
S
Scheme 9. Shibasaki's Method for Catalytic Enantioselective Me2Zn Additions to -Ketoesters
1
39
N
O
R'
Zn
R
O
O
Zn
Zn R
R
R
Rs
Rl
Lewis acid
Lewis base
Figur e 4. Proposed Transition State for Shibasaki's Method
for Catalytic Enantioselective Me2Zn Additions to -
Ketoesters
                                                
21 Kitamura, M.; Suga, S.; Kawai, K.; Noyori, R. J. Am. Chem. Soc. 1986, 108, 6071–6072.
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This method allows for the addition of Me2Zn to aryl--ketoesters as well as
alkynyl--ketoesters and isatins affording tertiary alcohols such as 41, 6 and 43; slightly
lower enantioselectivities, however, are observed for non-aryl ketone alkylations (see 
Scheme 9). As previously mentioned, 2-substituted heteroaromatic -ketoesters offer
competitive binding for bidentate activation, which could potentially decrease the reactivity 
and selectivity of the catalytic reaction. For this method 2-substituted heteroaromatic -
ketoesters are tolerated, providing 42 in 91% yield and 96% ee, demonstrating the 
effectiveness of the catalytic system.
The use of additives can improve catalytic reactions as shown by many 
methods.22  Professor Shibasaki’s group has shown that a protic additive, in this case i-
PrOH, increases the efficiency and selectivity for Me2Zn additions to -ketoesters. 
Studies indicate positive non-linear effects in the absence of isopropanol. 23   When 
isopropanol is present, zinc isopropoxide is formed, leading to the formation of a 
monomerically active catalytic structure. Dimethylzinc is the only nucleophile illustrated 
                                                
22 (a) Vogl, E. M.; Gröger, H.; Shibasaki, M.  Angew. Chem., Int. Ed. 1999, 38, 1570–1577. (b) Denmark, S. 
E.; Heemstra Jr., J. R. Org. Lett. 2003, 13, 2303-2306. (c) Denmark, S. E.; Beutner, G. L. J. Am. Chem. Soc.
2003, 125, 7800-7801. (d) Ma, J.-A.; Cahard, D. Angew. Chem., Int. Ed. 2004, 43, 4566-4583. (e) Chen, F.-
X.; Zhou, H.; Liu, X.; Qin, B.; Feng, X.; Zhang, G.; Jiang, Y. Chem. Eur. J. 2004, 10, 4790-4797. (f) Kanai, 
M.; Kato, N.; Ichikawa, E.; Shibasaki, M. Synlett, 2005, 10, 1491-1508. (g) Lundgren, S.; Wingstrand, E.; 
Penhoat, M.; Moberg, C. J. Am. Chem. Soc. 2005, 127, 11592-11593. (h) Denmark, S. E.; Wynn, T. J. Am. 
Chem. Soc. 2001, 123, 6199-6200. (i) Zhao, G.-L.; Shi, M. J. Org. Chem. 2005, 70, 9975-9984. (j) Chen, 
F.-X.; Qin, B.; Feng, X.; Zhang, G.; Jiang, Y. Tetrahedron 2004, 60, 10449-10460. (k) Kanemasa, S.; Ito, 
K. Eur. J. Org. Chem. 2004, 4741-4753. (l) Denmark, S. E.; Beutner, G. L.; Wynn, T.; Eastgate, M. D. J. 
Am. Chem. Soc. 2005, 127, 3774-3789.
23 (a) Kagan, H. B; Luukas, T. O. Chapter 4.1 Non-Linear Effects and Autocatalysis Jacobsen, E. N.; Faltz, 
A.; Yamamoto, H. Eds. Comprehensive Asymmetric Catalysis I  Springer-Verlag: Berlin Heidelberg 1999, 
102-118.  (b) Guillaneux, D.; Zhao, S.-H.; Samuel, O.; Rainford, D.; Kagan, H. B. J. Am. Chem. Soc. 1994, 
116, 9430-9439. (c) Zhang, S.-Y.; Girard, C.; Kagan, H. B. Tetrahedron: Asymmetry 1995, 6, 2637-2640. 
(d) Girard, C.; Kagan, H. B. Angew. Chem., Int. Ed. 1998, 37, 2922-2959. (e) Girard, C.; Kagan, H. B. 
Tetrahedron: Asymmetry 1997, 8, 3851-3854. (f) Puchot, C.; Samuel, O.; Dunach, E.; Zhao, S.-H.; Agami, 
C.; Kagan, H. C.  J. Am. Chem. Soc. 1986, 108, 2353-2357. (g) Kagan, H. C. Synlett 2001, 888-889. (h) 
Kagan, H. B. Adv. Synth.& Catal. 2001, 343, 227-233. (i) Brunel, J.-M.; Luukas, T. O.; Kagan, H. B. 
Tetrahedron: Asymmetry, 1998, 9, 1941-1946. 
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and even at -20 oC, additions must be done over 30 hours in order to minimize the 
uncatalyzed background reaction.  
N
H
N
Ot-Bu
O
NHn-Bu
O
Me OTrt
MeO
OH
Me15 mol %
15 mol % Al(Oi-Pr)3, R'2Zn
toluene, –78 oC, 20min or 24 h
C6H5
OMe
O
R'HO
C6H5
O
O
OMe
P
OEt
OEt
O
NH2
50 mol %
24 h, 44% yield, 92% ee
24 h, 93% conv ., 70% ee
W it h 45, Et2Zn: 20 min, 98% yield, 83% ee
W it hout 45, Et2Zn: 20 min, 95% y ield, 75% ee
W i th 45, Me2Zn: 24 h, 98% yield, 83% ee
W it hout 45, Me2Zn: 24 h, 95% y ield, 75% ee
Et
OMe
O
MeHO
OMe
O
EtHO
O
20 min, 90% yield , 72% ee
20 min, 88% y ield, 44% ee
24 h, 91% y ield , 56% ee
24 h, 97% conv., 30% ee
OMe
O
MeHO
C6H5
1
44
46 47 48
Scheme 10. Aluminum Catalyzed Enantioselective Addition of Et2Zn and Me2Zn to -Ketoesters
45
More recently, a report from the Hoveyda group details a catalytic 
enantioselective method for the addition of both Et2Zn and Me2Zn to -ketoesters.24  
With the use of Al(Oi-Pr)3 and the easily modifiable dipeptide ligand (44) in the presence 
of a Lewis basic additive 45, moderate to high enantioselectivities can be achieved 
(Scheme 10).22
It is proposed that the ligand complex acts in a bifunctional manner (Figure 5).  
Aluminum activates the substrate for addition and the amide of the second amino acid 
delivers the nucleophile for a highly selective reaction.  Lewis basic additive 45 is not 
necessary to achieve reactivity or selectivity. In all cases, however, additive 45 further 
activates the nucleophile for addition, and increases the Lewis acidity of the aluminum,
                                                
24 Wieland, L. C.; Deng, H.; Snapper, M. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2005, 127, 15453–15456.
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making catalytic turnover more facile; as a result, enantioselectivities are improved (i.e. 
46 70% ee without 45, and 92% ee with 45). 
O
R1
N
Zn
O
O
NHn-Bu
R2H
R
R
N
Al
OMeO
G
HN
O
MeO +
–
–
O
P
EtO
OEt
Figure 5. Proposed Transition State for Aluminum
Catalyzed Enantioselective Addition of Et2Zn and Me2Zn to
-Ketoesters
Me
Me
Et2Zn: 96% ee, 65% y ield, 37 h
Me2Zn: 98% ee, 55% yield, 40 h
Me
O
HO C8H17Et
R
EtHO
HO
HO
MeO
51
94% ee, 24% y ield
111 h
52
76% ee, 83% y ield
40 h
Me
HNNH SO2SO2
OH HOMe
Me
Me
10 mol %
1.2 equiv Ti(Oi-Pr)4
3 equiv (alkyl)2Zn
hexanes/toluene, 22 oC
Me
O
53
70% ee, 68% yield
68 h
Me
(CH3)4OTBSHO
HO
(CH2)4OPiv
54
90% ee, 65% yield
5 d
55
97% ee, 33% yield
40 h
49
50
Scheme 11. Titanium-Catalyzed Enantioselective Addition of Dialkylzinc Reagents to
a Diverse Class of Unactivated Ketones
(CH2)4OPivHO
Me Me
Me
56
87% ee, 88% yield
3 d
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Chiral dipeptide ligand 44 is prepared in six easy steps, using previously 
developed methods.25 The molecular weight of the catalyst is 707.90 g/mol; ligand 44, 
however, cannot be recovered and reused.  Similarly to previous reports by Kozlowski 
and Shibaski, limitations for asymmetric alkylation of -ketoesters are present. The 
method disclosed by our group is sensitive; thus, reactions require freshly distilled 
reagents and glovebox techniques in order afford products in high yields and selectivities.
The most extensive method reported to date for catalytic enantioselective 
alkylation of ketones using dialkylzinc reagents has been developed by the Walsh group.
After investigating dialkylzinc additions to aldehydes, 26  the Walsh group targeted a 
method for enantioselective alkylation of ketones. 27   Some examples of this practical, 
highly enantioselective catalytic process are illustrated in Scheme 11. Combination of 
bis(camphor-sulfonamide)diol ligand 50 and Ti(Oi-Pr)4 allows for the addition of many
dialkylzinc reagents, including those bearing various functionality, to unactivated ketones 
producing tertiary alcohol products in good selectivities and yields (70-98% ee and 27-
98% yields). 28   Chiral ligand 50 is prepared in two easy steps from commercially 
                                                
25 (a) Cole, B. M.; Shimizu, K. D.; Krueger, C. A.; Harrity, J. P. A.; Snapper, M. L.; Hoveyda, A. H. Angew. 
Chem., Int. Ed. 1996, 35, 1668–1671. (b) Krueger, C. A.; Kuntz, K. W.; Dzierba, C. D.; Gleason, J. D.; 
Snapper, M. L.; Hoveyda, A. H. J. Am. Chem. Soc. 1999, 121, 4284–4285. (c) Degrado, S. J.; Mizutani, H.; 
Hoveyda, A. H. J. Am. Chem. Soc. 2001, 123, 755–756. (d) Porter, J. R.; Traverse, J. F.; Hoveyda, A. H.; 
Snapper, M. L. J. Am. Chem. Soc. 2001, 123, 984–985. (e) Luchaco-Cullis, C. A.; Mizutani, H.; Murphy, K. 
E.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2001, 40, 1456–1460. (e) Josephsohn, N. S.; Snapper, M. L.; 
Hoveyda, A. H. J. Am. Chem. Soc. 2004, 126, 3734–3735. (f) Wu, J.; Mampreian, D. M.; Hoveyda, A. H. J. 
Am. Chem. Soc. 2005, 127, 4584–4585.
26 (a) Chen, Y. K.; Lurain, A. E.; Walsh, P. J. J. Am. Chem. Soc. 2002, 124, 12225-12231. (b) Lurain, A. 
E.; Walsh, P. J. J. Am. Chem. Soc. 2003, 125, 10677-10683.
27 (a) Garcia, C.; LaRochelle L. K.; Walsh, P. J.  J. Am. Chem. Soc. 2002, 124, 10970-10971. (b) Jeon, S.-
J.; Li, H.; Garcia, C.; LaRochelle L. K.; Walsh, P. J J. Org. Chem. 2005, 70, 448-455. (c) Jeon, S.-Y.; 
Walsh, P. J. J. Am. Chem. Soc. 2003, 125, 9544-9545.
28  Knochel’s method for the preparation of functionalized dialkylzinc reagents was used. (a) Knochel, P.; 
Vettel, S.; Eisenberg, C. Appl. Organomet. Chem. 1995, 9, 175-188. (b) Rozema, M. J.; Eisenberg, C.; Lu,
Utjens, H.; Ostwald, R.; Belyk, K.; Knochel, P. Tetrahedron Lett. 1993, 34, 3115-3118. (c) Langer, F.; 
Devasagayaraj, A.; Chavant, P.-Y.; Knochel, P. Synlett 1994, 410-412. (d) Knochel, P. Chemtracts: Org. 
Chem. 1995, 8, 205-221. (e) Rozema, M. J.; Sidduri, A.; Knochel, P. J. Org. Chem. 1992, 57, 1956-1958. 
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available materials and has a molecular weight of 546.78 g/mol.  In addition to 
developing an efficient method for the alkylation of ketones, Walsh and coworkers 
illustrate a diastereoselective epoxidation as a two-step, one-pot process, affording highly 
useful chiral synthons (Scheme 12).
n
Me
O
10 mol % ligand,
n
Me
Et OTi(O i-Pr)3
0 oC-22 oC
1-6 h n
O
Me
Et OH
–50 oC to 22 oC, 2 hn
O
Et
Me
OH
Scheme 12. In situ Functionalization of Tertiary Alcohol Products from Titanium-
Catalyzed Enantioselective Additions of Dialkylzinc Reagents
1.2 equiv Ti(Oi -Pr)4, 3 equiv Et2Zn,
hexanes/toluene, 22 °C, 40 h
O2
2 BF3•OEt2
I II III
IV
n=1: 97%ee, 60% y ield
n=2: 99% ee, 80% yield
V. Conclusion for the Addition of Alkyl Groups to Ketones
In general, methods for ketone alkylations involve the use of commercially 
available Me2Zn and/or Et2Zn with activated ketones (-ketoesters).  Catalytic systems 
for alkylation of -ketoesters are not generalized. For example, Kozlowski and 
coworkers have developed a method involving only Et2Zn and a complimentary method 
by Shibasaki which simply utilizes Me2Zn.  Moreover,  Shibasaki's variant requires that 
Me2Zn be added over a 30 h period, in order to eliminate uncatalyzed (non-
enantioselective) additions. Hoveyda and coworkers have developed a more general 
catalytic method for alkylation of activated ketones with both Me2Zn and Et2Zn for a
wider substrate scope; this catalytic asymmetric protocol, however, involves a sensitive 
                                                                                                                                                
(f) Langer, F.; Schwink, L.; Devasagayaraj, A.; Chavant, P.-Y.; Knochel, P. J. Org. Chem. 1996, 61, 8229-
8243. (g) Schwink, L.; Knochel, P. Tetrahedron Lett. 1994, 35, 9007-9010.
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reaction. Walsh's program developed the most general method considering both the 
range of nucleophiles and substrates; long reaction times, however, are typically 
necessary (24 hours to 5 days).  Even with the aforementioned methods, there is room for 
improvement when it comes to catalytic enantioselective alkylations of ketones to afford 
enantiomerically enriched tertiary alcohols.
VI. Overview of Vinyl and Dienyl Group Additions to Ketones
[Cp2ZrHCl]n
Ph
Ph
ClCp2Zr
1.2 equiv
Me2Zn
Ph
MeZn PhC6H5
HO Me
1.2 equiv
58
98% yield,
95% ee
+
Scheme 13. Titanium-Catalyzed Enantioselective Addition of Vinyzinc Reagents to Unactivated Ketones
MeHO
Bu
60
88% y ield,
80% ee
Ph
Bu
HO Me
59
81% yield,
79% ee
Me
HNNH SO2SO2
OH HOMe
Me
Me
10 mol %
1.2 equiv Ti(Oi-Pr)4
3 equiv R2Zn
hexanes/toluene, 22 oC, 16-24 h
50
O
C6H5 Me
17
MeHO
62
98% yield,
90% ee
HO Me
61
98% y ield,
92% ee
OTBDPS
Me
Me
Cl
Me
HO
Me Me
OTBDPS
63
94% yield,
97% ee
1.2 equiv
Me
57
+
In addition to the aforementioned method for dialkylzinc additions to ketones, the 
Walsh group has disclosed a method for the addition of  vinyl- and dienylzinc reagents to 
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ketones using the same catalytic components as for the addition of dialkylzinc reagents.29  
Illustrated in Scheme 13 is the route for addition of vinyl groups to ketones. Vinylzinc 
reagents can be prepared in situ using methods developed by Knochel and coworkers.28  
A diverse class of acetylenes can be used in preparation of nucleophiles, including those 
containing various functional groups; the representative allylic tertiary alcohols 58-63 are 
obtained in good to excellent selectivities and yields (79-97% ee and 81-98% yield) . 
Terminal enynes bearing aliphatic, cyclic or sterically encumbered substituents
are also appropriate nucleophilic precursors for dienylation of ketones. This class of 
nucleophiles is applicable for additions to aliphatic, cyclic and aromatic ketones (Scheme 
14); substituted acetophenone derivatives, however, are the most commonly employed 
substrates.
MeHO
68
87% yield,
77% ee
F3C C6H13
MeMeHO
66
88% yield ,
94% ee
ClCp2Zr
Me
C6H5
Me OH
1.2 equiv
Me
1.2 equiv
Me2Zn
Me
+
[Cp2ZrHCl]n
Scheme 14. Titanium Catalyzed Enantioselective Addtion of Dienylzinc Reagents to Unactivated Ketones
65
99% y ield
93% ee
Me
HNNH SO2SO2
OH HOMe
Me
Me
10 mol %
1.2 equiv Ti(O i-Pr)4
3 equiv R2Zn
hexanes/toluene, 22 oC, 16-24 h
50
O
C6H5 Me
17
MeZn
Me
1.2 equiv
64
MeHO
67
85% yield,
89% ee
Cl
                                                
29 (a) Li, H.; Walsh, P. J.  J. Am. Chem. Soc. 2004, 126, 6538–6539. (b) Li, H.; Walsh, P. J. J. Am. Chem. 
Soc. 2005, 127, 8355–8361.
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VII. Conclusion for the Addition of Vinyl and Dienyl Groups to Ketones
To the best of our knowledge, the above study represents the only catalytic 
enantioselective vinylation and dienylation of ketones.
VIII. Overview of Arylzinc Additions to Ketones
In 1998, Dosa and Fu reported the first example of catalytic enantioselective 
phenylations of ketones.  Both aryl-alkyl ketones and dialkyl ketones30 were effective 
substrates when amino alcohol 71 (used by Noyori for Et2Zn addition to aldehydes)
21  
was used as a chiral ligand. Outlined below (Scheme 15) are representative examples of
the products generated with this method.
O
Me
15 mol % (+)-daib
3.5 equiv (C6H5)2Zn
1.5 equiv MeOH
toluene, 22 oC, 48 h 70
76% yield,
75% ee
NMe2
OH
Me OH
C6H5
Me
Me
Me
Me
C6H5
HO
72
53% yield,
80% ee
Me
C6H5
HO
73
76% yield,
75% ee
Et C6H5
HO
74
79% yield,
86% ee
Et
Br
Scheme 15. The First Example of Catalytic Enantioselective Diphenylzinc
Additions to Ketones
69
71
In the Dosa-Fu method, methanol is used as an additive to alter the nature of the 
zinc species; presumably, methanol breaks up arylzinc aggregates.31  A range of aryl-
                                                
30 Dosa, P. I.; Fu, G. C. J. Am. Chem. Soc. 1998, 120, 445–446.
31 Markles, P. R.; Schat, G.; Akkerman, O. S.; Bickelhaupt, F.  Organometallics, 1990, 9, 2243-2247.
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alkyl ketones were investigated; there are, however, no examples of highly electron rich 
aromatic substrates (i.e. p-OMe-C6H4). When nonlinear studies were conducted, the 
positive effect observed was attributed to the formation of a relatively unreactive 
dinuclear zinc complex that sequesters the heterodimer species, which is consistent with 
the studies of Noyori.21
Me
HNNH SO2SO2
OH HO
Me
Me
MeO
R
75
98% yield,
92% ee
1 equiv (C6H5)2Zn
5 mol %
O
C6H5Me
B(OH)2
X
1) Et2Zn, toluene, 70
oC, 12 h
77
65% yield,
93% ee
In si tu generation of arlyzinc reagents:
X=H, Me, Br, CF3
+
1.1 equiv Ti(O i-Pr)4
toluene, 25 oC, 24 h
2) 5 mol % ligand,
1.1 equiv Ti(Oi-Pr)4, 22
oC, 48 h
C6H5
MeHO
Br
R'
C6H5
HO Me
Me
C6H5
HO Et
Br
76
95% y ield,
80% ee
75
65% y ield,
84% ee
C6H5
MeHO
Me
50
17
Scheme 16. Titanium-Catalyzed Enantioselective Diarylzinc Additions to Aryl Ketones
C6H5
MeHO
X
In 2003, Ramón and Yus reported a highly enantioselective method for arylzinc 
addition to ketones, complementing previous reports.32,33  The ranges of ketones and 
                                                
32 Prieto, O.; Ramón, D. J.; Yus, M.  Tetrahedron: Asymmetry 2003, 14, 1955–1057.
33 For other alkylzinc catalytic enantioselective additions to unfunctionalized ketones by Yus, see: (a) 
Ramón, D. J.; Yus, M. Tetrahderon Lett., 1998, 39, 1239–1242. (b) Ramón, D. J.; Yus, M. Tetrahedron
1998, 54, 5651–5666. (c) Yus, M.; Ramón, D. J.; Prieto, O. Tetrahedron: Asymmetry 2002, 13, 2291–2293. 
(d) Forrat, V. J.; Ramón, D. J.; Yus, M. Tetrahedron: Asymmetry 2005, 16, 3341–3344. (e) For ligand 
synthesis, see: Yus, M.; Ramón, D. J.; Prieto, O. Tetrahedron: Asymmetry 2003, 13, 1103–1114. (f) Yus, 
M.; Ramón, D. J.; Prieto, O. Eur. J. Org. Chem. 2003, 2745–2748 (synthesis of (–)-frontalin). (g) Ramón, 
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nucleophiles investigated include many electronically modified components (Scheme 
16) .  Yus applies Knochel’s in situ method for the formation of various arylzinc reagents
and is able to prepare an extensive group of enantiomerically enriched tertiary alcohols.  
The arylzinc reagents must be formed in the manner outlined in Scheme 16 because 
aryllithium or arylmagnesium reagents form achiral metal salts that catalyze addition to 
the ketones, generating racemic products.
O
Me
70
55% y ield,
75% ee
Me OH
C6H5
Me
Me
Me
Me
C6H5
HO
78
99% y ield,
88% ee
Et
C6H5
HO
79
81% y ield,
87 % ee
Me C6H5
HO
80
99% yield,
96% ee
Me
Cl
Me
HNNH SO2SO2
OH HOMe
Me
Me
10 mol %
0.6 equiv Ti(Oi-Pr)4
1.6 equiv (C6H6)2Zn
hexanes/toluene, 22 oC, 6-24 h
C6H5
HO
81
58% yield,
91% ee
Me
C6H5
69
50
Scheme 17. Titanium-Catalyzed Enantioselective Diphenylzinc Additions to Aryl, Alkyl and
Alkenyl Ketones
Further building on the programs outlined in Schemes 11-14, Walsh and 
coworkers elaborated on the utility of their catalytic system.  Some examples for the 
phenylation of aryl, alkyl and alkenyl ketones affording tertiary alcohols with high 
enantioselectivities and yields (75-96% ee and 55-99% yields)34 are illustrated in Scheme 
17.  The main difference between this procedure (Scheme 17) compared to Walsh’s 
                                                                                                                                                
D. J.; Yus, M. Chem. Rev. 2006, 106, 2126-2208. For a brief overview of catalytic enantioselective 
alkylations of ketones, see:  Ramon, D. J.; Yus, M. Angew. Chem., Int. Ed. 2004, 43, 284–287.
34 For detailed account of alkyl- and arylzinc additions to ketones by Walsh and co-workers, see: Betancort, 
J. M.; Garcia, C.; Walsh, P. J. Synlett 2004, 5, 749–760.
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previously disclosed methods is the amount of Ti(Oi-Pr)4.  The amount of Lewis acid has 
been reduced to 0.6 mol % vs. 1.2 mol %; additionally, reaction times are much shorter 
(6-24 h vs. 24-72 h). No examples for strongly electron rich substrates (i.e. p-OMe-
C6H4) are mentioned for phenylation of ketones using this method.
IX. Conclusion for the Addition of Aryl Groups to Ketones
The catalytic enantioselective aryl addition methods reported thus far have a 
reasonably small substrate scope and nucleophile scope. Many classes of ligands that 
have been successful for similar transformations have yet to be explored. The above 
methods report good efficiencies and selectivities for simple arylzinc reagents but more 
complex aryl groups (heteroaryl, for example) have yet to be investigated.  One can 
imagine the importance of tertiary alcohols neighbored by heterocyclic moieties in 
biological systems; thus having a method to furnish these heteroaryl tertiary alcohols is 
still in demand.  
X. Overview of Allyl Group Additions to Ketones
In 1999, Tagliavini and coworkers published the first catalytic enantioselective 
method for the allylation of ketones to afford homoallylic alcohols with low to moderate 
enantioselectivities (29-65% ee).35 It is proposed that decreased enantioselectivities are
caused by the formation of more reactive tin alkoxides, which add in a nonselective 
fashion. Tagliavini’s method provides aryl (84, 87, 88) and alkenyl (85) homoallylic 
alcohols in moderate enantioselectivities; aliphatic derivatives, however, are obtained 
with poor enantioselectivity (86, 29% ee, Scheme 18).  The catalyst can be formed in situ, 
                                                
35 Casolari, S. J.; D’Addario, D. Tagliavini, E. Org. Lett. 1999, 1, 1061–1063.
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making the method attractive, although use of the more reactive tetraallyltin is needed in 
order to afford isolated products in high yields.  An unattractive factor of this method is 
that it requires the use of highly toxic tin nucleophiles.
O
C6H5 Me
+ Sn
20 mol %
(R)-binol-Ti
C6H5 Me
HO
Catalyst pr epared in situ:
OH
OH
+ Cl2Ti(Oi-Pr)2 + SnBu3
CH2Cl2
1 h, 22 oC
(R)-binol-Ti
1 equiv
81
1 equiv 2 equiv
82
1 equiv
17
1.5 equiv
83
CH2Cl2, 22
oC4
84
77% yield,
65% ee
Me
HO
85
83% yield,
51% ee
n-C6H13 Me
HO
86
89% yield,
29% ee
Me
HO
87
80% yield,
55% ee
HO
88
91% yield,
35% ee
C6H5
O2N
Scheme 18. Titanium-Binolate Catalyzed Enantioselective Allylation of Aryl, Alkyl and
Alkenyl Ketones
Between the years 2002 and 2006, Simon Woodward and colleagues developed a 
detailed method for the allylation of aryl-ketones.36,37 There is one example of alkenyl 
ketone allylation demonstrated, affording alcohol 85 in 47% ee and 63% yield (Scheme 
19). Two protocols are outlined: a “wet” method and a “dry” method.  The “wet” method 
involves the use of undistilled allylstannane reagents, which lead to slightly decreased 
                                                
36 For review on catalytic asymmetric allylation of ketones: Denmark, S. E.; Fu, J. Chem. Rev. 2003, 103, 
2763–2794.
37 (a) Cunningham, A.; Woodward, S. Synlett 2002, 1, 43–44. (b) Cunningham, A.; Mokal-Parekh, V.; 
Wilson, C.; Woodward, S. Org. Biomol. Chem.,  2004, 2, 741-748. (c)  Prieto, O.; Woodward, S.  J. 
Organometallic Chem. 2006, 691, 1515-1519.
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enantioselectivities, but an increase in isolated yield, presumably due to the formation of 
tin alkoxides.  The “dry” protocol involves the use of Schlenk techniques with distilled 
allylstannane reagents, leading to increased selectivities but decreased isolated yields
(Scheme 19). The use of either protocol requires the use of mixed stannanes (70 % 
tetraallyltin and 30 % triallyl(alkyl)tin) to form the appropriate allylating species, also
making this method unattractive due to the toxicity of tin reagents. 
O
C6H5 Me
20 mol %
C6H5 Me
HO
84
wet: 75% yield, 86% ee
dry: 43% yield, 92% ee
SH
OH
1.1 equiv of 70% Sn(CH2CH=CH2)4
and 30% RSn(CH2CH=CH2)3, toluene
22 oC, 16 h, R=Et, Bu
Me
HO
85
47% y ield, 66% ee
C6H5 Et
HO
89
8% yield, 3% ee
Me
HO
90
97% y ield, 86% ee
51% y ield, 92% ee
HO
91
7 8% yield, 82% ee
32% y ield, 90% ee
C6H5
Br
Me
Me
Scheme 19. Woodward's Protocol for Enantioselective Allylation of Aryl, Alkyl and Alkenyl
Ketones
17
92
As previously mentioned, Walsh and coworkers have used zinc nucleophiles in a 
variety of different catalytic enantioselective manners: alkylation of aldehydes and 
ketones as well as vinyl-, dienyl- and phenyl additions to ketones.27, 29  Examples using 
tetraallyltin for the allylation of ketones reported by the Walsh group are illustrated in 
Scheme 20.38  The titanium-binolate catalyst is formed in situ, giving rise to practical, 
efficient and selective reactions (67-99% yields and 76-96% ee).  This catalytic system is
similar to that of Tagliavani’s,35 as it uses all the same catalytic components and
                                                
38 Waltz, K. M.; Gavinonis, J.; Walsh, P. J. Angew. Chem., Int. Ed. 2002, 41, 3697-3699.
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nucleophile (compare Schemes 20 and 18). The major differences are that Walsh’s 
system uses a protic additive, i-PrOH, in the pre-formation of the catalyst, whereas
Tagliavini uses tributylallyltin during this process.  Enantioselectivities and yields are 
significantly improved with Walsh’s method, (85, 90% ee and 99% yield vs. 51% ee and 
83% yield) .  
O
Me
+
Sn
4
20-30 mol % catalyst
Me
HO
OH
OH
+ Ti(Oi -Pr)4 + i -PrOH catalyst
20-30 mol %
81
20-30 mol % 20 equiv
CH2Cl2, 22
oC, 1 h
94
82% yield,
96% ee
Me
Me
HO
85
99% y ield,
90% ee
C6H5
HO
95
99% y ield,
76% ee
HO
C6H5
Me
Cl
HO
88
96% y ield,
95% ee
O
96
67% yield,
84% ee
Me
Scheme 20. Walsh's Method for Titanium-Binolate Catalyzed Enantioselective Allylation of
Aryl, Alkyl and Alkenyl Ketones
93 83
22 h
Initial mechanistic observations for Walsh’s method show strong positive 
nonlinear effects.  There are several possible explanations: hetero- and homo- chiral 
(binolate)2Ti species or [(binolate)TiX2]2 dimers (X = Oi-Pr, or X2 = O) may be formed.  
The role of the protic alcohol additive is still unknown. The nature of alcohol has no 
effect on enantioselectivity; isopropanol, cyclopentanol, cyclohexanol, and cycloheptanol 
provide tertiary alcohol products with identical selectivities, suggesting that the 
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mechanism does not involve initial protonation of  allyltin to generate tin alkoxides
(which could have been the active allylating reagent).  Regardless, i-PrOH is necessary as 
selectivities suffer, (51% vs. 73% for alcohol 94) when i-PrOH is removed.  Additionally, 
when the catalyst is prepared with excess i-PrOH, an increase in enantioselectivity from 
73% to 96% is observed for alcohol 94. Like many other allylation protocols, the reaction
exhibits an induction period.36  The induction period can be eliminated for Walsh’s 
method when binol, Ti(Oi-Pr)4, tetraallylstannane, and i-PrOH were premixed for 22 h 
prior to addition of ketone.
Sn
4
20-30 mol % catalyst Me
HO
OH
OH
+ Ti(Oi -Pr)4 + i -PrOH catalyst
20-30 mol %
99
20-30 mol % 20 equiv
CH3CN, 0-22
oC, 1 h
98a R=CF3: 67% y ield, 95% ee
98b R=OMe: 72% y ield, 99% ee
R
HO
102
46 yield,
81% ee
Me
Me
Me
HO
101
49% yield,
55% ee
I
HO
C6H5
100
46% yield,
91% ee
MeMe
O
Me
+
R
Scheme 21. Walsh's Method for Titanium-Binolate Catalyzed Enantioselective
Methallylation of Aryl and Alkenyl Ketones
97
22 h
In 2006, Walsh and coworkers reported the first example of catalytic 
enantioselective methallylation of ketones. 39   Under conditions previously used for 
                                                
39 Kim, J. G.; Camp, E. H.; Walsh, P. J. Org. Lett. 2006, 8, 4413-4416.
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allylation of ketones (as in Scheme 20), only 53% ee was observed for methallylations 
(as in Scheme 21). When H8-binol 99 was utilized, a 25% increase in enantioselectivity 
was observed.  Reactions can be conducted in a variety of solvents, although experiments 
performed in acetonitrile or propionitrile resulted in the highest enantioselectivities 
(Scheme 21), compared to the allylation method illustrated in Scheme 20 (CH2Cl2).  
Isopropanol was again necessary for enantioselectivity (<2% ee in the absence of i-PrOH).  
If i-PrOH is used as a solvent, only a slight decrease in enantioselectivity is observed 
(87% ee to 81% ee for acetophenone). In attempts to optimize the reaction conditions and 
increase selectivity, a decrease in temperature produced mixed results: lower selectivities 
were observed for acetophenone derivatives but higher selectivities were achieved for 
-unsaturated substrates. Chiral tertiary -hydroxyketones (ketoaldol products) can be 
obtained via ozonolysis of the methallylated products without errosion of 
enantioselectivity.
In 2005, Loh and coworkers presented three protocols for catalytic 
enantioselective allylation of ketones, two of the methods developed involve the use of 
indium in combination with pybox ligand 103.40  Moderate to high enantioselectivities
could be achieved for allylation of aryl, alkyl and alkenyl ketones affording tertiary
allylic alcohols.  These reactions can be performed with the less reactive allyltributyltin 
and the catalyst can be recovered and reused without loss of enantioselectivity. 
Chlorotrimethylsilane is required in order to obtain high enantioselectivities because it 
protects the resultant tertiary alcohol products, inhibiting the formation of tin alkoxides 
which cause a decrease in enantioselectivity.  This methodology was extended when Loh 
                                                
40 (a) Lu, J.; Hong, M.-L.; Teo, Y.-c.; Loh, T.-P. Chem. Commun., 2005, 4217-4218. (b) Lu, J.; Ji, S.-J.; 
Teo, Y.-C.; Loh, T.-P. Tetrahedron Lett., 2005, 46, 7435-7437.
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and coworkers illustrated that the reaction could be run in the presence of ionic liquid 
solvents without detriment to the reaction.41b  
O
C6H5 Me C6H5 Me
HO
84
W it hout [hmim]PF6:
80% y ield, 62% ee
W it h [hmim]PF6:
82% y ield, 65% ee
20 mol % PYBOX-In complex
1.2 equiv. TMSCl
4 Å MS/ CH2Cl2,
0 oC, 70 h
+
SnBu3
1 equiv
17
1 equiv
82
N
O
N N
O
PhPh
i-Pr
Ph Ph
i-Pr
In(OTf)3+
Repr esentativ e Subst rat e Scope:
O
MeC6H5
O
MeC6H5
O O
107
68% y ield,
84% ee
106
90% yield,
95% ee
105
80% yield,
55% ee
104
71% yield ,
54% ee
PYBOX-In complex
0.22 equiv
103
0.2 equiv
or
20 mol % PYBOX-In complex
1.2 equiv. TMSCl
4 Å MS
[hmim]PF6 / CH2Cl2,
0 oC, 70 h
[hmim]PF6 = MeN NHC6H13
74% yield,
81% ee
80% y ield,
93% ee
68% yield,
55% ee
74% yield ,
56% ee
Scheme 22. Catalytic Enantioselective Allylation of Aryl, Alkyl and Alkenyl Ketones with
In(OTf)3
PF6
The third method (Scheme 23) developed by Loh and coworkers also uses indium 
as the Lewis acid, but the ligand has been changed to (R)-binol. Additionally, TMSCl is 
no longer required in order to obtain good enantioselectivities (80-90% ee).41  The re-face  
is attacked selectively as rationalized by the transition state shown in Figure 6.
                                                
41 Teo, Y.-C.; Goh, J.-D.; Loh, T.-P. Org. Lett. 2005, 7, 2743-2745.
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O
C6H5 Me
20 mol % (R)-binol-In
C6H5 Me
HO
84
7 4% y ield,
82% ee
4 Å MS/ CH2Cl2,
22 oC, 72 h
+
SnBu3
1 equiv
17
3 equiv
82
InBr3+
Representat ive Substr ate Scope:
O
MeC6H5
O
MeC6H5
O
106
61% yield ,
90% ee
105
60% yield ,
80% ee
104
82% yield,
90% ee
(R)-binol-In
0.22 equiv 0.2 equiv
(R)-binol
Scheme 23. Loh's Third Protocol for Enantioselective Allylation of Ketones with
(R)-binol-In Complex
O
O
In
MeO
R
r e-face
attack
Figure 6. Proposed binol-In(III)-Aldehyde Pre-transitions
State: Loh's Third Protocol for Enantioselective Allylation
of Ketones with (R)-binol-In Complex
Some differences in this method (Scheme 23), compared to the first two disclosed 
by Loh (Scheme 22), are that indium tribromide gives higher conversions and yields in 
comparison to In(OTf)3 or InCl3 (46% yield, 81% ee at -78 
oC to 22 oC). The (R)-binol
ligand can be recovered at the end of the reaction (94% yield); also the methodology 
outlined in Scheme 23 utilizes the weaker allylating agent (allyltributyltin), whereas,
other methods use tetraallylstannane. In order to prevent the formation of tin alkoxides,
solids must be azeotroped with anhydrous THF prior to addition of the reaction solvent.
In 2002, Shibasaki and coworkers reported a method that focused on allylation of 
aldehydes, ketones and imines.  There is only one example illustrated in this report for 
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catalytic enantioselective allylation of ketones,42 but this method represents the first 
using allyltrimethoxysilanes (eq 2). The method requires the use of an achiral additive, 
tetrabutylammonium difluorotriphenylsilicate (TBAT). Mechanistic studies (19F NMR) 
were conducted to determine the importance of TBAT and distinct shifting of the F-peak 
was observed (-155.7 ppm to -129.0 ppm), indicating that allylfluorodimethoxysilane was
formed and is most likely the nucleophile. Further investigations indicate that the 
fluoride ion is important for both initiation of reaction and it also plays an active role in 
the catalytic cycle.43
O
C6H5 Me
15 mol % CuCl-(R)-tol-binap
15 mol % Ph3F2Si[N(n-Bu)4]
THF, temp, t ime
C6H5 Me
HO
84
65% yield, 61% ee ( 4 oC, 90 h)
>98% y ield, 56% ee ( 22 oC, 7 h)
+ Si(OMe)3
1 equiv
17
1.5 equiv
107
(2)
O
C6H5 Me
3 mol % CuF2 • 2H2O
4.5 mol % La(O i-Pr)3
DMF, -40 oC, 1 h
C6H5 Me
HO
84
94% yield,
82% ee
+
B
1 equiv
17
1.5 equiv
108
O
O
Me
Me
Me
Me
Repr esentative Substrate Scope:
S
Me
O
Me
O
Me
O
Me
O O
Me
Me
109
89% yield,
84% ee
110
84% y ield,
85% ee
107
88% yield,
84% ee
111
87% y ield,
90% ee
112
98% yield,
84% ee
Scheme 24. Copper-Catalyzed Enantioselective Allylation of Aryl, Alkyl and Alkenyl
Ketones with Allylboronates
P
P
i-Pr
i -Pr
i -Pr
i-Pr
(R, R)-i-Pr-DuPHOS
6 mol %
                                                
42 Yamasaki, S.; Fujii, K.; Wada, R.; Kanai, M.; Shibasaki, M.  J. Am. Chem. Soc. 2002, 124, 6536-6537.
43 There is no detailed description in this report that discusses the “active role” of the fluoride ion.
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In 2004, Shibasaki introduced a new protocol for catalytic enantioselective 
allylations using allylboron reagents (Scheme 24). 44 The enantioselectivities are 
moderate (79% ee for substrate 17, 15 mol % and 30 mol% i-Pr-DuPHOS) in the absence 
of La(Oi-Pr)3; yields of isolated products, however, are low (42% yield). It was expected 
that additives could increase yields by Lewis acid activation of both the allylboronate and 
the ketone.  Lanthanides were specifically investigated because of their dynamic 
coordinating ability. In the presence of  La(Oi-Pr)3, yields improved to 94%, allowing 
for a decrease in catalyst loading to 3 mol % CuF and i-Pr-DuPHOS. 
O
R Me R
HO Me
+
B
1 equiv
O
O
Me
Me
Me
Me
Me
O
R2
R1 R2R1
a) R1=Me, R2=H
b) R1=H, R2=Me
O
C6H5 Me
crotylboronate
(1.2 equiv)
time
(h)
yield
(%)
dr
(syn/anti)
ee (%)
syn/anti
a
b
a
b
1
5
3
4
73
94
80
90
30/70
84/16
27/73
38/62
75/90
87/74
90/93
90/92
syn: R1=Me, R2=H
anti: R1=H, R2=Me
3 mol % CuF2 • 2H2O
6 mol % (R, R)-i-Pr-DuPHOS
4.5 mol % La(Oi -Pr)3
DMF, -40 oC, 1 h
T able 1. Copper-Catalyzed Enantioselective Crotylation of Aryl and Alkenyl Ketones with
Allylcrotonates
17
111
Shibasaki’s method is also applicable for crotylation (see Table 1).  No 
crotylation products are observed in the absence of La(Oi-Pr)3, and as illustrated 
diastereoselectivity varies depending on the substrate.  For example, allylation of ketone 
17 with the syn-crotylbornonate provides higher diastereoselectivity than allylation of 
                                                
44 Wada, R.; Oisaki, K.; Kanai, M.; Shibasaki, M. J. Am. Chem. Soc. 2004, 126, 8910-1911.
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ketone 111 with the same nucleophile (84:16 vs. 38:62, respectively). This method 
represents the  first example of catalytic enantioselective crotylation of ketones.
Shortly after the above account, Professor Yamamoto presented a method for 
catalytic enantioselective allylation of ketones, including one example of catalytic 
enantioselective crotylation. 45 Aromatic, cyclic, heterocyclic and -unsaturated 
ketones were found to be effective substrates  for allylation (Scheme 25). 
C6H5 Me
O
Si(OMe)3
5 mol % (R)-difluorphos
5 mol % AgF
2 equiv
107
1 equiv MeOH
THF, –78 °C, 12 h
C6H5
84
86% yield
81% ee
Me OH
Me OH
Me
114
62% y ield,
92% ee
OH
115
89% y ield,
91% ee
O
OH
116
74% yield,
92% ee
O
O
O
O
PPh2
PPh2
F
F
F
F
OH
Cl
119
97% yield,
96% ee
Ph
OH
117
96% y ield,
84% ee
Me OH
118
56% yield,
95% ee
C6H5
120
60% yield,
95% ee,
90:10 E:Z
Me OH
Me
Representat ive Products
+
17
Scheme 25. Silver-Catalyzed Enantioselective Allylation and Crotylation of Aryl, Alkyl
and Alkenyl Ketones with Allyltrimethoxysilane
113
                                                
45 Wadamoto, M.; Yamamoto, H. J. Am. Chem. Soc. 2005, 127, 14556–14557.
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Scheme 26. Proposed Catalytic Cycle for Silver Catalyzed Enantioselective
Allylation and Crotylation of Aryl, Alkyl and Alkenyl Ketones with Allyltrimethoxysilane
C6H5 Me
O
Si(OMe)3
+
(R)-binap-AgX
C6H5
Me OAg+
C6H5
Me OH
C6H5
Me OSi(OMe)3
MeOH XSi(OMe)3F ast Slow
84
17 107
121
122
Yamamoto demonstrates the successful use of allyltrimethoxysilanes as
nucleophiles.  Silver fluoride (AgF) is not soluble in aprotic solvents such as THF; the 
silver-ligand complex, however, is formed in MeOH, and is then soluble in THF, thus
premixing to form the catalyst is necessary.  Aryl and alkenyl substrates are tolerated and 
1,2-addition is the exclusive product when -unsaturated ketones are utilized. Since 
alcohol products are isolated exclusively, proton transfer from MeOH must occur much 
faster then silyl transfer as illustrated in the proposed mechanism (Scheme 26).
Yamamoto’s method also allows for catalytic enantioselective crotylation; high 
enantioselectivities are achieved for both E- and Z- isomers when crotyltrimethoxysilane 
nucleophiles are utilized (see alcohol 120).  Crotylation with cis-crotylsiloxanes a 60% 
yield and 95% ee is observed in a 90:10 E:Z ratio, whereas a 95% yield and 94% ee was
obtained when trans-crotylsiloxanes are used (90:10 E:Z).
Professor Schaus has contributed a method, which allows for both allylation and 
crotylation of ketones. 46 , 47  Representative examples of allylation using allylboron 
nucleophiles to yield enantiomerically enriched homoallylic alcohols are illustrated in 
Scheme 27.
                                                
46 Lou, S.; Moquist, P. N.; Shaus, S. E. J. Am. Chem. Soc. 2006, 128, 12660–12661.
47 For previously reported asymmetric allylboration of aldehydes and ketones using similar catalyst 
structures please see: Wu, T. R.; Shen, L.; Chong, J. M. Org. Lett., 2004, 6, 2701-2704.
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O
C6H5 Me
1:3 toluene:PhCF3, -35
oC, 15 h
C6H5 Me
HO
74
83% yield,
94% ee
+ B
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C6H5
C6H5
OH
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Scheme 27. Catalytic Enantioselective Allylation of Aryl, Alkyl, Alkynyl and Alkenyl
Ketones with Allylboronates
124
Higher selectivities were achieved at lower temperatures (-35 oC). When 
trifluorotoluene is used as the solvent instead of toluene, enantioselectivities are higher, 
but it freezes at -29 oC requiring a mixture of solvents. In comparison to Shibasaki’s 
method, allylpinacol boronates afforded <2% conv when used as the nucleophile. 
Positive non-linear effects were observed; lower yields, however, were obtained linearly 
with catalyst ee. 
This method is also applicable to crotylation, but acetophenone is the only 
substrate represented (Scheme 28). The observed diastereoselectivity is consistent with 
the Zimmerman-Traxler transition state model. 48 Superior enantioselectivities and 
diastereoselectivities are observed compared to other catalytic enantioselective 
crotylation methods (72-75% yield, >98:2 dr and 97-98% ee).
                                                
48 (a) Zimmerman, H. E.; Traxler, M. D. J. Am. Chem. Soc. 1952, 79, 1920-1923. (b) Denmark, S. E.; 
Henke, B. R. J. Am. Chem. Soc. 1991, 113, 2177-2194. (c) Eliel, E. L. Angew. Chem., Int. Ed. Engl. 1965, 
14, 761-774.
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1 equiv
17
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127
O i-Pr
Oi-Pr
Me C6H5
HO Me
Me
O
C6H5 Me 1:3 toluene:PhCF3, -35
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129
75% yield, 99:1 dr,
97% ee
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1 equiv
17
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HO Me
Me
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Scheme 28. Catalytic Enantioselective Crotylation of Aryl Ketones with Allylcrotonates
OH
OH
Br
Br
15 mol %
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OH
OH
Br
Br
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XI. Conclusion for the Addition of Allyl Groups to Ketones
Enantiopure homoallylic alcohols are versatile building blocks for a variety of 
natural products.3 Despite progress in the discovery of methods for catalytic 
enantioselective allylations and crotylation of ketones, many challenges still remain.  
Most protocols require the use of toxic allylstannanes, often in superstoichiometric 
quantities.  Frequently, utilization of other less reactive allyl-species (allylsilanes or 
allylboronates) are poor nucleophiles for allylation of ketones.  To the best of our 
knowledge, catalytic enantioselective crotylation, is, to date, limited to the three 
aforementioned methods.
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Chapter 2 
Development of a Catalytic Enantioselective Method for the Addition of Et2Zn to 
Pyridyl-Ynones Using Easily Modifiable Salicyl-Based Amino Acid Ligands. 
I. Project prospective 
 Chiral amino acid-based ligands, developed in these laboratories, have been used 
in conjunction with early and late transition metals in a variety of enantioselective 
carbon-carbon bond forming reactions. 1   Pertinent to the current investigations are 
reports of enantioselective additions of dialkylzinc reagents to imines and carbonyls.2  
Zr-catalyzed enantioselective additions of dialkylzinc reagents to aldimines with amino 
acid-based chiral ligands afford secondary carbinimines in good yields (58->98%) and 
high selectivities (80->98% ee, Scheme 1).2a  In a more recent project, investigations have 
focused on alkylation of ketoimines to yield enantiomerically enriched N-substituted 
quarternary stereogenic centers in excellent selectivities and yields (i.e. 95% ee and 89% 
yield, as shown in Scheme 2). 2c  Moreover, Al-catalyzed enantioselective Me2Zn and 
Et2Zn additions to activated ketones (α-ketoesters) have been reported.2b  Representative 
products are illustrated in Scheme 3 and a more critical analysis of this method was 
discussed in Chapter 1. 
                                                 
1 For representative examples, see: (a) Deng, H; Isler, M.; Snapper, M. L.; Hoveyda, A. H.  Angew. 
Chem., Int. Ed. 2002, 41, 1009-1012. (b) Krueger, C. A.; Kuntz, K. W.; Dzierba, C. D.;  Wirschun, W. 
G.; Gleason, J. D.; Snapper, M. L.; Hoveyda, A. H.  J. Am. Chem. Soc. 1999, 121, 4282-4285. (c) 
Porter, J. R.; Kuntz, K. W.; Wirchun, W.; Snapper, M. L. Hoveyda, A. H. J. Am. Chem.  Soc. 2000, 
122, 2657-2658. (d) Josephsohn, N. S.; Kuntz, D. W.; Snapper, M. L.; Hoveyda, A. H.  J. Am. Chem.  
Soc. 2001, 123, 11594-11599.  
2 (a) Akullian, L. C.; Porter, J. R.; Traverse, J. F.; Snapper, M. L.; Hoveyda, A. H. Adv. Synth. Catal. 
2005, 347, 417-425. (b) Wieland, L. C.; Deng, H.; Snapper, M. L.; Hoveyda, A. H. J. Am. Chem.  Soc. 
2005, 127, 15453-15456. (c) Fu, P.; Snapper, M. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2008, accepted 
for publication. 
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5-20 mol %
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Scheme 1. Catalytic Enantioselective Additions of Dialkylzinc Reagents to Imines
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Scheme 2. Catalytic Enantioselective Additions of Me2Zn Reagent to α-Ketoiminoesters
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Me OTrt
MeO
OH
Me15 mol %
15 mol % Al(Oi-Pr)3, 3 equiv Et2Zn
50 mol % H2NP(O)(OEt)3 (9)
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20 min, 88% yield, 44% ee
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24 h, 97% conv., 30% ee
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O
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Scheme 3. Aluminum Catalyzed Enantioselective Addition of Et2Zn and Me2Zn to α-Ketoesters
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W ithout 9: 95% yield , 75% ee
W ith 9: 98% y ield, 83% ee
 
Our goal was to further utilize these easily modifiable amino acid-based ligands 
to afford biologically important tertiary alcohol products in high enantiomeric excess that 
would be difficult to access through other means.  Our focus was to develop a method for 
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catalytic enantioselective alkylation of pyridyl-ynones with dialkylzinc reagents to afford 
pyridyl-propargyl substituted tertiary alcohols.  Pyridyl-propargyl alcohols have been 
illustrated to have important biological activity. Some targets of pharmacological interest 
are shown in Figure 1.3
N
Me
Ph
OH
∗
N
O
OCHF2
F2HCO
I
PDE4 inhibitor
PDE: phosphodiesterase
N
OHPh
N
MeO
II
possible pharmacological ant i-muscar inic
overacti ve bladder therapy
Figure 1. Molecules of Pharmacalogical Interest
Containing Pyridyl Tertiary Alcohols
                                                
 
To the best of our knowledge, there are no existing methods to afford pyridyl-
propargyl tertiary alcohols resulting from asymmetric alkylation of ynones. 4 , 5  The 
 
3 For pyridyl-substituted tertiary propargyl alcohols that exhibit biological activity, see: Starck, J-P.; 
Talaga, P.; Quéré, L.; Collart, P.; Christophe, B.; Lo Brutto, P.; Jadot, S.; Chimmanada, D.; Zanda, M.; 
Wagner, A.; Mioskowski, C.; Massingham, R.; Guyaux, M. Bioorg. Med. Chem. 2006, 16, 373–377. 
4 For catalytic enantioselective additionss of C-based nucleophiles to ynones, see: (a) Deng, H.; Isler, 
M. P.; Snapper, M. L.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2001, 41, 1009–1012. (b) Christensen, 
C.; Juhl, K.; Hazell, R. G.; Jørgensen, K. A. J. Org. Chem. 2002, 67, 4875–4881. (c) Funabashi, K.; 
Jachmann, M.; Kanai, M.; Shibasaki, M. Angew. Chem., Int. Ed. 2003, 42, 5489–5492. (d) Tian, S-K.; 
Deng, L. J. Am. Chem. Soc. 2003, 125, 9900–9901. 
5 For catalytic enantioselective additions of alkynyl metals to ketones, see: (a) Cozzi, P. G. Angew. 
Chem., Int. Ed. 2003, 42, 2895–2898. (b) Saito, B.; Katsuki, T. Synlett. 2004, 1557–1560. (c) Zhou, Y.; 
Wang, R.; Xu, Z.; Yan, W.; Liu, L.; Kang, Y.; Han, Z. Org. Lett. 2004, 6, 4147–4149. (d) Liu, L.; 
Wang, R.; Kang, Y-F.; Chen, C.; Xu, Z-Q.; Zhou, Y-F.; Ni, M.; Cai, H-Q.; Gong, M-Z. J. Org. Chem. 
2005, 70, 1084–1086. 
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acetylene moiety of the resultant enantiomerically enriched propargylic alcohol can be 
manipulated into a assortment of useful functional groups through a variety of chemical 
transformations: hydrogenations to form (cis and trans) allylic alcohols, exhausted 
reduction to afford alkyl alcohols, 6  Cu-catalyzed cyclizations to afford bicyclic 
heterocyclic structures7 and conjugate additions with low order cuprates to afford tetra-
substituted chiral allenes.8
 
II. Initial Studies 
N
C6H5
O
N
N
O
OMe
Me
1.2 equiv n-BuLi
1.2 equiv phenylacetylene
THF, -78 oC, 1 h
15
73% y ield
16a
64% yield
N
OH
O 1.2 equiv EDC,
0.2 equiv DMAP
1.1 equiv (Me)H2N(OMe)Cl
3.0 equiv Et3N, CH2Cl2,
22 oC, 6 h
Scheme 4. Synthesis of Ynones
14
 
 We set out to examine pyridyl-ynones as substrates for catalytic 
enantioselective alkylations with dialkylzinc reagents. In most cases, substrate 
synthesis was two steps beginning with commercially available picolinic acid (14).  
As shown in Scheme 4, picolinic acid was converted to Weinreb amide 15,9 followed 
by alkylation with lithiated-phenylacetylene or the appropriate nucleophile to afford 
                                                 
6 Corey, E. J.; Katzellenbogen, J. A.; Posner, G. H. J. Am. Chem. Soc. 1967, 89, 4245–4247. 
7 Yan, B.; Zhou, Y.; Zhang, H.; Chen, J.; Liu, Y. J. Org. Chem. 2007, 71, 7783-7786. 
8 (a) Jansen, A.; Krause, N. Synthesis 2002, 1987–1992. (b) Jansen, A.; Krause, N. Inorg. Chim. Acta 
2006, 359, 1761–1766. 
9 Nahm, S.; Weinreb, S. M. Tetrahedron Lett. 1981, 22, 3815. 
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pyridyl-ynone products such as 16a.10  In cases where functionality was contained on 
the pyridyl ring, a slightly longer synthesis was required (see Scheme 5).11  Treatment 
of N-oxide 17 with TMSCN, undergoes a Reissert reaction to form o-nitrile 18. 
Hydrolysis of the cyano-group on 18, under acidic conditions, affords the appropriate 
carboxylic acid.12  Amide bond coupling to form Weinreb amide 19 was performed,9 
which was followed by alkylation to provide pyridyl-ynones, such as 20. 
Scheme 5. Synthesis of Substrates Containing Functionalization on the Pyridine Ring
N
Ph
O
N
O
OMe
N
OMe
CN N
OMe
N
O
OMe
Me
1.3 equiv TMSCN
1.3 equiv Me2NC(O)Cl
CH2Cl2, 22 oC, 24 h
1) 6 N HCl, 100 oC, 24 h
2) 1.2 equiv EDC,
0.2 equiv DMAP
1.1 equiv (Me)H2N(OMe)Cl
3.0 equiv Et3N, CH2Cl2,
22 oC, 6 h
1.2 equiv n-BuLi
1.2 equiv phenyl acetylene
THF, -78 oC, 1 h
OMe
19
43% yield
(over 2 steps)
18
50% yield
20
64% yield
17
 
We began investigations for the asymmetric additions of dialkylzinc reagents 
with pyridyl-ynone 16a.  Initial studies were conducted with conditions developed for 
alkylation of α-ketoesters and imines.2  Gratifyingly, the use of conditions developed 
for the alkylation of α-ketoesters (ligand 8) result in conversion of 16a to tertiary 
alcohol 21a in >98% conv. and 75% ee (Scheme 6). However, <2% conv. was 
                                                 
10 Nielson, T. E.; Cubillo de Dios, M. A.; Tanner, D. J. Org. Chem.  2002, 67, 7309-7313. 
11 Ketone E3 (see experimentals) was prepared from the commercially available carboxylic acid (via 
the derived Weinreb amide and subsequent alkylation with the alkynyl lithium). 
12 The Reissert-Henze cyanation of pyridine oxides in Scheme 2 is based on the following reported 
procedure: Fife, W. J. Org. Chem. 1983, 48, 1375–1377. 
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observed for Me2Zn addition under the same reaction conditions (see Chapter 3 for 
optimization of Me2Zn to pyridyl-ynones).  
N
H
N
O t-Bu
O
NHn-Bu
O
Me OTrt
MeO
OH
Me
O HO R
15 mol % Al(Oi -Pr)3
3 equiv R2Zn
50 mol % H2NP( O)( OEt)2 ( 9)
toluene, -78 oC, 20 min
N
Ph
N
Ph
15 mol %
21a R = Et: >98% conv,
75 % ee
22a R = Me: <2% conv
Scheme 6. Preliminary Screening Data for Diethy- and Dimethyzinc Additions to Pyridyl-
Ynones
16a
8
 
 A series of reactions were conducted to investigate reactivity in the absences 
of various catalytic components.  Results confirm that treatment of 16a with Et2Zn at 
-78 oC leads to >98% conv to only 21a in just 20 min (see Scheme 7, eq 1).   Data in 
equations 2, and 3 show that when reactions were performed in the presence of Lewis 
basic additive 9, racemic secondary alcohol 23a was formed (42% conv to 23a).  The 
experiment illustrated in equation 4 demonstrates >98% conv but only 32% ee in the 
absence of Lewis basic additive 9; thus, additive 9 is beneficial to the catalytic 
reaction when chiral ligand 8 is used (Scheme 7, eq 5).  Enantioselectivity can be 
improved from 32% ee to 79% ee, in the company of  9.  
Further screening of reaction conditions were conducted, which included 
modification of temperature, time, amount of additive and nucleophile and catalyst 
loadings. These modifications lead to optimized reactions conditions of  5 mol % 
catalyst loading,  50 mol % 9,  3 equiv of Et2Zn, and optimal  reaction temperature of 
-78 oC for 20 min, which affords alcohol 21a in >98% conv and 79% ee.   At this 
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point it was evident that screening strategies would be needed to improve selectivities 
for the formation of enantiomerically enriched alkynyl-pyridyl tertiary alcohols. 
Scheme 7. Condition Screening of Uncatalyzed Reactions for the Addition of Et2Zn to 16a
N
Ph
O
N
Ph
OH
3 equiv Et2Zn
toluene, -78 oC, 20 min
N
Ph
EtHO
16a 21a
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rac-23a
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N
Ph
O
N
Ph
OH
50 mol % 9
3 equiv Et2Zn
toluene, -78 oC, 20 min
N
Ph
EtHO
16a 21a rac-23a
N
38% conv 42% conv
Ph
O
N
Ph
OH
10 mol % Al(Oi -Pr)3, 50 mol % 9
3 equiv Et2Zn
toluene, -78 oC, 20 min
N
Ph
EtHO
16a -2
N
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10 mol % 8
10 mol % Al(Oi -Pr)3
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Ph
O
N
Ph
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<2% conv>98% conv,
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O
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N
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16a 21a rac-23a
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III. Ligand Screening Strategies:  N-Terminus 
X
N
H
N
O
AA1 O
C-Terminus
AA2
N-Terminus
Figure 2. Modular Peptide Ligand Structure  
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Ligand screening for the addition of Et2Zn to 16a was carried out with 5 
mol % ligand, 5 mol% Al(Oi-Pr)3, 50 mol % 9 in toluene at -78 oC for 20 min for the 
alkylation of 16a to form 21a.  The moieties of the ligand that were modified to 
achieve the optimal catalytic system are highlighted in Figure 2.  Starting with ligand 
8, which was developed in these laboratories for the Al-catalyzed enantioselective 
addition of Me2Zn and Et2Zn to α-ketoesters,2b  21a was afforded in >98% conv and 
75% ee.  Due to the cost of the threonine-based ligand (8),13  initial screening was 
pursued with a ligand containing L-valine-L-phenylalanine as AA1 and AA2 
respectively. 14  The L-valine-L-phenyl ligand afforded 21a in 98% conv and 59% ee 
(Chart 1).  Both antipodes valine and phenylalanine amino acids are very common, 
cost efficient and are representative in size for a range of amino acids. 
Screening began with extensive electronic an steric modification of the aryl N-
terminus of the ligand (See Chart 1).  Ligands were synthesized in solution using 
previously developed modification strategies.15  Since the Schiff base portion of the 
ligand is responsible for the binding of the Al-salt and therefore, making a chiral 
Lewis acid, the electronics of this moiety were expected to play a significant role in 
the reactivity and selectivity of the catalytic system. 
                                                 
13  Fmoc-L-Thr(Ot-Bu)-OH: $9/g [$3,577/mol] and Fmoc-L-Thr(OTrt)-OH: $20/g [$11,674/mol], 
purchased from NovaBiochem April 2008. 
14 Boc-L-Val: $3/g [$651/mol], Boc-L-Phe: $2/g [$530/mol], purchased from Advanced Chemtech 
April 2008. 
15 (a) Cole, B. M.; Shimizu, K. D.; Krueger, C. A.; Harrity, J. P. A.; Snapper, M. L.; Hoveyda, A. H. 
Angew. Chem., Int. Ed. 1996, 35, 1668–1671. (b) Krueger, C. A.; Kuntz, K. W.; Dzierba, C. D.; 
Gleason, J. D.; Snapper, M. L.; Hoveyda, A. H. J. Am. Chem. Soc. 1999, 121, 4284–4285. (c) Degrado, 
S. J.; Mizutani, H.; Hoveyda, A. H. J. Am. Chem. Soc. 2001, 123, 755–756. (d) Porter, J. R.; Traverse, 
J. F.; Hoveyda, A. H.; Snapper, M. L. J. Am. Chem. Soc. 2001, 123, 984–985. (e) Luchaco-Cullis, C. 
A.; Mizutani, H.; Murphy, K. E.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2001, 40, 1456–1460. (e) 
Josephsohn, N. S.; Snapper, M. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2004, 126, 3734–3735. (f) Wu, 
J.; Mampreian, D. M.; Hoveyda, A. H. J. Am. Chem. Soc. 2005, 127, 4584–4585. 
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By screening the Schiff base terminus it was determined that the unsubstituted 
salicyl moiety as the N-terminus was optimal affording 21a in >98% conv and 59% 
ee (Chart 1). Conversions were high for most ligands investigated (44->98%); 
enantioselectivities, however, were low with the exception of the unsubstituted salicyl 
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(59% ee), 5-OH (33% ee), 3-Me (53% ee), 3,5-t-Bu (50% ee), and 4-OH (47% ee) 
where moderate enantioselectivities are observed. The listed results could indicate 
that an electron rich Schiff base is important; further screening, however, was 
conducted with the unsubstituted salicyl Schiff base. 
 
 
IV. Ligand Screening Strategies:  AA1 
Chg
Phe
Thr(Bn)
Ser(Bn)
Tyr(Bn)
Val
Val
>98
>98
>98
>98
>98
>98
>98
>98
AA1 conv
(%)b
N
AA1
O
H
N
Ph
O
NHn-Bu
OH
Trp
29
<10
<10
18
21
-30
19
59
ee
(%)d
N
AA1
O
H
N
Ph
O
NHn-Bu
OH
MeO
L2
L2
L2
L2
L2
L2
7
4
6
3
5
2
1
entry
8
Phg
Leu
Tle
Ala
Ile >98
>98
87
>98
87
26
-44
<10
<10
10
L2
L2
13
10
12
9
11
L2
L1
L1
L1
L1
21a:23ac
1.1:1
1:1
1:1.1
1:1
1:1.1
1:1
1:0
1:0
1:0
1.1:1
1.3:1
1:1
1.3:1
L2
a All reactions perfomed under a N2 atmosphere. bConversions
determined by 400 MHz 1H NMR analysis. c Ratios determined by analysis
of 400 MHz 1H NMR spectra. d Enantioselectivities determined by chiral
HPLC analysis.
5 mol %
5 mol % Al(Oi -Pr)3
3 equiv Et2Zn
50 mol % 9, toluene
-78 oC, 20 min
N
ligandO OHHO Et
N
Ph
N
PhPh
16a 21a rac-23a
L1
+
Table 1. AA1 Screening Data for Et2Zn Addition to 16aa
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Since N-terminus modifications yielded no significant improvement in the 
catalytic system, subsequent investigations of AA1 were carried out (See Table 1).  
From this data, it was determined that L-valine as AA1 was optimal, affording 
product 21a in 59% ee with <2% rac-23a formed (see Table 1, entry 1).  Screening 
results indicated that any amino acid except Val or Ile at the AA1 position resulted in 
a 1:1 mixture of 21a:23a.16  It is unclear why reduction of ynone 16a was increased 
by modification of the AA1 of the ligand structure.  
 
V. Ligand Screening Strategies:  AA2 and Site Selective Screening 
L-PheL-Val
L-Phe
L-Val
>98
>98
>98
>98
AA1 conv. (%)b
59
-70
<2
<2
ee (%)c
D-Val >98 664
3
5
2
1
entry
a All reactions perfomed under an N2 atmosphere. b Conversions
determined by 400 MHz 1H NMR analysis. cEnantioselectivities determined
by chiral HPLC analysis. d Ligand resulted in a 1:1 mixture of 21a:23a
-
-
D-Phe
L-Phe
L-Val
>98 9
L-Val >98 -156
7 L-Phe
Gly
Gly
L3c
L3e
L3b
L3a
L3d
L3gd
L3f
AA2
N
AA1
O
H
N
O
NHn-Bu
AA2
OH L3
Table 2. Site Selective Positional Ligand Screening for Et2Zn Addition to 16aa
5 mol %
5 mol % Al(Oi -Pr)3
3 equiv Et2Zn
50 mol % 9, toluene
-78 oC, 20 min
N
ligandO OHHO Et
N
Ph
N
PhPh
16a 21a rac-23a
+
                                                
 
Modification of the ligand structure was continued to further improve 
selectivity and reactivity for the addition of Et2Zn to ynone 16a.  Ligands that tested 
 
16 Secondary alcohol 23a was always racemic. 
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the need for chirality, as well as the sense  of chirality (diastereomers), at both the 
AA1 and AA2 positions were prepared, along with mono-amino acid ligands.  
Peptide ligands with Gly at AA1 or AA2  (Table 2 entries, 6 and 7) indicate that 
chirality at both amino acid sites is important for selectivity (<20% ee observed).  
This was further verified when mono amino acid ligands showed that both 
sites (AA1 and AA2) were required to achieve any selectivity (Table 2, entries 1 and 
2, <2% ee)  It was determined that ligand L3e, which bears D-Phe at the AA2 position, 
afforded 21a in higher enantioselectivity, albeit of the opposite enantiomer, ((S)-
enantiomer of 21a in 70% ee), than ligand L3c, bearing two L-amino acids ((R)-
enantiomer of 21a in 59% ee).  The sense of stereochemistry of the product is 
determined by the stereochemistry of AA2 (see Table 2, entries 3-5). 
 
VI. Ligand Screening Strategies:  C-Terminus 
Having identified the N-terminus of the ligand, and having learned more about 
the requirements for AA1 and AA2, modification of the C-terminus was conducted 
with both L-L and L-D ligands.  Experiments revealed ligand L4a as an optimal ligand 
for the addition of Et2Zn to 16a, providing tertiary alcohol 21a in >98% conv, 80% 
isolated yield and >98 % ee, (see Table 3, entry 1). 
  The screening illustrated in Table 3, indicated that aniline derived C-termini 
provided tertiary alcohol 21a with higher selectivities than alkyl derived C-termini 
(98% ee vs. 60% ee respectively, entries 1 and 7).  This could be due to the increased 
acidity of the amide proton or an interaction between the π-system of the C-terminus 
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and the π-system of the substrate. Further explanation about the ligand structure and 
mechanistic details are discussed in Chapter 2, section 10.  
N
O
H
N
Ph
O
NR'R''
OH
MeMe
L4
N
O
H
N
Ph
O
NR'R''
OH
MeMe
L5
conv
(%)b
ee
(%)c
entry
a All reactions perfomed under an N2 atmosphere. bConversions determined by 400
MHz 1H NMR analysis. c Enantioselectivities determined by chiral HPLC analysis. d
Ratios determined by 1H NMR analysis.
21a:23ad
T able 3. C-Terminus Screening for Et2Zn Addition to 16aa
NR'R"
5 mol %
5 mol % Al(Oi -Pr)3
3 equiv Et2Zn
50 mol % 9, toluene
-78 oC, 20 min
N
ligandO OHHO Et
N
Ph
N
PhPh
16a 21a rac-23a
+
1
2
3
4
5
6
7
8
NH(p-CF3)C6H4
NH(p-CF3)C6H4
NHC6H5
NHC6H5
NH(p-OMe)C6H4
NH(p-OMe)C6H4
NHn-Bu
NHn-Bu
L4a
L5a
L4b
L5b
L4c
L5c
L4d
L5d
>98
77
>98
85
>98
>98
>98
>98
>98
-70
>98
-55
97
-54
60
-50
1:0
7.7:1
1:0
2.4:1
1:0
5.1:1
1:0
1:0
L
D
L
L
 
 
VII. Examination of Substrate Scope 
Having identified the optimal catalytic system for the asymmetric addition of 
Et2Zn to ynone 16a to provide the tertiary alcohol product 21a in >98% conv, 80% 
isolated yield with >98% ee, we began to investigate various pyridyl-ynones (see 
Table 4).  
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O
entry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
N
R
HO
N
R
Et
16 21
R
C6H5
o-MeC6H4
o-MeC6H4
m-MeC6H4
p-MeC6H4
p-OMeC6H4
p-CF3C6H4
p-CF3C6H4
p-IC6H4
p,m-Cl2C6H3
o-BrC6H4
o-BrC6H4
3-thiophene
n-hex
Cy
(i-Pr)3Si
conv
(%)b
yield
(%)c
ee
(%)d
>98
>98
>98
>98
>98
>98
>98
>98
>98
>98
>98
>98
>98
>98
>98
>98
80
68
65
62
74
67
80
83
72
84
51
87
77
73
74
84
>98
89
>98
>98
>98
>98
>98
>98
>98
>98
92
>98
>98
98
>98
>98
>98
>98
>98
>98
>98
>98
>98
>98
>98
>98
>98
>98
>98
79
72
>98
61
64
65
70
68
64
80
83
58
54
46
46
56
63
67
74
95
82
89
95
92
96
81
93
80
81
77
84
93
75
78
85
conv
(%)b
yield
(%)c
ee
(%)d
with 50 mol % 9without 50 mol % 9
a
b
b
c
d
e
f
f
g
h
i
i
j
k
l
m
T able 4. Al-Catalyzed AA Reactions with Et2Zna
mol %
5
5
10
10
10
10
5
10
10
10
5
10
10
10
10
10
N
H
N
N
HO Bn
Oi-Pr
OH
CF3
L4a
5–10 mol %
5–10 mol % 3 equiv Et2Zn
50 mol % H2NP(O)(OEt)2 (9)
toluene, –78 °C, 20 min
Al(Oi-Pr)3,
HO Et
N
Ph
24
>98% ee, 7 4% y ield
93% ee, 68% y ield
N
Ph
EtHO
Br
25
>98% ee, 88% yield
60% ee, 72% yield
N
HO Et
Ph
OMe
26
>98% ee, 78% yield
-50 oC, 5 equiv of Et2Zn
a All reactions performed under N2 atmosphere. b Determined through analysis of 400 MHz 1H
NMR spectra. c Yields of products after purification. d Enantioselectivities were determined by
chiral HPLC analysis.
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  Most alkylations require 10 mol % L4a and Al(Oi-Pr)3, but reduced catalyst 
loadings can be used for the certain substrates (Table 4, entries 1, 7, 11).  An advantage 
of using higher catalyst loading is that the undesired secondary alcohol (23) is not 
observed.  For example, Table 4 entry 13, when 5 mol % catalyst loading is used, rac-
23j is observed (~20%). 
Ynones bearing electron deficient (Table 4 entries 7-12), electron rich (Table 4 
entry 6), heteroaromatic (Table 4 entry 13), alkyl (Table 4 entries 14-15) and sterically 
hindered substituents  (Table 4 entries 2-3) on the alkyne are tolerated, affording the 
pyridyl-propargylic alcohols in 98 to >98% ee.  Substrates with functionalization on the 
pyridine ring are also efficient, affording the propargylic alcohols in >98% ee, (see 
products 24, 25, and 26). 
 
VIII. Lewis Basic Additives 
It was evident from substrate screening that the Lewis basic additive played a 
significant role in chemoselectivity and enantioselectivity; the slower reacting alkyl-
substituted ynones produced more secondary alcohol in the absence of the additive 9.  
Screening various Lewis basic additives showed that commercially available 9 was 
the most selective for the formation of 21k (Table 5).  This additive screen indicates 
that hard Lewis bases (i.e. RO-, Table 5, entries 1, 2 and 5) improved the 
enantioselectivity and efficiency better then soft Lewis basic additives (i.e. NR3, 
dative type, Table 5, entries 3 and 4).  
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>98
conv. (%)b
98
ee (%)c
77 852
1
entry
a All reactions perfomed under an N2 atmosphere. bConversions
determined by 400 MHz 1H NMR analysis. c Enantioselectivities determined
by chiral HPLC analysis.
addItIve
>98 253
>98 73
85 304
5 NMO
P(O)Ph3
H2NP(O)(OEt)2 (9)
Me2NP(O)(OEt)2
N
C6H13
O 10 mol % L4a
10 mol % Al(Oi -Pr)3, 3 equiv Et2Zn
50 mol % Lew is Basic Addit ive,
toluene, -78 oC, 20 min
N
C6H13
EtHO
16k 21k
T able 5. Lewis Base Screen for Et2Zn Addition to 16ka
H2NP(O)(Oi-Pr)2
 
  The amount of additive was also investigated; indicating that 50 mol% 9 was 
most advantageous (Table 6, entry 5).  Results were improved for most substrates 
when 9 was used; additive 9, however, was not required to achieve moderate to high 
enantioselectivity, see (Table 4, entries 1, 4, 5, 6, 8 and 13). For example, 21a is 
formed in 95% ee in the absence of 9 (Table 6, entry 1). 
entry ee
(%)c
9
mol %
yield
(%)b
1
2
95
95
61
78
3
4
95
97
65
74
5
6
>98
>98
74
83
0
5
10
25
50
75
7 9574100
a All reactions perfomed under a N2 atmosphere.
b Yields of isolated products. c Enantioselectivities
determined by chiral HPLC analysis.
T able 6. Screening for the Amount of Lewis Basic Additive 9 Needed for Et2Zn
Addition to 16aa
N
Ph
O 5 mol % L4a
5 mol % Al(O i-Pr)3, 3 equiv Et2Zn
50 mol % 9, toluene, -78 oC, 20 min
N
Ph
EtHO
16a 21a
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As Scheme 8 illustrates, the reaction can be preformed on the benchtop; some 
precautions, however, must be utilized. Al(Os-Bu)3 was used because Al(Oi-Pr)3 is 
not air or moisture stable.17  Identical results are achieved, when reactions are run on 
the benchtop in comparison to those performed under anhydrous and oxygen free 
conditions (Scheme 8).   
N
Ph
O 10 mol % L4a
10 mol % Al(X)3
3 equiv Et2Zn, 50 mol % 9
toluene, -78 oC, 20 min16a
N
HO
Ph
Et
21a
Scheme 8. Comparison of Al(Oi-Pr)3 and Al(Os-Bu)3: Benchtop Reaction for Et2Zn
Addition to 16a
74% yield, >98% ee
73% yield, >98% ee
N
Al( Oi-Pr) 3:
Al( Os-Bu)3:
Glovebox T echniques: Comparison of Al(O i-Pr)3 and Al(Os-OBu)3
O
Ph
10 mol % L4a
10 mol % Al(Os-Bu)3
3 equiv Et2Zn, 50 mol % 9
toluene, -78 oC, 20 min16a
N
HO Et
Ph
21a
72% yield, 98% ee
Benchtop React ion Using Al(Os-Bu)3
 
N
TIPS
O 10 mol % L4a
10 mol % Al(Os-Bu)3
3 equiv Et2Zn, 50 mol % 9
toluene, -78 oC, 20 min
N
TIPS
EtHO
3
entry ee
(%)d, e
conv.
(%)b
yield
(%)c
ligand
recovery
(%)
>98 9371
1
2
>98 9298
>98 9294
58
42
92
cycle
number
4 >98 9387 92
I
II
III
IV
aAll reactions perfomed using bench-top techniques.
b Conversions determined by 400 MHz 1H NMR analysis.
cYields of isolated products. d Enantioselectivity determined by
chiral HPLC analysis. e In order to determine enantioselectivity
the TIPS group was removed,
T able 7. Ligand Recovery and Recyclea
16m 21m
 
                                                 
17  (a) Shiner Jr., V. J.; Wittaker, D.; Fernandez, V. P.  J. Am. Chem Soc. 1963, 85, 2318-2322. (b) 
Shiner Jr., V. J.; Wittaker, D. J. Am. Chem Soc. 1963, 85, 2337-2338. 
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Chiral ligand L4a can be recovered and reused without loss of selectivity as 
demonstrated in Table 7.  Chiral ligand L4a, can be recovered by two means: When 
recovered by silicia gel chromatography (Table 7, entries 1-2) lower recoveries are 
observed due to limited solubility of  L4a in a variety of solvents (42-58% recovery). 
Ligand L4a can also be recovered by trituration and filtration to isolate the ligand in  
70-83%  yield (see Table 7, 3-4).  
 
IX.  Mechanistic Consideration 
10 mol % L4a
10 mol % Al(Oi -Pr)3
3 equiv. Et2Zn, 50 mol % 9
toluene, -78 oC, 20 minPh
O
Ph
EtHO
O O
30
<2% conv
10 mol % L4a
10 mol % Al(O i-Pr)3
3 equiv. Et2Zn, 50 mol % 9
toluene, -78 oC, 20 min
Ph
O
Ph
EtHO
28
<2% conv
29
27
Scheme 9. Probing the Need for Bidentate Chelation of the Ynone Substrates for
Et2Zn Addition
 
The nitrogen of the pyridine ring is necessary for asymmetric alkylation to 
proceed (Scheme 10). Aryl-ynone 27 and 2-furyl-ynone 29 do not undergo 
asymmetric alkylations when the optimized reaction conditions are used. These 
observations emphasize the importance of the bidentate chelation, involving a Lewis 
acidic metal, the Lewis basic carbonyl and the N-atom of the pyridine. 
Al-catalyzed enantioselective additions of Et2Zn with ligands that bear L-
valine and L-phenylalanine (L5d, Table 3) can be explained by complexes I and/or II, 
illustrated in Scheme 10.  The Lewis basic amide at the C-terminus of the chiral 
ligand chelates with Et2Zn and enhances its nucleophilicity, leading to directed 
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addition to the substrate (which is activated by a bidentate chelation).18  It is unclear 
whether it is the cationic complex I or the neutral complex II that promotes the 
reaction.  In both cases (I and II), it is conceivable that the strongly Lewis basic 
phosphoramidate additive, replaces an i-propoxy ligand on Al, increasing the Lewis 
acidity19 of the Al center therefore making the chelated substrate more electrophilic.  
The competing mode of addition is also represented in I and II (dotted arrows in 
Scheme 10), where Et2Zn adds to the bound substrate without activation by the amide 
terminus. 
O
N
Al
O
N
Ph O
O N
Et2Zn
NH
Ph
P
N
EtO
EtO
H
H
O
Zn
O
N
Al
O
N
Ph O
O N
Et2Zn
NH
Ph
P
N
EtO
EtO
H
O
Zn
+ HOi -Pr
Ligand w ith two L5d : Directed Mode of Addition ( solid ar row) Competes w ith Non-directed
Addition (dashed arr ow)
I II
Scheme 10. Mechanistic Models for Al-Catalyzed AA Reactions with Et2Zn
i-PrO
                                                
 
In contrast to the reactions promoted by L,L-dipeptide ligands, catalytic 
enantioselective addition of Et2Zn in the presence of chiral ligands that bear an L-
valine and a D-phenylalanine (L4a) may proceed through complexes III and/or IV 
(Scheme 11). The previously favored (with L5d in I and II) diastereotopic face is 
now blocked by the substituent of the AA2 moiety, thus favoring the non-directed 
 
18 (a) Josephsohn, N. S.; Kuntz, K. W.; Snapper, M. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2001, 123, 
11594–11599. (b) Carswell, E. L.; Snapper, M. L.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2006, 45, 
7230–7233. 
19 For a discussion of Lewis base activation of Lewis acids, see: (a) Denmark, S. E.; Wynn, T. J. Am. 
Chem. Soc. 2001, 123, 6199–6200.  For recent applications of this concept towards development of 
new chiral catalysts and catalytic enantioselective protocols from these laboratories, see: (b) Ref 2b. (c) 
Zhao, Y.; Rodrigo, J.; Hoveyda, A. H.; Snapper, M. L. Nature, 2006, 443, 67–70. (d) Lee, Y.; 
Hoveyda, A. H. J. Am. Chem. Soc. 2006, 128, 15604–15605. 
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addition, which facilitates formation of the opposite enantiomer.  The proposed 
scenario is consistent with the absolute stereochemistry for Et2Zn addition product 
21g, determined by X-ray crystallography. 
O
N
Al
O
N
Ph O
O N
Et 2Zn
H
N
OP HN
ZnOEt
EtO
CF3
H
H
O
N
Al
O
N
Ph O
O N H
NEt2Zn
OP HN
ZnOEt
EtO
H
CF3
+ HOi-Pr
Ligand with an L and a D amino acid: Directed Mode of Addition Sterically Blocked, Non-directed
Addition (arrow) is Favor ed
III IV
i-PrO
Scheme 11. Mechanistic Models for Al-Catalyzed AA Reactions with Et2Zn
                                                
 
High level calculations20 suggest that a Zn bridge consisting of the Lewis 
basic phosphoramidate and the carbonyl of AA2 leads to a high degree of rigidity for 
complexes III and IV, resulting in the enhanced enantioselectivity observed for L,D-
dipeptide L4a versus L,L-ligand L5d.  The elevated enantioselectivity observed with 
ligands that contain arylamide C-termini (e.g., entries 1-6 of Table 3 vs. alkylamides 
entries 7-8) may be due to deprotonation of the more acidic amide proton, thus 
increasing the Lewis basicity of the amide carbonyl, which in turn helps to strengthen 
the proposed Zn bridge. 
Coordination of the phosphoramidate additive (9) at the apical position anti to 
the i-Pr substituent of the AA1 moiety (valine) is likely due to minimization of 
unfavorable steric interactions.  Phorphoramidate association determines the manner 
in which the pyridyl ynones bind to the Al-center, which establishes whether the 
chiral ligand can participate in directed alkylation (delivery of the dialkylzinc by the 
 
20 All structures were minimized using MMFF94 method as supplied by Spartan ’04, Wavefuncton, 
Inc. Irvine, CA, performed by Adil Zhugralin. 
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Lewis basic amide of AA2).  Assessment of molecular models indicates that with 
ligands bearing L-Val and D-Phe (see III-IV), the bridged Et2Zn cannot be directed 
for addition to the Al-bound pyridyl-ynone.  Furthermore, as illustrated below (V, 
Figure 3), similar Zn bridge complex with an L,L-ligand requires the participation of 
the higher energy amide bond and is therefore unlikely. 
high energy amide bond
Ligand with two L amino acids: Complexation Involving R2Zn is Disfavored
O
N
Al
O
N
Ph O
O N
P N
OEt
EtO
H
H
Ph
OZn
N
H
V
i-PrO
F igure 3. Mechanistic Models for Al-Catalyzed AA Reactions with Et2Zn  
The proposed function of the phosphoramidate additive, is to provide 
structural rigidity through Zn chelation in complexes III and IV.  This is supported 
by the data summarized in Table 5.  Use of Me2NP(O)(OEt)2 leads to complete 
conversion (entry 2 of Table 5), yet product 17k is obtained in only 25% ee (vs. 98% 
ee with H2NP(O)(OEt)2, entry 1).  This difference in enantioselectivity may be 
attributed to the absence of a Zn bridge due to the presence of the alkylated 
phosphoramide, resulting in a less structurally rigid complex leaving both faces of the 
bound substrate almost equally exposed for alkylation.  Di-i-propylphosphoramidate 
(entry 3) can participate in the formation of a Zn bridge, but less efficiently than 9 
(entry 1, Table 5) because of the larger alkoxy groups (i-PrO vs. MeO).  The low 
enantioselectivity observed when triphenylphosphine oxide is used (entry 4, Table 5) 
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is likely due to the absence of the Zn bridge, resulting in a less structurally rigid 
complex, leaving both faces of the bound substrate equally exposed for alkylation. 
Catalytic enantioselective reactions in entries 3 and 4 of Table 5 do not 
proceed to full conversion in spite of complete conversion with only Et2Zn 
(background reactions, see Scheme 7 eqs. 1, 2 and 3).  This difference in reactivity 
may advocate that the Lewis basic additive associates with the dialkylzinc reagent (in 
addition to the Al center), giving rise to a Et2Zn•phosphoramidate complex that is 
significantly more bulky, resulting in diminished rates of alkylation in spite of the 
enhanced alkylmetal nucleophilicity.  The involvement of a sterically demanding 
Et2Zn•phosphoramidate-9 complex would result in an increase in enantioselectivity 
when reactions proceed through complexes III or IV, where stereocontrol is based on 
steric blockage of one face of the ynone. The sterically demanding 
Et2Zn•phosphoramidate-9 complex may be unfavorable with L,L-ligands (reaction via 
I or II) as the binding of the additive is in competition with the carbonyl of the amide 
terminus. 
 
X. Conclusion 
We have developed an Al-catalyzed enantioselective method for the addition 
of Et2Zn to pyridyl-ynones.  Chiral ligands can be easily prepared in gram quantities 
and substrates are prepared in, at most, four steps.  The protocol outlined allows for 
the formation of quaternary carbon centers bearing three modular substituents: a 
pyridine, and alkyne and an alcohol. 
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XI. X-ray Crystallography and Absolute Stereochemistry 
Crystal Data for 21g: Stereochemistry Proof. 
 
 
Table 8.  Crystal data and structure refinement. 
Identification code  df04a 
Empirical formula  C16 H14 I N O 
Formula weight  363.18 
Temperature  193(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P 21 
Unit cell dimensions a = 7.2273(11) Å α= 90°. 
 b = 9.3866(14) Å β= 96.481(2)°. 
 c = 10.9730(16) Å γ = 90°. 
Volume 739.65(19) Å3 
Z 2 
Density (calculated) 1.631 Mg/m3 
Absorption coefficient 2.156 mm-1 
F(000) 356 
Crystal size 0.20 x 0.10 x 0.10 mm3 
Theta range for data collection 1.87 to 28.37°. 
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Index ranges -9<=h<=9, -10<=k<=12, -14<=l<=14 
Reflections collected 5594 
Independent reflections 3099 [R(int) = 0.0199] 
Completeness to theta = 28.37° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.8132 and 0.6723 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3099 / 1 / 174 
Goodness-of-fit on F2 1.063 
Final R indices [I>2sigma(I)] R1 = 0.0252, wR2 = 0.0581 
R indices (all data) R1 = 0.0269, wR2 = 0.0589 
Absolute structure parameter -0.002(18) 
Largest diff. peak and hole 1.057 and -0.208 e.Å-3 
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 Table 9.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters 
(Å2x 103).  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
I(1) 2359(1) 8792(1) 4929(1) 46(1) 
O(2) 11752(3) 10830(2) -218(2) 41(1) 
N(1) 9456(3) 7697(3) -1558(2) 33(1) 
C(1) 4551(3) 8843(4) 3833(2) 31(1) 
C(2) 5463(5) 10102(3) 3708(3) 36(1) 
C(3) 6888(5) 10170(4) 2962(3) 37(1) 
C(4) 7370(3) 8965(4) 2329(2) 30(1) 
C(5) 6451(4) 7684(3) 2481(3) 32(1) 
C(7) 8767(4) 9069(3) 1496(2) 31(1) 
C(8) 9850(4) 9210(3) 765(2) 32(1) 
C(9) 10003(3) 9042(3) -1428(2) 26(1) 
C(11) 8551(5) 7296(4) -2629(3) 41(1) 
C(12) 8155(5) 8226(4) -3597(3) 42(1) 
C(13) 8670(5) 9607(4) -3444(3) 39(1) 
C(16) 11120(4) 9409(3) -190(2) 30(1) 
C(17) 12812(4) 8429(4) 52(2) 40(1) 
C(19) 14244(4) 8634(6) -839(3) 52(1) 
C(30) 5040(4) 7624(4) 3236(3) 35(1) 
C(31) 9616(4) 10046(3) -2342(3) 34(1) 
________________________________________________________________________________ 
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 Table 10.   Bond lengths [Å] and angles [°]. 
_____________________________________________________  
I(1)-C(1)  2.095(2) 
O(2)-C(16)  1.412(3) 
O(2)-H(2A)  0.8400 
N(1)-C(9)  1.327(3) 
N(1)-C(11)  1.333(4) 
C(1)-C(2)  1.367(5) 
C(1)-C(30)  1.384(4) 
C(2)-C(3)  1.388(4) 
C(2)-H(2)  0.9500 
C(3)-C(4)  1.392(4) 
C(3)-H(3)  0.9500 
C(4)-C(5)  1.393(4) 
C(4)-C(7)  1.440(4) 
C(5)-C(30)  1.386(4) 
C(5)-H(5)  0.9500 
C(7)-C(8)  1.189(4) 
C(8)-C(16)  1.481(4) 
C(9)-C(31)  1.382(4) 
C(9)-C(16)  1.539(3) 
C(11)-C(12)  1.380(5) 
C(11)-H(11)  0.9500 
C(12)-C(13)  1.354(5) 
C(12)-H(12)  0.9500 
C(13)-C(31)  1.383(5) 
C(13)-H(13)  0.9500 
C(16)-C(17)  1.529(4) 
C(17)-C(19)  1.514(4) 
C(17)-H(17A)  0.9900 
C(17)-H(17B)  0.9900 
C(19)-H(19A)  0.9800 
C(19)-H(19B)  0.9800 
C(19)-H(19C)  0.9800 
C(30)-H(30)  0.9500 
C(31)-H(31)  0.9500 
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C(16)-O(2)-H(2A) 109.5 
C(9)-N(1)-C(11) 118.3(3) 
C(2)-C(1)-C(30) 121.0(2) 
C(2)-C(1)-I(1) 118.8(2) 
C(30)-C(1)-I(1) 120.1(2) 
C(1)-C(2)-C(3) 119.8(3) 
C(1)-C(2)-H(2) 120.1 
C(3)-C(2)-H(2) 120.1 
C(2)-C(3)-C(4) 120.1(3) 
C(2)-C(3)-H(3) 119.9 
C(4)-C(3)-H(3) 119.9 
C(3)-C(4)-C(5) 119.4(2) 
C(3)-C(4)-C(7) 119.7(3) 
C(5)-C(4)-C(7) 120.9(3) 
C(30)-C(5)-C(4) 120.0(3) 
C(30)-C(5)-H(5) 120.0 
C(4)-C(5)-H(5) 120.0 
C(8)-C(7)-C(4) 176.0(3) 
C(7)-C(8)-C(16) 177.1(3) 
N(1)-C(9)-C(31) 122.5(3) 
N(1)-C(9)-C(16) 115.4(2) 
C(31)-C(9)-C(16) 122.1(2) 
N(1)-C(11)-C(12) 122.6(3) 
N(1)-C(11)-H(11) 118.7 
C(12)-C(11)-H(11) 118.7 
C(13)-C(12)-C(11) 118.7(4) 
C(13)-C(12)-H(12) 120.7 
C(11)-C(12)-H(12) 120.7 
C(12)-C(13)-C(31) 119.7(3) 
C(12)-C(13)-H(13) 120.2 
C(31)-C(13)-H(13) 120.2 
O(2)-C(16)-C(8) 111.3(2) 
O(2)-C(16)-C(17) 108.5(2) 
C(8)-C(16)-C(17) 110.5(2) 
O(2)-C(16)-C(9) 109.3(2) 
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C(8)-C(16)-C(9) 106.9(2) 
C(17)-C(16)-C(9) 110.4(2) 
C(19)-C(17)-C(16) 113.8(3) 
C(19)-C(17)-H(17A) 108.8 
C(16)-C(17)-H(17A) 108.8 
C(19)-C(17)-H(17B) 108.8 
C(16)-C(17)-H(17B) 108.8 
H(17A)-C(17)-H(17B) 107.7 
C(17)-C(19)-H(19A) 109.5 
C(17)-C(19)-H(19B) 109.5 
H(19A)-C(19)-H(19B) 109.5 
C(17)-C(19)-H(19C) 109.5 
H(19A)-C(19)-H(19C) 109.5 
H(19B)-C(19)-H(19C) 109.5 
C(1)-C(30)-C(5) 119.5(3) 
C(1)-C(30)-H(30) 120.2 
C(5)-C(30)-H(30) 120.2 
C(9)-C(31)-C(13) 118.1(3) 
C(9)-C(31)-H(31) 120.9 
C(13)-C(31)-H(31) 120.9 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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 Table  11.   Anisotropic displacement parameters  (Å2x 103).  The anisotropic displacement 
factor exponent takes the form:  -2π2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
I(1) 46(1)  48(1) 47(1)  11(1) 27(1)  11(1) 
O(2) 46(1)  37(1) 44(1)  -11(1) 20(1)  -13(1) 
N(1) 38(1)  29(1) 30(1)  3(1) 0(1)  -1(1) 
C(1) 32(1)  37(1) 25(1)  6(2) 7(1)  6(2) 
C(2) 41(2)  34(2) 34(2)  -7(1) 10(1)  5(1) 
C(3) 38(2)  34(2) 40(2)  -2(1) 11(1)  -4(1) 
C(4) 28(1)  37(2) 23(1)  3(1) 4(1)  0(1) 
C(5) 35(2)  31(2) 33(2)  -3(1) 10(1)  4(1) 
C(7) 34(1)  30(2) 30(1)  -2(1) 6(1)  -1(1) 
C(8) 37(1)  31(2) 29(1)  -5(1) 6(1)  -4(1) 
C(9) 24(1)  29(2) 27(1)  1(1) 8(1)  3(1) 
C(11) 49(2)  36(2) 35(2)  -2(1) -1(1)  -4(2) 
C(12) 37(2)  57(2) 30(2)  1(1) -4(1)  2(2) 
C(13) 31(2)  51(2) 37(2)  14(2) 6(1)  7(2) 
C(16) 32(1)  31(1) 29(1)  -4(1) 9(1)  -5(1) 
C(17) 34(1)  51(3) 33(1)  -2(1) 0(1)  6(1) 
C(19) 35(1)  72(3) 50(2)  -5(2) 10(1)  13(2) 
C(30) 36(2)  34(2) 35(2)  5(1) 10(1)  -3(1) 
C(31) 33(2)  32(2) 37(2)  5(1) 9(1)  4(1) 
______________________________________________________________________________ 
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 Table 12.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 
3). 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(2A) 11205 11326 268 62 
H(2) 5123 10928 4131 43 
H(3) 7536 11040 2883 44 
H(5) 6792 6852 2068 39 
H(11) 8163 6332 -2729 49 
H(12) 7534 7903 -4356 50 
H(13) 8383 10271 -4091 47 
H(17A) 13414 8601 895 48 
H(17B) 12382 7427 7 48 
H(19A) 13656 8485 -1679 78 
H(19B) 15258 7947 -656 78 
H(19C) 14745 9604 -760 78 
H(30) 4412 6751 3343 41 
H(31) 9989 11010 -2217 40 
________________________________________________________________________________  
 
 Table 13.  Torsion angles [°]. 
________________________________________________________________  
C(30)-C(1)-C(2)-C(3) 0.8(5) 
I(1)-C(1)-C(2)-C(3) -178.4(2) 
C(1)-C(2)-C(3)-C(4) 0.9(5) 
C(2)-C(3)-C(4)-C(5) -2.0(5) 
C(2)-C(3)-C(4)-C(7) 176.0(3) 
C(3)-C(4)-C(5)-C(30) 1.5(5) 
C(7)-C(4)-C(5)-C(30) -176.5(3) 
C(3)-C(4)-C(7)-C(8) -64(4) 
C(5)-C(4)-C(7)-C(8) 114(4) 
C(4)-C(7)-C(8)-C(16) -22(9) 
C(11)-N(1)-C(9)-C(31) 2.2(4) 
C(11)-N(1)-C(9)-C(16) -177.2(3) 
C(9)-N(1)-C(11)-C(12) -0.4(5) 
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N(1)-C(11)-C(12)-C(13) -1.5(6) 
C(11)-C(12)-C(13)-C(31) 1.7(5) 
C(7)-C(8)-C(16)-O(2) 87(6) 
C(7)-C(8)-C(16)-C(17) -152(6) 
C(7)-C(8)-C(16)-C(9) -32(6) 
N(1)-C(9)-C(16)-O(2) 174.8(2) 
C(31)-C(9)-C(16)-O(2) -4.6(3) 
N(1)-C(9)-C(16)-C(8) -64.7(3) 
C(31)-C(9)-C(16)-C(8) 115.9(3) 
N(1)-C(9)-C(16)-C(17) 55.5(3) 
C(31)-C(9)-C(16)-C(17) -123.9(3) 
O(2)-C(16)-C(17)-C(19) -54.1(3) 
C(8)-C(16)-C(17)-C(19) -176.3(3) 
C(9)-C(16)-C(17)-C(19) 65.7(4) 
C(2)-C(1)-C(30)-C(5) -1.3(5) 
I(1)-C(1)-C(30)-C(5) 177.9(2) 
C(4)-C(5)-C(30)-C(1) 0.1(5) 
N(1)-C(9)-C(31)-C(13) -2.0(4) 
C(16)-C(9)-C(31)-C(13) 177.3(3) 
C(12)-C(13)-C(31)-C(9) 0.0(5) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
 Table 14.  Hydrogen bonds [Å and °]. 
____________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________  
 O(2)-H(2A)...N(1)#1 0.84 2.01 2.831(3) 165.6 
____________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 -x+2,y+1/2,-z       
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XII. Experimental 
GENERAL: Infrared (IR) spectra were recorded on a Perkin Elmer 781 
spectrophotometer, νmax in cm-1. Bands are characterized as broad (br), strong (s), 
medium (m) or weak (w). 1H NMR spectra were recorded on a Varian Unity INOVA 
400 (400 MHz) spectrometer. Chemical shifts are reported in ppm from 
tetramethylsilane with the solvent resonance resulting from incomplete deuteration as 
the internal standard (CDCl3: δ 7.26). Data are reported as follows: chemical shift, 
integration, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = broad, m 
= multiplet), coupling constants, and assignment. 13C NMR spectra are recorded on a 
Varian Unity INOVA 400 (100 MHz) with complete proton decoupling. Chemical 
shifts are reported in ppm from tetramethylsilane with the solvent resonance as the 
internal standard (CDCl3: δ 77.16). Enantiomeric ratios were determined by chiral 
HPLC analysis (Chiral Technologies Chiralpak OD column (0.46 cm x 25 cm), OJ 
(0.46 cm x 0.25cm), AS (0.46 cm x 25 cm) AD (0.46 cm x 25 cm) and OB-H (0.46 
cm x 25 cm) in comparison with authentic racemic materials. Elemental analyses 
were performed by Robertson Microlit Laboratories (Madison, New Jersey). High 
resolution mass spectrometry was performed at the Mass Spectrometry Facility at 
Boston College by Mr. Marek Domin (on a Micromass LCT ESI-MS (positive 
mode)) or at the University of Illinois Mass Spectrometry Laboratories (Urbana, 
Illinois). Optical rotation values were recorded on a Rudolph Research Analytical 
Autopol IV polarimeter. 
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MATERIALS: Unless otherwise stated, all reactions were conducted in oven- 
(135 °C) and flame-dried glassware under an inert atmosphere of nitrogen.  
Acetic anhydride: Purchased from Aldrich and used as received. 
Acetylenes: C6H5, o-Me-C6H4, m-Me-C6H4, p-Me-C6H4, p-OMe-C6H4, p-CF3-C6H4, 
o-Br-C6H4, Si(i-Pr)2, 3-thiophene, C6H13, cyclohexyl, (4-iodophenyl)ethynyl-
trimethylsilane and 3,5-Cl2-C6H3 were purchased from Aldrich and distilled from 
CaH2 under vacuum prior to use. 
Aluminum tri-iso-propoxide: Purchased from Strem and distilled (under vacuum, 
air-cooled condenser) immediately prior to use.21  
Aluminum tri-sec-butoxide: Purchased from Aldrich and used without purification. 
Benzoic acid: Purchased from Aldrich and used as received. 
Boc-protected amino acids: Purchased from Advanced ChemTech or NovaBioChem 
and used as received. 
3-Bromopyridine: Purchased from Aldrich and used as received. 
2-Butanol: Purchased form Aldrich in a sure-seal bottle and used as received. 
n-Butylamine: Purchased from Aldrich and used as received. 
n-Butyllithium: Purchased from Strem and titrated prior to use with 2-butanol and 
1,10-phenanthrolene (indicator).  
t-Butyllithium: Purchased from Strem and titrated prior to use with 2-butanol and 
1,10-phenanthrolene (indicator).  
3-Chloroperbenzoic acid: Purchased form Aldrich and recrystallized from reagent 
grade CH2Cl2.  
                                                 
21 Al(Oi-Pr)3 is a white powder prior to distillation and insoluble in toluene; it exists as a clear liquid 
after distillation and is highly soluble in toluene. For details, see: Shiner, V. J. Jr.; Whittaker, D.; 
Fernandez, V. P. J. Am. Chem.Soc. 1963, 85, 2318–2322. 
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Copper cyanide:  Purchased from Strem and used as received. 
Copper Iodide: Purchased from Strem and purified by recrystallization from water 
and potassium iodide. 
Dichloromethane: Purchased from Doe & Ingalls and purified through two alumina 
columns under a positive pressure of dry argon by a modified Advanced ChemTech 
purification system. 
Diethyl ether: Purchased from Doe & Ingalls and purified through two alumina 
columns under a positive pressure of dry argon by a modified Advanced ChemTech 
purification system. 
Diethylphosphoramidate: Purchased from Aldrich or synthesized using a known 
procedure22 and distilled (under vacuum, air-cooled condenser).23  
Diethylzinc: Purchased from Aldrich (neat) and used without purification. 
Diisopropyl amine: Purchased from Aldrich and distilled from CaH2 prior to use. 
4-Dimethylaminopyridine: Purchased from Advanced ChemTech and used as 
received. 
Dimethylcarbamyl chloride: Purchased from Aldrich and distilled from CaH2 prior 
to use. 
N,O-dimethylhydroxylamine hydrochloride: Purchased from Aldrich and used as 
received. 
Dimethylzinc: Purchased from Strem (neat) and used without purification.  
EDC•HCl: Purchased from Advanced ChemTech and used as received. 
                                                 
22 Zwierzac, A.; Koziara, A. Tetrahedron 1970, 26, 3521–3525. 
23 Diethylphosphoramidate only needs to be distilled from CaCl2 the first time it is used. As long as the 
material is stored under nitrogen in a desiccator or glovebox it can be used for up to 2 months without 
needing to be redistilled. 
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Ethanol: ASC Reagent Grade, Purchased from Doe & Ingalls and used as received. 
1-ethynyl-4-iodobenzene: Prepared according to literature procedure.24
Fmoc-protected amino acids: Purchased from Advanced ChemTech or 
NovoBioChem and used as received. 
Furanoic acid: Purchased from Aldrich and used as received. 
HOBt•H2O: Purchased from Advanced ChemTech and used as received. 
HCl (4.0 M in 1,4-dioxane): Purchased from Aldrich and used as received. 
Hydrogen: Ultra High Purity, compressed gas purchased from Air Gas, Boston, MA. 
Isoquinoic acid: Purchased from Aldrich and used as received. 
Lindlars Catalyst: Pd/CaCO3 poisoned with lead, 10 mol % w/w, purchased from 
Aldrich and used as received. 
Methanol: Purchased from Aldrich in a sure-seal bottle and used as received. 
4-Methoxypyridine N-oxide: Purchased from Aldrich and used as received. 
Palladium on Carbon:  Purchased from Strem and used as received. 
1,10-Phenanthroline:  Purchased from Aldrich and used as received. 
Picolinic acid: Purchased from Acros and used as received. 
Piperidine:  Purchased from Advanced ChemTech and used as received, 
Pyridine: Purchased from Aldrich in a sure-seal bottle and used as received. 
Red-Al ®:  Purchased from Aldrich as a 60% w/w in a solution of toluene and used 
as received. 
Salicylaldehydes: Purchased from Acros or Aldrich and used as received. 
Tetrabutyl ammonium fluoride (1 M solution in THF): Purchased from Acros and 
used as received. 
                                                 
24 Holmes, B. T.; Pennington, W. T.; Hanks, T. W. Synth. Commun.,  2003, 33, 2447-2461. 
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Tetrahydrofuran: Purchased from Aldrich and purified by distillation from sodium 
benzophenone ketal immediately prior to use unless otherwise specified.  
Toluene: Purchased from Doe & Ingalls and purified through Cu and alumina 
columns under a positive pressure of dry argon by a modified Innovative 
Technologies purification system. 
Triethylamine: Purchased from Aldrich and distilled over CaH2.  
Trifluoroacetic acid: Purchased from Acros and used as received. 
4-(Trifluoromethyl)aniline: Purchased from Aldrich and used as received. 
Trimethylsilyl cyanide: Purchased from Aldrich and used as received. 
Unless otherwise noted, all work-up and purification procedures were carried out with 
reagent grade solvents (purchased from Doe & Ingalls) under an atmosphere of air. 
 
Representative Experimental Procedure for the Synthesis of Pyridyl-Ynones  
Important note on ynone-substrates:  1) All ynones examined in this study 
are light sensitive, they change color when exposed to light (especially UV 
light). 2) Ynones begin to decompose when placed in halogenated solvents for 
longer then 1 h.  3) Decomposition of all ynones is observed by a color change 
to greenish-blue or brown.  4) Decomposition products cannot be detected by 
1H NMR spectroscopy, but can detected by TLC. Decomposition products 
have not been identified. 5) In most cases, solutions of ynones were passed 
through a plug of silica prior to use to remove any of the decomposed material. 
Decomposition products do not affect the selectivity of the reaction.  6) 
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Ynones must be stored at -15 oC, under N2 (g) and wrapped in foil to help 
prevent decomposition. 
 
N-Methoxy-N-methylpicolinamide (15):  Picolinic acid 14 (5.00 g, 40.6 mmol), 
DMAP (992 mg, 0.812 mmol), EDC (9.34 g, 48.7 mmol) and N,O-
dimethylhydroxylamine hydrochloride (3.96 g, 40.6 mmol) were weighed into a 
flame-dried round bottom flask and sealed with a septa.  Dry CH2Cl2 (150 mL) was 
added through a syringe, and the solution was allowed to cool to 0 oC (ice bath).  
Triethylamine (9.60 mL, 81.2 mmol) was added through a syringe and stirring was 
allowed to continue at 0 oC for 15 min.  The ice bath was removed and the mixture 
was allowed to warm with stirring for an additional 6 hours. The reaction was then 
quenched through addition of a 10% solution of citric acid (10 mL).  After removal of 
the organic layer, the aqueous layer was neutralized with a saturated solution of 
NaHCO3. After a pH of 7-8 was reached the aqueous layer was washed with CH2Cl2 
(5 x 50 mL).  Combined organic layers were washed with a saturated solution of 
NaHCO3 (aq, 2 x 30 mL), saturated solution of NaCl (2 x 30 mL), dried with MgSO4, 
filtered and concentrated under reduced pressure to yield amide 15 as a yellow oil 
(4.90 g, 29.6 mmol, 73% yield).  Pyridyl-amide 15 was used without further 
purification. IR (neat): 2980 (w), 2942 (w), 1658 (s), 1583 (m), 1432 (m), 1381 (m), 
997 (s), 815 (s), 752 (s) cm-1.  1H NMR (400 MHz, CDCl3): δ 8.59 (1H, d, J = 4.8 
Hz, Ar-H), 7.75 (1H, dt, J = 7.6 Hz, 1.2 Hz, Ar-H), 7.60 (1H, bs, Ar-H), 7.33 (1H, 
dddd, J = 7.2, 4.8, 4.4, 0.8 Hz Ar-H), 3.72 (3H, s, OCH3), 3.38 (3H, s, NCH3).  13C 
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NMR (100 MHz, CDCl3):  δ 152.9, 148.3, 136.5, 124.6, 122.9, 61.2. HRMS (ESI+): 
Calcd for C8H11N2O2 [M+1] 167.0820; Found 167.08250. 
 
3-Phenyl-1-(pyridin-2-yl)-prop-2-yn-1-one (16a): A flame-dried round bottom flask 
was charged with a stir bar and sealed with septa.  Tetrahydrofuran (10 mL) and 
phenylacetylene (0.730 mL, 6.02 mmol) were added through a syringe.  The solution 
was allowed to cool to -40 oC (dry ice/acetonitile) upon which n-butyllithium (3.92 
mL, 6.63 mmol of a 1.69 M solution in hexanes) was added dropwise by syringe over 
5 minutes.25  The mixture was allowed to stir at -40 oC for 10 min, the ice bath was 
removed and the solution was allowed to warm for to -15 oC.  After 15 min the 
mixture was allowed to cool to -78 oC (dry ice/acetone) and a solution of Weinreb’s 
amide (1.00 g, 6.02 mmol in 5 mL of dry THF) was added through a syringe.  The 
mixture was allowed to stir at -78 oC for 10 min, the ice bath was removed and the 
solution was allowed to warm to 22 oC.  As the mixture warmed it changed color 
from yellow to red. After the solution temperature reached 22 oC, the reaction was 
quenched through addition of a saturated solution of NaHCO3 (2 mL).  The mixture 
was diluted with EtOAc (10 mL) and washed with a saturated solution of NaCl (2 x 
25 mL). The aqueous layer was washed with EtOAc (2 x 15 mL) and the combined 
organic layers were dried over MgSO4, filtered and concentrated under reduced 
pressure.  The resulting oil was purified by silica gel chromatography. The resulting 
red oil was loaded onto silica with toluene:CH2Cl2 (1:1, 3 mL).  While maintaining 
1% Et3N in all solvent mixtures, the desired product was eluted with pet. ether, 
                                                 
25 Nielson, T. E.; Cubillo de Dois, M.; Tanner, D. J. Org. Chem. 2002, 67, 7309-7313. 
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followed by pet. ether:Et2O (9:1), pet. ether:Et2O (4:1), pet. ether:Et2O (7:3), pet. 
ether:Et2O (1:1), 100% Et2O, which yielded 16a as a greenish-white solid (795 mg, 
3.84 mmol, 64.0% yield).  mp: 67-69 oC. IR (neat): 2193 (s), 1646 (s), 1583 (m), 
1482 (m), 1312 (s), 1035 (m), 683 (s) cm-1.  1H NMR (400 MHz, CDCl3): δ 8.82 (1H, 
d, J = 3.6 Hz, Ar-H), 8.19 (1H, d, J = 7.6 Hz, Ar-H), 7.68 (1H, t, J = 7.6 Hz, Ar-H), 
7.71 (2H, d, J = 7.2 Hz, Ar-H), 7.53-7.38 (4H, m, Ar-H).  13C NMR (100 MHz, 
CDCl3):  δ 178.3, 153.3, 137.1, 128.6, 127.6, 130.9, 128.6, 127.6, 123.4, 120.3, 95.1, 
88.0. HRMS (EI+): Calcd for C14H9NO [M+1] 207.0684; Found 207.0689. 
 
1-Pyridin-2-yl-3-o-tolyl-propynone (16b): 66.0% yield. mp: 42-44 oC. IR (neat): 
2193 (s), 1646 (s), 1595 (m), 1583 (s), 1488 (m), 1438 (m), 1325 (s), 1287 (s), 1218 
(s), 1023 (s), 777 (s), 683 (s) cm-1.  1H NMR (400 MHz, CDCl3): δ 8.81 (1H, d, J = 
4.8 Hz, Ar-H), 8.19 (1H, d, J = 8.0 Hz, Ar-H), 7.87 (1H, t, J = 8.4 Hz, Ar-H), 7.68 
(1H, d, J = 7.6 Hz Ar-H), 7.50 (1H, t, J = 6.0 Hz, Ar-H), 7.36 (1H, t, J = 7.6 Hz, Ar-
H), 7.27 (1H, d, J = 8.0 Hz, Ar-H), 7.20 (1H, t, J = 8.0 Hz, Ar-H), 2.62 (3H, s, Ar-
CH3).  13C NMR (100 MHz, CDCl3): δ 178.4, 153.5, 150.0, 143.0, 137.1, 133.9, 
131.0, 129.9, 127.5, 125.9, 123.4, 120.2, 94.8, 91.8, 20.8.  Elemental Analysis: Anal 
Calcd for C15H11NO: C, 81.43; H, 5.01; N, 6.33. Found: C, 81.49; H, 4.87; N, 6.10. 
 
1-Pyridin-2-yl-3-m-tolyl-propynone (16c): 67.0% yield. mp: 38-39 oC. IR (neat): 
2187 (s), 1658 (s), 1576 (m), 1318 (m), 1249 (m), 1041 (m), 683 (s) cm-1.  1H NMR 
(400 MHz, CDCl3): δ 8.81 (1H, d, J = 4.8 Hz, Ar-H), 8.15 (1H, d, J = 8.0 Hz, Ar-H), 
7.85 (1H, t, J =8.0 Hz, Ar-H), 7.51-7.49 (3H, m, Ar-H), 7.26-7.25 (2H, m, Ar-H), 
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2.34 (3H, s, Ar-CH3).  13C NMR (100 MHz, CDCl3): δ 178.2, 153.3, 150.0, 138.4, 
137.0, 133.9, 131.9, 130.6, 128.5, 127.5, 123.5, 119.9, 95.9, 87.8, 21.2.  HRMS 
(+TOF): Calcd for C15H12NO [M+1] 222.0918; Found 222.0914. 
 
1-Pyridin-2-yl-3-p-tolyl-propynone (16d): 72.0% yield. mp: 71-72 oC. IR (neat): 
2212 (s), 1658 (s), 1589 (m), 1501 (m), 1325 (s), 1035 (s), 840 (m), 689 (m) cm-1.  1H 
NMR (400 MHz, CDCl3): δ 8.83 (1H, d, J = 4.4 Hz, Ar-H), 8.18 (1H, d, J = 8.0 Hz, 
Ar-H), 7.89 (1H, t, J = 7.6 Hz, Ar-H), 7.62 (2H, d, J = 7.2 Hz, Ar-H), 7.52 (1H, t, J = 
7.6 Hz, Ar-H), 7.21 (2H, d, J = 7.6 Hz, Ar-H), 2.40 (3H, s, Ar-CH3).  13C NMR (100 
MHz CDCl3): δ 178.2, 153.3, 150.0, 141.7, 137.0, 133.5, 129.4, 127.4, 123.4, 117.1, 
96.2, 87.9, 21.8.  HRMS (+TOF): Calcd for C15H12NO [M+1] 222.0918; Found 
222.0920. 
 
3-(4-Methoxy-phenyl)-1-pyridin-2-yl-propynone (16e): 77.0% yield. mp: 91-92 oC.  
IR (neat): 2193 (s), 1646 (s), 1602 (s), 1507 (m), 1255 (m), 1029 (s), 834 (m), 695 
(s) cm-1.  1H NMR (400 MHz, CDCl3): δ 8.81 (1H, d, J = 4.8 Hz, Ar-H), 8.16 (1H, d, 
J = 7.6 Hz, Ar-H), 7.87 (1H, t, J = 9.2 Hz, Ar-H), 7.65 (2H, d, J = 8.4 Hz Ar-H), 7.50 
(1H, t, J = 7.2 Hz, Ar-H), 6.90 (2H, d, J = 8.8 Hz, Ar-H), 3.84 (3H, s, Ar-OCH3).  
13C NMR (100 MHz, CDCl3): δ 201.1, 178.2, 161.9, 153.6, 150.0, 137.1, 135.7, 
127.5, 114.4, 112.1, 96.9, 88.1, 55.5.  Elemental Analysis: Anal Calcd for 
C15H11NO2: C, 75.98; H, 4.67; N, 5.90. Found: C, 75.98; H, 4.60; N, 5.96. 
 
 Chapter 2 Page 78 
1-Pyridin-2-yl-3-(4-trifluoromethyl-phenyl)-propynone (16f): 39.0% yield. mp: 
51-53 oC.  IR (neat): 2206 (s), 1652 (s), 1595 (m), 1583 (s), 1396 (m), 1318 (s), 1167 
(s), 1130 (s), 1023 (s), 853 (s), 714 (s) cm-1.  1H NMR (400 MHz, CDCl3): δ 8.83 
(1H, d, J = 4.8 Hz, Ar-H), 8.17 (1H, d, J = 7.6 Hz, Ar-H), 7.90 (1H, dt, J = 7.6, 1.6 
Hz, Ar-H), 7.82 (2H, d, J =7.6 Hz, Ar-H), 7.67 (2H, d, J = 8.0 Hz, Ar-H), 7.55 (1H, 
ddd, J = 7.2, 4.8, 1.2 Hz, Ar-H).  13C NMR (100 MHz, CDCl3): δ 178.3, 153.1, 
150.1, 137.2, 133.5, 132.3 (q, J = 32.6 Hz), 127.9, 125.5 (q, J = 3.8 Hz), 124.2, 123.8 
(q, J = 271.4 Hz), 123.3, 92.9, 89.2. HRMS (EI+): Calcd for C15H8NOF3 [M+1] 
275.0558; Found 275.0557. 
 
3-(4-Iodophenyl)-1-(pyridin-2-yl)-prop-2-yn-1-one (16g): Lithium 
diisopropylamide was used to deprotonate the acetylene. 48.0% yield.  mp: 83-84 oC. 
IR (neat): 3053 (w), 2986 (w), 2199 (s), 1649 (s), 1578 (m), 1477 (m), 1436 (m), 
1390 (m), 1313 (s), 1288 (m), 1265 (s), 1023 (s), 1006 (s), 818 (m), 742 (s), 719 (s), 
704 (s), 688 (m) cm-1.  1H NMR (400 MHz, CDCl3): δ 8.76 (1H, d, J = 4.4 Hz, Ar-
H), 8.10 (1H, d, J = 7.6 Hz, Ar-H), 7.83 (1H, dt, J = 7.6, 1.2 Hz, Ar-H), 7.70 (2H, d, 
J = 8.4 Hz, Ar-H), 7.47 (1H, t, J = 4.8 Hz, Ar-H), 7.37 (2H, d, J = 8.4 Hz, Ar-H).  
13C NMR (100 MHz, CDCl3): δ 178.4, 153.3, 150.1, 138.1, 137.3, 134.8, 127.8, 
123.5, 119.9, 98.0, 94.4, 89.1.  HRMS (ESI+): Calcd for C14H9NOI [M+1] 333.9728; 
Found 333.9724. 
 
3-(3, 4-Dichlorophenyl)-1-(pyridin-2-yl)-prop-2-yn-1-one (16h): Lithium 
diisopropylamide was used to deprotonate the acetylene. 65.0% yield. mp: 121-123 
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oC, IR (neat): 2979 (w), 2208 (s), 1701 (m), 1654 (m), 1463 (m), 1320 (m), 1129 (m), 
687 (m) cm-1.  1H NMR (400 MHz, CDCl3): δ 8.83 (1H, d, J = 4.8 Hz, Ar-H), 8.16 
(1H, d, J = 7.6 Hz, Ar-H), 7.90 (1H, dt, J = 8.0 Hz, 1.6 Hz, Ar-H), 7.81 (1H, d, J = 
1.6 Hz, Ar-H), 7.56-7.48 (3H, m, Ar-H). 13C NMR (100 MHz, CDCl3): δ 178.2, 
153.2, 150.0, 137.2, 136.7, 135.7, 134.9, 132.4, 130.9, 127.9, 123.4, 120.4, 92.3, 89.1. 
 HRMS (ESI+): Calcd for C14H8NOCl2 [M+1] 275.9983; Found 275.9979. 
 
3-(2-Bromo-phenyl)-1-pyridin-2-yl-propynone (16i): Lithium diisopropylamide 
was used to deprotonate the acetylene. 63.0% yield. mp: 74-75 oC. IR (neat): 2293 
(s), 1652 (s), 1589 (m), 1482 (s), 1438 (m), 1305 (s), 1249 (m), 1042 (m), 1029 (s), 
771 (m), 689 (m) cm-1.  1H NMR (400 MHz, CDCl3): δ 8.81 (1H, d, J = 4.0 Hz, Ar-
H), 8.25 (1H, d, J = 8.0 Hz, Ar-H), 7.88 (1H, t, J = 7.6 Hz, Ar-H), 7.70 (1H, d, J = 
6.4 Hz, Ar-H), 7.63 (1H, d, J = 7.2 Hz, Ar-H), 7.52-7.49 (1H, m, Ar-H), 7.35-7.26 
(2H, m, Ar-H). 13C NMR (100 MHz, CDCl3): δ 177.8, 153.1, 150.2, 137.1, 135.3, 
132.9, 131.9, 127.7, 127.4, 126.9, 124.1, 122.8, 92.7, 91.2.  HRMS (EI+): Calcd for 
C14H8NOBr [M+1] 284.9789; Found 284.9785. 
 
1-Pyridin-2-yl-3-thiophen-2-yl-propynone (16j): 67.0% yield. IR (neat): 3106 (w), 
2193 (s), 1652 (s), 1576 (m), 1306 (m), 1281 (m), 1035 (s) cm-1.  1H NMR (400 
MHz, CDCl3): δ 8.78 (1H, d, J = 4.8 Hz, Ar-H), 8.11 (1H, d, J = 8.0 Hz, Ar-H), 
7.86-7.81 (2H, m, Ar-H), 7.49-7.46 (1H, m, Ar-H), 7.30 (2H, d, J = 2.0 Hz, Ar-H).  
13C NMR (100 MHz, CDCl3): δ 178.2, 153.2, 149.9, 137.1, 134.6, 130.6, 127.6, 
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126.1, 123.3, 119.4, 90.9, 88.3.  HRMS (+TOF): Calcd for C12H8NOS [M+1] 
214.0326; Found 214.0335. 
 
3-Pyridin-2-yl-undec-4-yn-3-ol (16k):  53.0% yield. IR (neat): 2933 (m), 2860 (m), 
2206 (m), 1652 (m), 1583 (w), 1463 (w), 1438 (w), 1306 (m), 1274 (m), 1117 (m), 
991 (w), 683 (m) cm-1.  1H NMR (400 MHz, CDCl3): δ 8.77 (1H, d, J = 3.6 Hz, Ar-
H), 8.10 (1H, d, J = 7.6 Hz, Ar-H), 7.84 (1H, d, J = 7.6 Hz, Ar-H), 7.48 (1H, t, J = 
4.5 Hz, Ar-H), 2.52 (2H, t, J = 7.2 Hz, CH2CH2alkyne), 1.71-1.63 (2H, m, CH2CH2), 
1.48-1.42 (2H, m, CH2CH2CH2), 1.36-1.22 (4H, m, CH2CH2CH2), 1.09-0.82 (3H, m, 
CH2CH2CH2).  13C NMR (100 MHz, CDCl3): δ 178.3, 153.2, 149.9, 136.9, 127.4, 
123.3, 99.6, 80.5, 31.3, 28.6, 27.8, 22.4, 19.6, 14.0. HRMS (+TOF): Calcd for 
C14H18NO [M+1] 216.1388; Found 216.1390. 
 
3-cyclohexyl-1-pyridin-2-yl-propynone (16l): 53.0% yield. mp: 32-34 oC. IR 
(neat): 2936 (s), 2854 (m), 2205 (s), 1652 (s), 1576 (m), 1444 (m), 1300 (m), 1281 
(m), 1243 (m), 916 (m), 739 (m), 683 (m) cm-1.  1H NMR (400 MHz, CDCl3): δ 8.75 
(1H, d, J = 4.4 Hz, Ar-H), 8.10 (1H, t, J = 7.6 Hz, Ar-H), 7.81 (1H, t, J = 7.6 Hz, Ar-
H), 7.47-7.44 (1H, m, Ar-H), 2.73-2.66 (1H, m, CH2CH2), 1.92-1.77 (2H, m, 
CH2CH2), 1.76-1.72 (2H, m, CH2CH2), 1.65-1.52 (3H, m, CH2CH2), 1.50-1.33 (3H, 
m, CH2CH2). 13C NMR (100 MHz, CDCl3):  δ 178.3, 153.3, 150.0, 136.9, 127.3, 
123.6, 102.8, 80.5, 31.7, 29.7, 25.7, 24.8. HRMS (+TOF): Calcd for C14H16NO 
[M+1] 214.1232; Found 214.1234. 
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1-Pyridin-2-yl-3-triisopropylsilanyl-propynone (16m): 80.0% yield. IR (neat): 
2948 (s), 2879 (m), 2149 (m), 1671 (s), 1583 (m), 1463 (m), 1281 (m), 1237 (m), 
1054 (s), 1041 (s), 890 (m), 752 (m), 676 (m) cm-1. 1H NMR (400 MHz, 
CDCl3): δ 8.77 (1H, d, J = 2.4 Hz, Ar-H), 8.15 (1H, d, J = 8.0 Hz, Ar-H), 7.85 (1H, t, 
J = 7.6 Hz, Ar-H), 7.50-7.46 (1H, m, Ar-H), 1.20-1.14 (21H, m, SiCH(CH3)2). 13C 
NMR (100 MHz, CDCl3): δ 177.5, 153.1, 150.2, 136.9, 127.4, 124.0, 103.8, 100.9, 
18.7, 11.3.   HRMS (EI+): Calcd for C17H25NOSi [M+1] 287.1705; Found 287.1704. 
 
1-(Pyridin-2-yl)-prop-2-yn-1-one: 1-(Pyridin-2-yl)-prop-2-yn-
1-one: Procedure followed was identical to that used for substrate 
16a except that trimethylsilylacetylene was used and the work up was changed.  
Modified work up in comparison to 16a:  After the solution reached 22 oC, the 
reaction was quenched through the addition of 1 M HCl (aq, 2 mL).  The mixture was 
diluted with CH2Cl2 (10 mL) and washed with a saturated solution of NaCl (2 x 25 
mL). The aqueous layer was washed with CH2Cl2 (2 x 15 mL) and the combined 
organic layers were dried over MgSO4, filtered and concentrated under reduced 
pressure.  The resulting red oil was purified by silica gel chromatography. While 
maintaining 1% Et3N in all solvent mixtures, the desired product was eluted with pet. 
ether, followed by pet. ether:Et2O (9:1), pet. ether:Et2O (4:1), pet. ether:Et2O (7:3), 
pet. ether:Et2O (1:1), 100% Et2O, which afforded the title compound as a white solid 
(789 mg, 6.01 mmol, >98.0% yield). mp: 100-105 oC (decomposition). IR (neat): 
3162 (w), 2867 (w), 2099 (m), 1658 (s), 1306 (s), 1293 (s), 1142 (m), 1101 (m), 1029 
(s), 752 (m), 683 (m) cm-1.  1H NMR (400 MHz, CDCl3): δ 8.20 (1H, d, J = 4.4 Hz, 
H
O
N
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Ar-H), 8.12 (1H, d, J = 8.0 Hz, Ar-H), 7.68 (1H, t, J = 7.6 Hz, Ar-H), 7.54 (1H, t, J = 
5.6 Ar-H), 3.59 (1H, s, Alkyne-H).  13C NMR (100 MHz, CDCl3):  δ 177.8, 152.7, 
150.1, 137.3, 128.1, 123.3, 83.1, 81.1.  HRMS (+TOF): Calcd for C8H6NO [M+1] 
132.0449; Found 132.0452. 
 
N-Methoxy-N-methylisoquinoline-1-carboxamide: 82% yield. 
IR (neat): 3054 (w), 2977 (w), 2937 (w), 1716 (m), 1658 (s), 1584 
(m), 1456 (m), 1373 (m), 1328 (m), 1180 (w), 1103 (w), 976 (m), 
827 (m), 752 (m), 669 (w) cm-1. 1H NMR (400 MHz, CDCl3) mixture of 3:1 
rotamers: δ 8.51 (2H, d, J = 5.6 Hz, Ar-H), 8.18 (1H, bs, Ar-H), 7.97 (1H, d, J = 8.4 
Hz, Ar-H), 7.85 (1H, d, J = 8.0 Ar-H), 7.72-7.61 (7H, m, Ar-H), 4.03 (3H, bs, CH3), 
3.52 (3H, s, CH3), 3.49 (3H, s, CH3), 3.21 (3H, bs, CH3).  13C NMR (100 MHz, 
CDCl3):  δ 168.8, 155.3, 141.8, 137.5, 130.8, 128.1, 127.2, 126.0, 125.4, 121.6, 61.9, 
32.3.  HRMS (ESI+): Calcd for C12H13N2O2 [M+1] 217.09770; Found 217.09763. 
N
O
NMe
OMe
 
1-(Isoquinolin-1-yl)-3-phenylprop-2-yn-1-one: 76.0% conv, 
31.0% yield.  mp: 92-94 oC.  IR (neat): 3062 (w), 2979 (w), 
2193 (m), 1733 (s), 1661 (s), 1548 (m), 1488 (s), 1456 (s), 1374 
(s), 1284 (m), 1243 (m), 1097 (m), 775 (s) cm-1.  1H NMR (400 MHz, 
CDCl3): δ 9.12-9.10 (1H, m, Ar-H), 8.75 (1H, d, J = 5.6 Hz, Ar-H), 7.93-7.88 (2H, m, 
Ar-H), 7.76-7.72 (4H, m, Ar-H), 7.48-7.38 (3H, m, Ar-H).  13C NMR (100 MHz, 
CDCl3): δ 180.1, 151.8, 141.9, 137.2, 133.5, 130.8, 130.7, 129.8, 128.6, 127.3, 126.6, 
Ph
O
N
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126.5, 125.3, 120.6, 94.8, 89.8, 70.62.  HRMS (ESI+): Calcd for C18H12NO [M+1] 
258.0919; Found 258.0922. 
 
N-Methoxy-N-methylbenzamide: 74.0% yield. IR (neat): 2948 
(b), 1646 (s), 1457 (m), 1375 (m), 1211 (w), 991 (w), 802 (w), 708 
(s) cm-1.  1H NMR (400 MHz, CDCl3): δ 7.67 (2H, d, J = 8.4 Hz, Ar-H), 7.44-7.37 
(3H, m, Ar-H), 3.55 (3H, s, NOCH3), 3.51 (3H, s, NCH3).  13C NMR (100 MHz, 
CDCl3):  δ 170.1, 134.2, 130.6, 128.3, 128.1, 61.1, 33.9.   HRMS (ES+): Calcd for 
C9H12NO2 [M+1] 166.0868; Found 166.0860. 
N
O
Me
OMe
 
1,3-Diphenylprop-2-yn-1-one (27): >98.0% yield. IR (neat): 3068 (w), 2200 (s), 
1646 (s), 1595 (m), 1501 (w), 1457 (m), 1325 (s), 1281 (s), 1180 (s), 1061 (s), 765 (s), 
620 (m) cm-1.  1H NMR (400 MHz, CDCl3): δ  8.22-8.20 (2H, m, Ar-H), 7.66-7.64 
(2H, m, Ar-H), 7.62-7.58 (1H, m, Ar-H), 7.51-7.43 (3H, m, Ar-H), 7.40-7.36 (2H, m, 
Ar-H). 13C NMR (100 MHz, CDCl3):  δ 177.9, 136.8, 134.1, 133.0, 130.8, 129.5, 
128.7, 128.6, 120.0, 93.1, 86.8.  HRMS (+TOF): Calcd for C15H11O [M+1] 
207.0809; Found 207.0817. 
 
N-Methoxy-N-methylfuran-2-carboxamide: 79.0% yield. 1H 
NMR (400 MHz, CDCl3): δ 7.58 (1H, s Ar-H), 7.13 (1H, d, J = 3.2 
Hz, Ar-H), 6.50 (1H, dd, J = 3.2, 1.6 Hz, Ar-H) 3.75 (3H, s, NOCH3), 3.34 (3H, s, 
NCH3).  13C NMR (100 MHz, CDCl3):  δ 159.3, 145.8, 145.3, 117.5, 111.7, 61.5, 
33.3.  
N
O
Me
OMe
O
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1-(Furan-2-yl)-3-phenylprop-2-yn-1-one (29): 75.0% yield. mp: 51-53 oC. IR 
(neat):  2206 (s), 1646 (s), 1570 (m), 1463 (s), 1394 (m), 1318 (m), 1041 (s), 765 (s), 
689 (m) cm-1.  1H NMR (400 MHz, CDCl3): δ 7.69-7.63 (3H, m, Ar-H), 7.49-7.46 
(1H, m, Ar-H), 7.43-7.39 (1H, m, Ar-H), 6.60 (1H, dd, J = 3.6, 1.6 Hz, Ar-H).  13C 
NMR (100 MHz, CDCl3):  δ 166.6, 153.3, 148.2, 133.2, 130.9, 128.8,  121.1, 119.9, 
112.8, 92.0, 86.3.  HRMS (+TOF): Calcd for C13H9O2 [M+1] 197.0602; Found 
197.0597. 
 
4-Methoxypicolinonitrile (17): Commercially available 4-methoxy-pyridine-N-oxide 
17 (1.00 g, 8.00 mmol) was weighed in a flame-dried round bottom flask. The flask 
was sealed with a septum, purged with N2 and dry CH2Cl2 (10 mL) was added 
through a syringe.  A solution of TMSCN (1.35 mL, 10.1 mmol) in CH2Cl2 (5 mL) 
was added to the resultant slurry. Neat dimethylcarbamyl chloride (0.930 mL, 10.1 
mmol) was added slowly through a syringe and stirring was allowed to proceed for 24 
h.26  The reaction was quenched through the addition of a saturated solution of K2CO3 
(5 mL) and allowed to stir vigorously for 1 h (CAUTION! HCN could be produced! 
Only work in a fume hood.) The biphasic mixture was washed with CH2Cl2 (3 x 20 
mL).  Combined organic fractions were dried over MgSO4, filtered and concentrated 
under reduced pressure. The bright yellow solid that results was triturated with Et2O 
(10 mL) and filtered to yield a pale yellow solid which was used without further 
purification (5.43 g, 3.98 mmol, 50.0% yield).  1H NMR (400 MHz, CDCl3): δ 8.51 
                                                 
26 Simeone, J. P.; Bugianesi, R. L.; Ponpipom, M. M.; Yang, Y. T.; Lo, J.-L.; Yudkovitz, J. B.; Cui, J.; 
Mount, G. R.; Ren, R. N.; Creighton, M.; Mao, A.-H.; Vincent, S. H.; Cheng, K.; Goulet, M. T. Biorg. 
Med. Chem. Lett. 2002, 12, 3329-3332. 
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(1H, d, J = 6.0 Hz, Ar-H), 7.22 (1H, s, Ar-H), 7.00 (1H, dd, J = 5.6, 2.4 Hz, Ar-H), 
3.91 (3H, s, OCH3).  13C NMR (100 MHz, CDCl3):  δ 165.8, 152.4, 135.3, 117.1, 
115.5, 112.8, 55.9. 
 
4-Methoxypicolinic acid hydrochloride:  Cyanopyridine 18 (5.43g, 3.98 mmol) was 
weighed into a round bottom flask and fitted with a reflux condenser.   An aqueous 
solution of 6 N HCl (30 mL) was added and the reaction is allowed to reflux for 24 
h;26 after 24h, the reaction was allowed to cool to 22 oC and placed on a rotary 
evaporator.  Aqueous acid was removed with slight heating to afford a white solid 
that was used without further purification. 
 
N-4-Dimethoxy-N-methylpicolinamide (19): 43.0% yield (over 2 steps).  IR (neat): 
3429 (bs), 2924 (s), 2853 (m), 2684 (w), 1634 (s), 1597 (s), 1565 (m), 1462 (m), 1399 
(m), 1308 (m), 1032 (m), 843 (w) cm-1.  1H NMR (400 MHz, CDCl3): δ 8.41 (1H, d, 
J = 5.6 Hz, Ar-H), 7.19 (1H, bs, Ar-H), 6.86 (1H, dd, J = 6.0, 2.4 Hz, Ar-H), 3.87 
(3H, s, OCH3), 3.76 (3H, s, NOCH3), 3.40 (3H, s, NCH3).  13C NMR (100 MHz, 
CDCl3):  δ 166.3, 154.9, 149.9, 111.6, 109.2, 61.6, 55.5.  HRMS (ESI+): Calcd for 
C9H13N2O3 [M+1] 197.0926; Found 197.0933. 
 
1-(4-Methoxypyridin-2-yl)-3-phenylprop-2-yn-1-one (20): 28.0% yield. mp: 100-
102 oC. IR (neat):  2203 (s), 1645 (s), 1591 (s), 1488 (m), 1426 (m), 1311 (s), 1028 
(s), 781 (m), 770 (m), 690 (m) cm-1.  1H NMR (400 MHz, CDCl3): δ 8.63 (1H, d, J = 
5.2 Hz, Ar-H), 7.74-769 (3H, m, Ar-H), 7.49-7.37 (3H, m, Ar-H), 7.02 (1H, dd, J = 
 Chapter 2 Page 86 
8.4, 2.4 Hz, Ar-H), 3.94 (3H, s, OCH3). 13C NMR (100 MHz, CDCl3):  δ 178.4, 
166.7, 155.2, 151.2, 133.7, 130.9, 128.7, 120.4, 114.2, 108.9, 95.7, 88.1, 55.8.  
HRMS (ESI+): Calcd for C15H12NO2 [M+1] 238.0868; Found 238.0874. 
 
 
3-Bromo-pyridine-N-oxide: Sodium bicarbonate (6.90 g, 81.6 mmol) 
was weighed into a round bottom flask containing a stir bar. 
Commercially available 3-bromopyridine (2.0 g, 20.4 mmol) and CH2Cl2 
(50 mL) were added through a syringe.27  The resultant slurry was allowed to cool to 
0 oC in an ice bath and a slurry of m-CPBA (7.00 g, 40.8 mmol) in CH2Cl2 (25 mL) 
was added (with a pipet).  The resulting mixture was allowed to warm to 22 oC and 
the mixture was allowed to stir for 24 h . After 4 h, large amounts of a white insoluble 
compound precipitated. After 24 h, the reaction was quenched through the addition of 
a saturated solution of K2CO3 (5 mL) and was allowed to stir for 10 min.  The 
mixture was further diluted with water (10 mL) and washed with CH2Cl2 (5 x 30 mL). 
The combined organic layers were dried with MgSO4, filtered and concentrated under 
reduced pressure providing a white solid that was used without further purification 
(2.87 g, 16.4 mmol, 81.0% yield).  (Note: if evaluation of the 1H NMR spectrum 
indicated the presence of 3-chlorobenzoic acid, the white solid was dissolved in 
CH2Cl2 and washed again with a saturated solution of  K2CO3, as stated above). 1H 
NMR (400 MHz, CDCl3): δ 8.08 (1H, s, Ar-H), 8.00 (1H, d, J = 7.6 Hz, Ar-H), 7.58 
(1H, d, J = 7.6 Hz, Ar-H), 7.13 (1H, t, J = 8.0 Hz, Ar-H). 13C NMR (100 MHz, 
CDCl3):  δ 164.9, 134.0, 130.5, 130.1, 128.5.  
N
Br
O
                                                 
27 Denmark, S. E.; Fan, Y. Tetrahedron:Asymmetry 2006, 174, 687-707. 
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3-Bromopicolinonitrile: Procedure followed as described for 18 with 
the appropriate N-oxide. The reaction yielded a mixture of 2- and 5-
substituted compounds (1:1). 46.0% yield. 1H NMR (400 MHz, CDCl3): δ  8.65 (1H, 
d, J = 4.4 Hz, Ar-H), 8.03 (1H, d, J = 8.0 Hz, Ar-H), 7.41 (1H, dd, J = 8.4, 1.2 Hz, 
Ar-H). 13C NMR (100 MHz, CDCl3):  δ 149.2, 140.7, 135.5, 127.7, 124.7, 115.8.  
N CN
Br
  
1-(3-Bromopyridin-2-yl)-3-phenylprop-2-yn-1-one: 52.0% 
yield. mp: 73-74 oC. IR (neat):  3060 (w), 2195 (s), 1657 (s), 
1488 (m), 1442 (m), 1419 (w), 1303 (m), 1190 (m), 1074(m), 1008 (s), 995 (m), 757 
(m), 731 (m) cm-1.  1H NMR (400 MHz, CDCl3): δ 8.70 (1H, dd, J = 4.8, 1.6 Hz, Ar-
H), 8.04 (1H, dd, J = 8.0, 1.2 Hz, Ar-H), 7.66 (2H, d, J = 6.8 Hz, Ar-H), 7.48-7.44 
(1H, m, Ar-H), 7.40-7.32 (3H, m, Ar-H). 13C NMR (100 MHz, CDCl3):  δ 177.1, 
151.8, 148.0, 142.9, 133.6, 131.1, 128.8, 127.3, 120.3, 119.1, 95.8, 88.7.  HRMS 
(ESI+): Calcd for C14H9NOBr [M+1] 285.9867; Found 285.9855. 
Ph
O
N
Br
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Representative Experimental Procedure for Enantioselective Additions of Et2Zn 
Additions to Pyridyl-Substituted Ynones: A 13 x 100 mm test tube was charged 
with Al(Oi-Pr)3 (2.50 mg in 250 μL toluene, 12.3 μmol), L4a (6.29 mg in 1.45 mL 
toluene; 12.3  μmol) and H2NP(O)(OEt)2 (9) (19.1 mg, in 250 μL toluene, 0.123 
μmol) under an atmosphere of N2 in a glove box.  Ketone 16a (50.0 mg in 500 μL 
toluene, 0.245 mmol) was added to this solution.28  The test tube was sealed with a 
septum, electrical tape, and Teflon® tape and removed from the glove box.  The 
solution was allowed to cool to -78 oC (dry ice/acetone) and Et2Zn (CAUTION, 
PYROPHORIC! USE EXTREME CAUTION!, 80.0  μL, 0.736 mmol) was added by 
syringe with continued stirring. The reaction was allowed to proceed for 20 min 
before addition of a saturated solution of aqueous NaHCO3 (1 mL).  After removal of 
the organic layer, the aqueous layer was washed with EtOAc (3 x 2 mL).  Combined 
organic layers were concentrated under reduced pressure and loaded on to a plug of 
silica with CHCl3 and eluted with pet. ether, followed by  pet. ether:Et2O (20:1), pet. 
ether:Et2O (9:1), pet. ether:Et2O (4:1), pet. ether:Et2O (7:3), pet. ether:Et2O (1:1), 
100% Et2O to afford 21a as a white solid (46.0 mg, 0.195 mmol, 80.0% yield). 
 
 (S)-1-Phenyl-3-pyridin-2-yl-pent-1-yn-3-ol (21a): mp: 63-64 oC. IR (neat): 3351 
(w), 2967 (w), 1583 (s), 1425 (s), 991 (m), 758 (m) cm-1.  1H NMR (400 MHz, 
CDCl3): δ 8.53 (1H, d, J = 6.0 Hz, Ar-H), 7.75 (2H, t, J = 8.0 Hz, Ar-H), 7.65 (1H, d, 
J = 6.8 Hz, Ar-H), 7.46-7.43 (2H, m, Ar-H), 7.29-7.24 (3H, m, Ar-H), 5.52 (1H, s, 
OH),  2.12 (1H, dq, J = 14.4, 7.2 Hz, CH3CH2), 2.12 (1H, dq, J = 14.4, 7.2 Hz, 
                                                 
28 It is imparitive that the dialkylzinc reagent is introduced into the reaction vessel last; the order of 
addition for other reagents and the catalyst is less critical. 
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CH3CH2), 1.01 (3H, t, J = 7.2 Hz, CH3CH2).  13C NMR (100 MHz, CDCl3):  δ 161.1, 
147.5, 137.4, 131.9, 128.5, 128.3, 123.8, 122.9, 120.8, 91.4, 84.6, 72.6, 38.2, 8.7. 
HRMS (ES+): Calcd for C16H15NO [M+1] 238.1232; Found 238.1239. Optical 
Rotation: [α]20D +40.5 (c = 0.653 in CHCl3) for a >98% ee sample.  Enantiomeric 
purity of the compound was determined by chiral HPLC analysis (Chiralcel OD, 
99.4:0.6 hexanes:i-PrOH eluent 0.500 mL/min and a lamp setting of 220 nm) tr = 66 
min. (minor) and tr = 50 min. (major). 
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Peak # Ret. Time Area Area %  Peak # Ret. Time Area Area %
1 49.89 10231000 49.154  1 47.96 69014130 100 
2 66.80 10583050 50.846      
 
 
(S)-3-Pyridin-2-yl-1-o-tolyl-pent-1-yn-3-ol (21b): IR (neat): 3370 (br), 2961 (w), 
2936 (w), 2930 (w), 1583 (m), 1432 (m), 1388 (m), 1136 (w), 985 (m), 777 (s) cm-1.  
1H NMR (400 MHz, CDCl3): δ 8.55 (1H, d, J = 4.0 Hz, Ar-H), 7.75 (1H, t, J = 8.0 
Hz, Ar-H), 7.68 (1H, d, J = 8.0 Hz, Ar-H), 7.42 (1H, d, J = 8.0 Hz, Ar-H), 7.28-7.19 
(2H, m, Ar-H), 7.20-7.19 (1H, m, Ar-H), 7.13 (1H, t, J = 4.0 Hz, Ar-H), 5.55 (1H, s, 
OH),  2.44 (3H, s, Ar-CH3), 2.14 (1H, dq, J =16.0, 8.0 Hz, CH3CH2), 2.02 (1H, dq, J 
= 20.0, 8.0 Hz, CH3CH2), 1.04 (3H, t, J = 8.0 Hz, CH3CH2). 13C NMR (100 MHz, 
CDCl3): δ 161.3, 147.5, 140.4, 137.3, 132.2, 129.5, 128.5, 125.6, 122.9, 122.6, 120.9, 
95.4, 83.6, 72.7, 38.2, 20.9, 8.7. HRMS (ES+): Calcd for C17H17NO [M+Na] 
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274.1208; Found 274.1215.  Optical Rotation: [α]20D +25.5 (c = 1.00 in CHCl3)  for 
a >98% ee sample.  Enantiomeric purity of the compound was determined by chiral 
HPLC analysis (Chiralcel OD, 99.4:0.6 hexanes:i-PrOH eluent 0.500 mL/min and a 
lamp setting of 220 nm) tr =92 min. (minor) and tr = 68 min. (major). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area %
1 68.27 25797490 52.643 1 58.41 29941020 100 
2 92.00 23206670 47.357     
 
 
(S)-3-Pyridin-2-yl-1-m-tolyl-pent-1-yn-3-ol (21c): IR (neat): 3370 (br), 2967 (w), 
2917 (w), 1589 (m), 1438 (m), 991 (m), 802 (s) cm-1.  1H NMR (400 MHz, 
CDCl3): δ 8.55 (1H, d, J = 8.0 Hz, Ar-H), 7.76 (1H, t, J = 16.0 Hz, Ar-H), 7.66 (1H, 
d, J = 8.0 Hz, Ar-H), 7.28-7.26 (3H, m, Ar-H), 7.18 (1H, t, J = 8.0 Hz, Ar-H), 7.11 
(1H, d, J = 8.0 Hz, Ar-H), 5.52 (1H, s, OH),  2.31 (3H, s, Ar-CH3), 2.12 (1H, dq, J 
=20.0, 8.0 Hz, CH3CH2), 2.00 (1H, dq, J = 20.0, 8.0 Hz, CH3CH2), 1.03 (3H, t, J = 
8.0 Hz, CH3CH2).  13C NMR (100 MHz, CDCl3): δ 161.2, 147.4, 138.0, 137.3, 132.5, 
129.3, 129.0, 128.2, 122.9, 122.7, 120.9, 91.0, 84.8, 72.6, 39.2, 21.3, 8.7. HRMS 
(ES+): Calcd for C17H17NO [M+Na] 274.1208; Found 274.1195.  Optical Rotation: 
[α]20D +35.1 (c = 1.00 in CHCl3) for a >98% ee sample.  Enantiomeric purity of the 
compound was determined by chiral HPLC analysis (Chiralcel OJ, 98.0:2.0 
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hexanes:i-PrOH eluent 1.00 mL/min and a lamp setting of 220 nm) tr = 25 min. 
(minor) and tr = 18 min. (major). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area %
1 18.98 19662530 47.272 1 22.70 33104700 100 
2 25.60 21932280 52.728     
 
 
(S)-3-Pyridin-2-yl-1-p-tolyl-pent-1-yn-3-ol (21d): IR (neat): 3364 (br), 2967 (w), 
2974 (w), 2923 (w), 1507 (m), 1432 (m), 1406 (w), 1117 (w), 809 (s) cm-1.  1H NMR 
(400 MHz, CDCl3): δ 8.54 (1H, d, J = 4.0 Hz, Ar-H), 7.75 (1H, t, J = 8.0 Hz, Ar-H), 
7.67 (1H, d, J = 4.0 Hz, Ar-H), 7.35 (2H, d, J = 8.0 Hz, Ar-H), 7.26 (2H, t, J = 4.0 Hz, 
Ar-H), 7.10 (1H, d, J = 8.0 Hz, Ar-H), 5.50 (1H, s, OH),  2.34 (3H, s, Ar-CH3), 2.10 
(1H, dq, J =20.0, 8.0 Hz, CH3CH2), 1.99 (1H, dq, J = 16.0, 8.0 Hz, CH3CH2), 1.02 
(3H, t, J = 8.0 Hz, CH3CH2).  13C NMR (100 MHz, CDCl3): δ 161.2, 147.4, 138.5, 
137.3, 131.8, 129.1, 122.8, 120.9, 119.8, 90.7, 84.8, 72.6, 38.2, 21.6, 8.7. HRMS 
(ES+): Calcd for C17H17NO [M+Na] 274.1208; Found 274.1216.  Optical Rotation: 
[α]20D +47.8 (c = 1.00 in CHCl3) for a >98% ee sample.  Enantiomeric purity of the 
compound was determined by chiral HPLC analysis (Chiralcel OJ, 98.0:2.0 
hexanes:i-PrOH eluent 1.00 mL/min and a lamp setting of 220 nm) tr = 39 min. 
(minor) and tr = 18 min. (major). 
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1 26.90 12559190 48.529 1 17.94 82377090 100 
2 39.55 13320810 51.471     
 
 
(S)-1-(4-Methoxy-phenyl)-3-pyridin-2-yl-pent-1-yn-3-ol (21e): IR (neat): 3414 
(br), 2974 (w), 1639 (m), 1608 (m), 1507 (s), 1287 (m), 1243 (m) cm-1.  1H NMR 
(400 MHz, CDCl3): δ 8.53 (1H, d, J = 8.0 Hz, Ar-H), 7.75 (1H, t, J = 8.0 Hz, Ar-H), 
7.65 (1H, d, J = 8.0 Hz, Ar-H), 7.38 (2H, d, J = 8.0 Hz, Ar-H), 7.26-7.25 (1H, m, Ar-
H), 6.81 (2H, d, J = 8.0 Hz, Ar-H), 5.51 (1H, s, OH), 3.79 (3H, s, OCH3), 2.10 (1H, 
dq, J = 16.0, 8.0 Hz, CH3CH2), 1.98 (1H, dq, J = 16.0, 8.0 Hz, CH3CH2), 1.01 (3H, t, 
J = 8.0 Hz, CH3CH2).  13C NMR  (100  Hz,CDCl3): δ 161.4, 159.8, 147.5, 137.4, 
133.5, 122.9, 120.9, 115.0, 114.0, 90.0, 84.7, 72.7, 55.5, 38.3, 8.8.  HRMS (ES+): 
Calcd for C17H17NO2 [M+Na] 290.1157; Found 290.1161.  Optical Rotation: [α]20D 
+37.0 (c = 1.00 in CHCl3) for a >98% ee sample.  Enantiomeric purity of the 
compound was determined by chiral HPLC analysis (Chiralcel OD, 99.4:0.6 
hexanes:i-PrOH eluent 0.500 mL/min and a lamp setting of 220 nm) tr = 80 min. 
(minor) and tr =63 min. (major). 
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1 62.77 74711060 52.42 1 63.98 13309530 100 
2 80.05 67812170 47.58     
 
 
(S)-3-Pyridin-2-yl-1-(4-trifluoromethyl-phenyl)-pent-1-yn-3-ol (21f): IR (neat): 
3383 (br), 2980 (w), 2936 (w), 2879 (w), 1639 (m), 1614 (s), 1589 (s), 1438 (s), 1406 
(s), 1325 (s), 1174 (s), 1067 (s), 846 (m) cm-1.  1H NMR (400 MHz, CDCl3): δ 8.26 
(1H, d, J = 4.0 Hz, Ar-H), 7.50 (1H, t, J = 8.0 Hz, Ar-H), 7.35 (2H, d, J = 8.0 Hz, Ar-
H), 7.30-7.22 (2H, m, Ar-H), 7.01-6.97 (2H, m, Ar-H), 5.37 (1H, s, OH), 1.86 (1H, 
dq, J = 14.8, 7.6 Hz, CH3CH2), 1.69 (1H, dq, J = 14.4, 7.2 Hz, CH3CH2), 0.73 (3H, t, 
J = 8.0 Hz, CH3CH2).  13C NMR (100 MHz, CDCl3): δ 160.6, 146.5, 137.5, 132.2, 
130.2, (q, J = 32.6 Hz), 126.7, 125.2 (q, J = 3.86 Hz), 124.0 (q, J = 271.0 Hz), 123.1, 
120.7, 94.1, 83.2, 72.4, 37.9, 8.5.  HRMS (ES+): Calcd for C17H15NOF3 [M+1] 
306.1106; Found 306.1096.  Optical Rotation: [α]20D +28.0 (c = 1.00 in CHCl3) for 
a >98% ee sample.  Enantiomeric purity of the compound was determined by chiral 
HPLC analysis (Chiralcel OD, 99.4:0.6 hexanes:i-PrOH eluent 0.500 mL/min and a 
lamp setting of 220 nm) tr = 100 min. (minor) and tr = 64 min. (major). 
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1 62.84 26424280 52.287 1 64.62 14450590 100 
2 100.11 24112550 47.713     
 
 
(S)-1-(4-Iodophenyl)-3-(pyridin-2-yl)-pent-1-yn-3-ol (21g): mp: 83-85 oC. IR 
(neat): 3374 (br), 2970 (w), 2935 (w), 1592 (m), 1482 (s), 1433 (m), 1389 (m), 1249 
(w), 1131 (m), 1006 (m), 819 (s), 770 (m), 665 (s) cm-1.  1H NMR (400 MHz, 
CDCl3): δ 8.54 (1H, d, J = 4.4 Hz, Ar-H), 7.65 (1H, dt, J = 7.6, 1.2 Hz, Ar-H), 7.63 
(1H, d, J = 12.0 Hz, Ar-H), 7.29-7.26 (3H, m, Hz, Ar-H), 5.56 (1H, s, OH),  2.11 (1H, 
dq, J =14.4, 7.6 Hz, CH3CH2), 1.99 (1H, dq, J = 14.4, 7.2 Hz, CH3CH2), 1.00 (3H, t, 
J = 7.6 Hz, CH3CH2).  13C NMR (100 MHz, CDCl3): δ 160.9, 147.6, 137.6, 137.5, 
133.6, 123.1, 122.5, 120.8, 94.5, 93.0, 83.7, 72.6, 38.1, 8.7.  HRMS (ESI+): Calcd 
for C16H15NOI [M+1] 364.0198; Found 364.0207.  Optical Rotation: [α]20D +331.3 
(c = 1.17 in CHCl3) for a >98% ee sample.  Enantiomeric purity of the compound was 
determined by chiral HPLC analysis (Chiralcel OD, 99.0:1.0 hexanes:i-PrOH eluent 
0.500 mL/min and a lamp setting of 220 nm) tr = 37 min. (minor) and tr = 27 min. 
(major). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area %
1 28.70 7190954 45.749 1 27.15 24947460 100 
2 37.83 8527212 54.251     
 
 
(S)-1-(3,4-Dichlorophenyl)-3-(pyridin-2-yl)-pent-1-yn-3-ol (21h): IR (neat): 3351 
(b), 2961 (w), 2924 (m), 2855 (w), 1730 (w), 1680 (m), 1533 (w), 1464 (m), 1406 (w), 
1263 (w), 1131 (w) cm-1.  1H NMR (400 MHz, CDCl3): δ 8.54 (1H, d, J = 4.8 Hz, 
Ar-H), 7.77 (1H, dt, J = 7.6, 1.6 Hz, Ar-H), 7.60 (1H, d, J = 8.0 Hz, Ar-H), 7.52 (1H, 
d, J = 1.6 Hz, Ar-H) 7.37-7.35 (1H, m, Ar-H), 7.29-7.25 (2H, m, Ar-H), 5.61 (1H, s, 
OH), 2.12 (1H, dq, J = 14.8, 7.6 Hz, CH3CH2), 1.98 (1H, dq, J = 14.8, 7.6 Hz, 
CH3CH2), 1.00 (3H, t, J = 7.2 Hz, CH3CH2).  13C NMR (100 MHz, CDCl3): δ 160.7, 
147.6, 137.6, 133.6, 133.0, 132.7, 131.2, 130.5, 123.1, 122.9, 120.8, 93.7, 82.3, 72.5, 
37.9, 8.6.  HRMS (ESI+): Calcd for C16H14NOCl2 [M+1] 306.0452; Found 306.0437. 
Optical Rotation: [α]20D +369.4 (c = 0.490 in CHCl3) for a >98% ee sample.  
Enantiomeric purity of the compound was determined by chiral HPLC analysis 
(Chiralcel OD, 99.0:1.0 hexanes:i-PrOH eluent 0.750 mL/min and a lamp setting of 
220 nm) tr = 45 min. (minor) and tr =34 min. (major). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area %
1 34.24 10239830 48.397 1 22.90 35158940 100 
2 43.90 10918330 51.603     
 
 
(S)-1-(2-Bromophenyl)-3-pyridin-2-yl-pent-1-yn-3-ol (21i): 3370 (br), 2980 (w), 
2923 (w), 1595 (m), 1476 (s), 1438 (m), 1388 (w), 1016 (w), 752 (s) cm-1.  1H NMR 
(400 MHz, CDCl3): δ 8.55 (1H, d, J = 4.8 Hz, Ar-H), 7.77 (2H, d, J = 3.6 Hz, Ar-H), 
7.56 (1H, d, J = 8.0 Hz, Ar-H), 7.48 (1H, d, J = 7.6 Hz, Ar-H), 7.29-7.24 (2H, m, Ar-
H), 7.16 (1H, t, J = 7.6 Hz, Ar-H), 5.59 (1H, s, OH),  2.15 (1H, dq, J =14.8, 7.6 Hz, 
CH3CH2), 2.03 (1H, dq, J = 14.8, 7.6 Hz, CH3CH2), 1.05 (3H, t, J = 7.2 Hz, CH3CH2).  
13C NMR (100 MHz, CDCl3): δ 160.7, 147.4, 137.4, 133.6, 132.4, 129.6, 127.1, 
125.0, 123.0, 122.9, 121.2, 96.1, 83.3, 72.7, 38.2, 8.7.  HRMS (ES+): Calcd for 
C16H15NOBr [M+1] 316.0337; Found 316.0034. Optical Rotation: [α]20D +41.4 (c = 
1.00 in CHCl3) for a >98% ee sample.  Enantiomeric purity of the compound was 
determined by chiral HPLC analysis (Chiralcel OD, 99.4:0.6 hexanes:i-PrOH eluent 
0.500 mL/min and a lamp setting of 220 nm) tr = 36 min. (minor) and tr = 44 min. 
(major). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area %
1 36.42 6500721 45.601 1 44.67 272292300 100 
2 43.77 7754796 54.399     
 
 
(S)-3-Pyridin-2-yl-1-thiophen-2-yn-3-ol (21j): IR (neat): 3364 (br), 3106 (w), 2961 
(w), 2930 (w), 2867 (w), 1583 (w), 1438 (m), 1375 (m), 1142 (w), 991 (w), 796 (s), 
626 (m) cm-1.  1H NMR (400 MHz, CDCl3): δ 8.54 (1H, d, J = 4.8 Hz, Ar-H), 7.59 
(1H, t, J = 1.6 Hz, Ar-H), 7.64 (1H, d, J = 8.0 Hz, Ar-H), 7.45 (1H, s, Ar-H), 7.28-
7.13 (2H, m, Ar-H), 7.11 (1H, d, J = 1.2 Hz, Ar-H), 5.53 (1H, s, OH), 2.12 (1H, dq, J 
= 21.2, 7.6 Hz, CH3CH2), 1.99 (1H, dq, J = 14.8, 7.2 Hz, CH3CH2), 1.00 (3H, t, J = 
7.6 Hz, CH3CH2).  13C NMR (100 MHz, CDCl3): δ 161.1, 147.5, 137.4, 130.2, 129.1, 
125.3, 122.9, 121.9, 120.8, 91.0, 79.7, 72.6, 38.0, 8.6.  HRMS (ES+): Calcd for 
C14H13NOS [M+Na] 266.0616; Found 266.0630.  Optical Rotation: [α]20D +38.6 (c 
= 1.00 in CHCl3) for a >98% ee sample.  Enantiomeric purity of the compound was 
determined by chiral HPLC analysis (Chiralcel OD, 99.4:0.6 hexanes:i-PrOH eluent 
0.550 mL/min and a lamp setting of 220 nm) tr = 96 min. (minor) and tr = 69 min. 
(major). 
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1 73.38 65407250 51.767 1 69.10 333246800 100 
2 96.33 60941030 48.233     
 
 
(S)-3-Pyridin-2-yl-undec-4-yn-3-ol (21k): IR (neat): 3370 (br), 2936 (m), 2860 (w), 
1589 (w), 1463 (w), 1432 (w), 1394 (w), 1174 (w), 979 (w), 771 (m) cm-1. 1H NMR 
(400 MHz, CDCl3): δ 8.50 (1H, d, J = 4.8 Hz, Ar-H), 7.71 (1H, t, J = 7.6 Hz, Ar-H), 
7.58 (1H, d, J = 8.0 Hz, Ar-H), 7.22 (1H, t, J = 5.6 Hz, Ar-H), 5.29 (1H, s, OH), 2.24 
(2H, t, J = 7.2 Hz, CH2CH2alkyne),  1.97 (1H, dq, J =14.8, 7.6 Hz, (HO)CCH2CH3), 
1.87 (1H, dq, J = 14.8, 7.6 Hz, (HO)CCH2CH3), 1.56-1.48 (2H, m, CH2CH2CH2), 
1.42-1.25 (6H, m, CH2CH2CH2), 0.94 (3H, t, J = 7.2 Hz, CH3CH2), 0.87 (3H, t, J = 
6.8 Hz, CH3CH2).  13C NMR (100 MHz, CDCl3): δ 161.9, 147.4, 122.6, 120.7, 85.6, 
82.3, 72.3, 31.4, 28.7, 22.6, 18.9, 14.2, 8.7. HRMS (ES+): Calcd for C16H23NO 
[M+Na] 268.1677; Found 268.1668.  Optical Rotation: [α]20D +25.5 (c = 1.00 in 
CHCl3) for a >98% ee sample.  Enantiomeric purity of the compound was determined 
by chiral HPLC analysis (Chiralcel OD, 99.4:0.6 hexanes:i-PrOH eluent 0.550 
mL/min and a lamp setting of 220 nm) tr =38 min. (minor) and tr =24 min. (major). 
 Chapter 2 Page 99 
 2
4.
51
 
 3
8.
01
 
22 24 26 28 30 32 34 36 38 40 42 44 46
Time - Minutes
0
20
40
60
80
100
120
140
R
es
po
ns
e 
- M
ill
iV
ol
ts
 2
4.
93
 
250
200
R
es
po
ns
e 
- M
ill
iV
ol
ts 150
100
50
0
0 5 10 15 20 25 30 35 40 45 50 55 60
 Time - Minutes
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area %
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2 38.01 11453900 50.049     
 
 
(S)-1-Cyclohexyl-3-pyridin-2-yl-pent-1-yn-3-ol (21l): IR (neat): 3389 (br), 2936 
(s), 2860 (m), 1614 (w), 1438 (w), 1174 (w), 966 (w), 783 (w), 771 (w) cm-1.  1H 
NMR (400 MHz, CDCl3): δ  8.50 (1H, d, J = 4.8 Hz, Ar-H), 7.71 (1H, t, J = 8.8 Hz, 
Ar-H), 7.59 (1H, d, J = 7.6 Hz, Ar-H), 7.22 (1H, t, J = 1.6 Hz, Ar-H), 5.28 (1H, s, 
OH), 2.49-2.41 (1H, m, CH2),  2.02-1.78 (4H, m, CH2), 1.72-1.68, (2H, m, CH2), 
1.54-1.41 (3H, m, CH2), 1.36-1.25 (3H, m, CH2),  0.95 (3H, t, J = 7.2 Hz, CH3CH2).  
13C NMR (100 MHz, CDCl3): δ 162.0, 147.4, 137.1, 122.6, 120.8, 110.1, 89.6, 82.2, 
72.4, 38.6, 32.7, 29.1, 26.0, 24.9, 8.8.  HRMS (ES+): Calcd for C16H21NONa 
[M+Na] 266.1521; Found 266.1530.  Optical Rotation: [α]20D +11.7 (c = 1.00 in 
CHCl3) for a >98% ee sample.   
 
 (S)-1-Cyclohexyl-3-(pyridin-2-yl)-pent-1-yn-3-yl acetate: 
Alcohol 21l (23.0 mg, 0.0950 mmol) and DMAP (11.6 mg, 
0.0950 mmol) were weighed into a test tube and sealed with a 
septum, electrical tape and Teflon ® tape.  The vessel was purged with N2 and the 
solids were dissolved in dry CH2Cl2 (3 mL, added by syringe).  The mixture was 
N
AcO Et
 Chapter 2 Page 100 
allowed to cool to 0 oC (ice bath) and Et3N (35.0 μL, 0.284 mmol) was added by a 
syringe.  The resulting mixture was allowed to stir at 0 oC for 5 min after which Ac2O 
(18.0 μL, 0.189 mmol) was added slowly with a syringe.  The mixture was allowed to 
stir for 16 h,  after which time the reaction was quenched by the addition of a 
saturated aqueous solution of NaHCO3 (1 mL) and washed with CH2Cl2 (3 x 3 mL).  
The organic layers were combined and dried over MgSO4, filtered and concentrated 
under reduced pressure.  The resulting yellow oil was purified by silica gel 
chromatography (pet. ether:Et2O (20:1), pet. ether:Et2O (9:1), pet. ether:Et2O (4:1), 
pet. ether:Et2O (7:3), pet. ether:Et2O (1:1), 100% Et2O while maintaining 1% Et3N to 
prevent racemization) providing the acetate as a clear oil  (14.0 mg, 0.052 mmol, 
56.0% yield).  1H NMR (400 MHz, CDCl3): δ 8.55 (1H, d, J = 4.0 Hz, Ar-H), 7.80 
(1H, d, J = 7.6 Hz, Ar-H), 7.67 (1H, t, J = 6.8 Hz, Ar-H), 7.16 (1H, dt, J = 5.2, 1.2 Hz, 
Ar-H), 2.57-2.55 (1H, m, CH2CH2), 2.20 (1H, dq, J = 13.6, 7.6 Hz, (HO)CCH2CH3), 
2.11-1.97 (4H, m, CH3CH2 and CH3CO),  1.90-1.83 (1H, m, CH2CH2), 1.82-1.66, 
(3H, m, CH2CH2), 1.65-1.44 (3H, m, CH2CH2), 1.42-1.25 (3H, m, CH2CH2),  0.94 
(3H, t, J = 7.6 Hz, CH3CH2).  13C NMR (100 MHz, CDCl3): δ 169.1, 159.9, 149.2, 
136.4, 122.5, 122.0, 93.3, 79.8, 78.2, 36.1, 32.7, 29.3, 26.1, 24.9, 21.8, 8.8. HRMS 
(ESI+): Calcd for C18H24NO2 [M+1] 286.1807; Found 286.1797.  Enantiomeric 
purity of the compound was determined by chiral HPLC analysis (Chiralcel OD, 
98.0:2.0 hexanes:i-PrOH eluent 0.500 mL/min and a lamp setting of 220 nm) tr = 18 
min. (minor) and tr = 21 min. (major). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area %
1 18.69 480858 49.68 1 20.94 17955670 100
2 21.01 487053 50.32     
 
 
(S)-3-Pyridin-2-yl-1-triisopropylsilanyl-pent-1-yn-3-ol (21m): IR (neat): 3395 (b), 
2955 (s), 2879 (s), 2174 (w), 1608 (m), 1463 (m), 1432 (m), 1394 (m), 1155 (w), 
1004 (m), 878 (m), 783 (m), 733 (m), 676 (m) cm-1.  1H NMR (400 MHz, 
CDCl3): δ 8.50 (1H, d, J = 4.0 Hz, Ar-H), 7.73 (1H, t, J = 7.6 Hz, Ar-H), 7.61 (1H, d, 
J = 8.0 Hz, Ar-H), 7.23 (1H, dt, J = 6.8,  1.6 Hz, Ar-H), 5.34 (1H, s, OH), 1.99 (1H, 
dq, J = 14.0, 6.8 Hz, CH3CH2), 1.89 (1H, dq, J = 14.4, 7.2 Hz, CH3CH2), 1.07 (21H, 
s, SiCH(CH3)2), 0.98 (3H, t,  J = 7.2 Hz, CH3CH2).  13C NMR (100 MHz, CDCl3): 
δ 161.3, 147.4, 137.1, 122.8, 120.9, 109.6, 85.4, 72.7, 68.3, 38.6, 18.7, 11.4, 8.7. 
HRMS (ES+): Calcd for C19H31NONaSi [M+Na] 340.2073; Found 340.2085. 
Optical Rotation: [α]20D -3.08 (c = 1.34 in CHCl3) for a 92% ee sample.   
 
 (S)-3-Pyridin-2-yl-undec-4-yn-3-ol: IR (neat): 3301 (m), 2974 
(w), 2930 (w), 2879 (w), 1595 (m), 1432 (s), 1400 (m), 1136 (m), 
1060 (w), 991 (w), 777 (m) cm-1.  1H NMR (400 MHz, CDCl3): δ 8.52 (1H, d, J = 
4.4 Hz, Ar-H), 7.73 (1H, t, J = 7.6 Hz, Ar-H), 7.59 (1H, d, J = 8.0 Hz, Ar-H), 7.25 
(1H, t, J = 7.2 Hz, Ar-H), 5.44 (1H, s, OH), 2.54 (1H, s, H-alkyne),  2.02 (1H, dq, J = 
21.2, 7.6 Hz, CH3CH2), 1.90 (1H, dq, J = 14.8, 7.2 Hz, CH3CH2), 0.96 (3H, t, J = 7.2 
H
N
HO Et
 Chapter 2 Page 102 
Hz, CH3CH2).  13C NMR (100 MHz, CDCl3): δ 160.6, 147.5, 137.4, 122.9, 20.6, 
86.2, 72.6, 72.0, 37.7, 8.4. HRMS (ES+): Calcd for C10H12NO [M+1] 162.0919; 
Found 162.0925.  Optical Rotation: [α]20D +6.43 (c = 1.00 in CHCl3) for a >98% ee 
sample. Enantiomeric purity of the compound was determined by chiral HPLC 
analysis (Chiralcel OD, 98.0:2.0 hexanes:i-PrOH eluent 1.00 mL/min and a lamp 
setting of 254 nm) tr =16 min. (minor) and tr = 33 min. (major). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area %
1 15.86 1056112 50.223 1 33.01 1972227 100 
2 23.92 1046721 49.777     
 
 
(S)-3-(Isoquinolin-1-yl)-1-phenylpent-1-yn-3-ol (24): IR (neat): 3285 (b), 3056 (w), 
2961 (w), 2924 (w), 2855 (w), 1665 (w), 1562 (w), 1334 (m), 1099 (w), 827 (s), 753 
(s), 690 (m) cm-1.  1H NMR (400 MHz, CDCl3): δ 8.87 (1H, d, J = 8.4 Hz, Ar-H), 
8.44 (1H, d, J = 5.6 Hz, Ar-H), 7.90 (1H, d, J = 8.0 Hz, Ar-H),  7.75-7.65 (3H, m, 
Ar-H), 7.43-7.39 (2H, m, Ar-H), 7.28-7.25 (3H, m, Ar-H), 7.18 (1H, s, OH), 2.52 
(1H, dq, J = 14.4, 7.2 Hz, CH3CH2), 2.17 (1H, dq, J = 14.4, 7.2 Hz, CH3CH2), 0.96 
(3H, t, J = 7.2 Hz, CH3CH2).  13C NMR (100 MHz, CDCl3): δ 158.8, 139.0, 137.7, 
131.9, 130.5, 128.6, 128.4, 127.9, 127.2, 126.7, 124.9, 123.1, 122.1, 92.2, 85.5, 71.1, 
37.5, 8.4. HRMS (ESI+): Calcd for C20H18NO [M+1] 288.1388; Found 288.1387.  
Optical Rotation:  [α]20D -149.4 (c = 0.360 in CHCl3) for a 92% ee sample.  
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Enantiomeric purity of the compound was determined by chiral HPLC analysis 
(Chiralcel OD, 99.5:0.5 hexanes:i-PrOH eluent 0.750 mL/min and a lamp setting of 
254 nm) tr = 29 min. (minor) and tr = 40 min. (major). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area %
1 29.53 7511548 46.008 1 40.30 26807900 100 
2 40.11 8814921 53.992     
 
(S)-3-(3-Bromopyridin-2-yl)-1-phenylpent-1-yn-3-ol (25): IR (neat): 3324 (b), 
3062 (w), 2978 (w), 2934 (w), 2875 (w), 1573 (w), 1488 (m), 1420 (s), 1391 (s), 
1291(w), 1140 (m), 1073 (m), 1028 (m), 798 (m), 755 (s), 690 (m) cm-1.  1H NMR 
(400 MHz, CDCl3): δ  8.50 (1H, d, J = 3.6 Hz, Ar-H), 8.01 (1H, dd, J = 8.0, 1.2 Hz, 
Ar-H), 7.48-7.46 (2H, m, Ar-H), 7.29-7.27 (3H, m, Ar-H), 7.22-7.19 (1H, m, Ar-H), 
6.54 (1H, s, OH), 2.45 (1H, dq, J = 14.8, 7.6 Hz, CH3CH2), 2.27 (1H, dq, J = 14.0, 
7.2 Hz, CH3CH2), 0.94 (3H, t, J = 7.2 Hz, CH3CH2).  13C NMR (100 MHz, CDCl3): 
δ 156.7, 145.3, 143.7, 131.8, 128.3, 128.3, 124.5, 123.1, 118.9, 89.9, 84.7, 71.8, 33.7, 
8.2. HRMS (ESI+): Calcd for C16H15NOBr [M+1] 316.0337; Found 316.0344. 
Optical Rotation: [α]20D -76.6 (c = 0.320 in CHCl3) for a >98% ee sample.  
Enantiomeric purity of the compound was determined by chiral HPLC analysis 
(Chiralcel OJ, 99.5:0.5 hexanes:i-PrOH eluent 0.500 mL/min and a lamp setting of 
254 nm) tr = 97 min. (minor) and tr = 77 min. (major). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area %
1 85.22 9655748 48.492 1 77.65 495577300 100 
2 97.92 10256180 51.508     
 
(S)-3-(4-Methoxypyridin-2-yl)-1-phenylpent-1-yn-3-ol (25): IR (neat): 3375 (b), 
3052 (w), 2969 (w), 2834 (w), 1598 (s), 1469 (m), 1480 (m), 1414 (w), 1304 (w), 
1265 (s), 1119 (w), 1038 (m), 844 (w), 739 (s) cm-1.  1H NMR (400 MHz, 
CDCl3): δ 8.35 (1H, d, J = 6.0 Hz, Ar-H), 7.47-7.44 (2H, m, Ar-H), 7.30-7.28 (3H, m, 
Ar-H), 7.15 (1H, d, J = 2.4 Hz, Ar-H), 6.78 (1H, dd, J = 5.6, 2.4 Hz Ar-H), 5.54 (1H, 
s, OH), 3.88 (3H, s, OCH3),  2.10 (1H, dq, J = 14.8, 7.6 Hz, CH3CH2), 1.98 (1H, dq, 
J = 14.4, 7.2 Hz, CH3CH2), 1.03 (3H, t, J = 7.2 Hz, CH3CH2).  13C NMR (100 MHz, 
CDCl3): δ 166.8, 163.2, 148.7, 131.9, 128.4, 128.3, 122.9, 109.4, 106.4, 91.4, 84.6, 
72.6, 55.5, 38.1, 8.6. HRMS (ESI+): Calcd for C17H18NO2 [M+1] 268.1338; Found 
268.1243.  Optical Rotation: [α]20D -97.9 (c = 0.390 in CHCl3) for a >98% ee 
sample.  Enantiomeric purity of the compound was determined by chiral HPLC 
analysis (Chiralcel OD, 99.5:0.5 hexanes:i-PrOH eluent 0.200 mL/min and a lamp 
setting of 220 nm) tr = 186 min. (minor) and tr = 160 min. (major). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area %
1 170.24 66802910 47.841 1 160.64 193944000 100 
2 186.53 72833580 52.159     
 
 
((S)-2-((E)-2-hydroxybenzylideneamino)-3-methyl-N-((R)-1-oxo-3-phenyl-1-(4-
(trifluoromethyl)-phenylamino)propan-2-yl)butanamide (L4a): Boc-D-Phe-OH 
(5.00 g, 18.8 mmol) was dissolved in 50 mL of CH2Cl2, and HOBt•H2O (3.17 g, 20.7 
mmol), EDC•HCl (3.96 g, 20.7 mmol) and p-CF3-aniline (3.04 mL, 24.4 mmol) were 
added successively at 22 °C to a round bottom flask. The resulting solution was 
allowed to stir at 22 °C for 4 h. Citric acid (50 mL of a 10 wt. % aqueous solution) 
was added and the two layers were separated. The aqueous layer was washed with 
CH2Cl2 (50 mL x 2) and the combined organic layers were washed with 10 wt. % 
aqueous citric acid (50 mL) then with a saturated aqueous solution of NaHCO3 ( 50 
mL x 2), followed by a saturated solution of NaCl (50 mL x 2). The organic layers 
were combined and dried over MgSO4 and filtered before removal of the volatiles in 
vacuo to afford Boc-D-Phe-NH(p-CF3)C6H4 as a white solid. Hydrochloric acid (4.0 
M solution in 1,4-dioxane) was added dropwise to Boc-D-Phe-NH(p-CF3)C6H4 at 
0 °C (ice bath) until complete dissolution was achieved (~10 mL). The resulting 
solution was allowed to warm to 22 °C with stirring for 30 min. After 30 min the 
mixture was concentrated in vacuo to afford ClH3N-D-Phe-NH(p-CF3)C6H4 (4.90 g, 
14.1 mmol, 75.0% yield over 2 steps). 
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Boc-L-Valine-OH (4.45 g, 20.5 mmol) was dissolved in CH2Cl2 (30 mL) and 
HOBt•H2O (3.50 g, 22.7 mmol), EDC•HCl (4.40 g, 22.7 mmol), ClH3N-D-Phe-NH(p-
CF3)C6H4 (4.90 g, 14.1 mmol), and Et3N (4.80 mL, 41.0 mmol) were successively 
added at 22 °C. The resulting solution was allowed to stir at 22 °C for 4 h, and citric 
acid (50 mL of a 10 wt. % aqueous solution) was added and the two layers were 
separated. The aqueous layer was washed with CH2Cl2 (50 mL) and the combined 
organic layers were washed with 10 wt. % aqueous citric acid (50 mL) and solution of 
saturated aqueous NaHCO3 (50 mL), followed by a wash with a saturated aqueous 
solution of NaCl (50 mL). The organic layer was dried over MgSO4 and filtered 
before removal of the volatiles in vacuo to afford Boc-L-Val-D-Phe-NH(p-CF3)C6H4.  
 
Boc-L-Valine-D-Phenylalinine-NH(p-CF3)C6H4 was dissolved in a minimal amount 
(to afford dissolution) of TFA (~10 mL) at 0 °C (ice bath). The solution was allowed 
to warm to 22 °C with stirring for 30 min.  After 30 min, the solution was allowed to 
cool to 0 °C (ice bath). A 1:1 mixture of EtOAc: H2O (30 mL) was added to this 
solution followed by NaOH (1 N solution) until pH >10 was obtained, after which the 
aqueous solution was washed with EtOAc (3 x 20 mL). NOTE: Normally CH2Cl2 is 
used for this extraction; H2N-L-Val-D-Phe-NH(p-CF3)Ph, however, was not soluble in 
CH2Cl2. The combined organic layers were dried over MgSO4 and concentrated to 
afford H2N-L-Val-D-Phe- NH(p-CF3)C6H4 as a white solid (4.10 g, 10.1 mmol, 49.0% 
yield over 2 steps).  
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Salicyl aldehyde (2.00 g, 1.07 mmol) was dissolved in CH2Cl2 (25 mL).  A slurry of 
H2N-L-Val-D-Phe-NH(p-CF3)C6H4 (4.10 g, 10.1 mmol) and MgSO4 (~500 mg) in 25 
mL CH2Cl2 were added to the solution at 22 °C.  The resulting solution was allowed 
to stir for 12 h, after which MgSO4 was removed by filtration and the organic filtrate 
was concentrated in vacuo. The resulting yellow solid purified by triteration 
(pentane:Et2O, 3:1 x 2) to afford L4a as white powder (2.35 g, 4.60 mmol, 45.0% 
yield). mp: 208-210 oC. IR (neat): 3582 (bs), 2977 (w), 2869 (w), 1648 (s), 1611 (s), 
1628 (s), 1546 (m), 1459 (w), 1411 (m), 1326 (s), 1278 (m), 1125 (m), 1067 (m) 848 
(w), 665 (s) cm-1.  1H NMR (400 MHz, CDCl3): δ 12.28 (1H, s, OH), 8.97 (1H, s), 
8.15 (1H, s), 7.53-7.42 (4H, m), 7.24 (1H, s), 7.08-6.94 (7H, m), 6.58 (1H, d, J = 7.0 
Hz), 4.75 (1H, q, J = 8.7 Hz), 3.61 (1H, d, J = 4.4 Hz), 3.24 (1H, dd, J = 6.3, 5.8 Hz), 
3.09-3.02 (1H, m), 2.46-2.34 (1H, m), 0.97 (3H, d, J = 7.0 Hz), 0.90 (3H, d, J = 7.0 
Hz).  13C NMR (100 MHz, CDCl3): δ 173.0, 169.2, 168.2, 160.8, 140.8, 136.0, 133.7, 
132.4, 129.1, 128.9, 128.2, 127.2, 126.3 (q, J = 3.8 Hz), 126.2 (q, J = 31.9 Hz), 125.5 
(q, J = 269.4 Hz), 119.5, 118.4, 117.4, 79.5, 55.5, 36.9, 32.5, 19.6, 17.6. HRMS 
(ES+): Calcd for C28H29N3O3F3 [M+1] 512.2161; Found 512.2178. Optical 
Rotation: [α]20D +81.6 (c = 1.26 in CHCl3). 
 
(S)-2-((E)-2-hydroxybenzylideneamino)-3-methyl-N-((S)-1-oxo-3-phenyl-1-(4-
(trifluoromethyl)phenylamino)propan-2-yl)butanamide (L5a):  mp: 230-232 oC. 
IR (neat): 3282 (bs), 3052 (w), 2960 (w), 2866 (w),  1652 (s), 1632 (s), 1628 (s), 
1538 (m), 1486 (w), 1411 (m), 1330 (s), 1273(m), 1122 (m), 1068 (m) 828 (m), 762 
(m) cm-1.  1H NMR (400 MHz, CDCl3): δ 12.15 (1H, s, OH), 9.18 (1H, s), 8.27 (1H, 
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s), 7.53-7.15 (11H, m), 7.04 (1H, d, J = 7.6 Hz), 6.97 (1H, s), 6.68 (1H, d, J = 4.3 Hz), 
4.86 (1H, q, J = 4.0 Hz), 3.69 (1H, s), 3.30 (1H, d, J = 11.7 Hz), 3.3.05 (1H, t, J = 7.6 
Hz), 2.50-2.39 (1H, m), 0.78 (3H, d, J = 3.6 Hz), 0.55 (3H, d, J = 4.7 Hz).  13C NMR 
(100 MHz, CDCl3): δ 173.0, 169.2, 168.7, 160.8, 140.8, 136.3, 133.7, 132.5, 129.3, 
129.2, 127.5, 126.2 (q, J = 1.9 Hz), 125.7 (q, J = 30.9 Hz), 124.1 (q, J = 248.2 Hz), 
119.5, 119.4, 118.4, 117.4, 79.1, 56.0, 36.9, 32.2, 19.6, 16.4.  HRMS (ES+): Calcd 
for C28H29N3O3F3 [M+1] 512.2161; Found 512.2165. Optical Rotation: [α]20D +69.7 
(c = 0.900 in CHCl3). 
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XIII. NMR Data for Ynones and Et2Zn Addition Products 
N
O
NMe
OMe
15
0123456789  
 
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 110 
Ph
O
N
16a
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.5  
 
 
102030405060708090100110120130140150160170180190  
 
 Chapter 2 Page 111 
O
N
Me 16b
0123456789  
 
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 112 
O
N
Me 16c
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 113 
O
N
Me
16d
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 114 
O
N
MeO 16e
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.5  
 
255075100125150175200  
 Chapter 2 Page 115 
O
N
F3C 16f
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 116 
O
N
I 16g
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 117 
O
N
Cl
Cl
16h
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 118 
O
N
Br
16i
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 119 
O
N
S 16j
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 120 
C6H13
O
N
16k
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 121 
O
N
16l
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 122 
TIPS
O
N
16m
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 123 
H
O
N
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 124 
N
O
NMe
OMe
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 125 
Ph
O
N
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 126 
N
O
Me
OMe
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 127 
Ph
O
Ph
22
0123456789  
 
102030405060708090100110120130140150160170180190  
 
 Chapter 2 Page 128 
N
O
Me
OMe
O
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 129 
Ph
O
O
24
0123456789  
 
102030405060708090100110120130140150160170180190  
 
 Chapter 2 Page 130 
NC N
OMe
18  
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 131 
N
O
Me
OMe
N
OMe
19
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 132 
Ph
O
N
OMe20
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 133 
N
Br
O
 
0123456789  
 
8090100110120130140150  
 
 Chapter 2 Page 134 
N CN
Br  
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 135 
Ph
O
N
Br
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 136 
Ph
N
EtHO
17a
012345678910  
 
 
 Chapter 2 Page 137 
N
Me
HO Et
17b
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 138 
N
HO Et
Me 17c
0123456789  
 
102030405060708090100110120130140150160170180190  
 
 Chapter 2 Page 139 
N
EtHO
Me 17d
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 140 
N
MeO
EtHO
17e
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.5  
 
 
 Chapter 2 Page 141 
EtHO
F3C
N
17f
0123456789  
 
102030405060708090100110120130140150160170180190  
 
 Chapter 2 Page 142 
N
I
HO Et
17g
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 143 
N
Cl
Cl
HO Et
17h
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 144 
N
Br
HO Et
17i
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 145 
N
S
HO Et
17j
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 146 
C6H13
N
HO Et
17k
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 147 
N
EtHO
17l
0123456789  
 
 
 Chapter 2 Page 148 
N
AcO Et
0123456789  
 
255075100125150175200  
 Chapter 2 Page 149 
TIPS
N
HO Et
17m
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 150 
H
N
HO Et
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 151 
Ph
N
HO Et
19
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 152 
Ph
N
HO Et
Br
20
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 153 
Ph
N
OMe
HO Et
21
0123456789  
 
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 154 
N
O
H
N
Ph
O
N
H
OH
MeMe CF3
L4a  
 
0123456789101112  
102030405060708090100110120130140150160170180190  
 Chapter 2 Page 155 
N
O
H
N
Ph
O
OH
MeMe
N
H
CF3
L5a  
 
 
 
0123456789101112
  
102030405060708090100110120130140150160170180190  
 
Chapter 3, Page 156 
Chapter 3 
Development of a Catalytic Enantioselective Method for the Addition of Me2Zn to 
Pyridyl-Ynones Using Easily Modifiable Salicyl-Based Amino Acid Ligands 
I. Introduction 
 As illustrated by many previously developed methods (see Chapter 1), the 
reactivity of Me2Zn and Et2Zn toward the alkylation of carbonyl groups are very different.  
There are no clear reasons or definite scientific evidence that proves why Et2Zn is more 
reactive then Me2Zn; some reports, however, discuss the length, strength and polarity of 
the Zn-C bonds in conjunction with theoretical calculations, to offer insight into the 
structural characteristics and reactivity of dialkylzinc reagents.1  It has been calculated 
that the C-Zn bond of Me2Zn is 1.945 Å long with a C-Zn bond strength of 44.4 Kcal/mol, 
whereas the C-Zn bond of Et2Zn is 1.960 Å and is 37.5 Kcal/mol strong.1a  The C-Zn-C 
bond angles in all dialkylzinc reagents is linear (179.4-180.0o), unless activated by a 
ligand.1  X-ray crystallography data has been collected for a triazine adduct of Me2Zn; 
there are two triazine ligands per Zn unit. It is evident from this structure that the bond 
angle between the C-Zn-C and N-Zn-N planes is 90o; the C-Zn-C bonds are also 
lengthened to 1.98 Å, leading to a more reactive C-Zn bond.1b  This activated tetrahedral 
species is what presumably alkylates electrophiles.   
Many supporting studies have reported that coordination of a ligand to a metal 
center increases the Lewis acidity of that center by pushing electron density to the 
                                                 
1 (a) Haaland, A.; Green, J. C.; McGrady, S.; Downs, A. J.; Gullo, E.; Lyall, M. J.; Timberlake, J.; Tutukin, 
A. V.; Volden, H. V. Dalton Trans., 2003, 4356-4366. (b) Hursthouse, M. B.; Motevalli, M.; Walsh, J. R.; 
Jones, A. C.; J. Mater. Chem., 1991, 1, 139-140. (c) Hursthouse, M. B.; Motevalli, M. ; O’Brien, P.; Walsh, 
J. R. Organometallics 1991,  10, 3196-3200. (d) Markles, P. R.; Schat, G.; Akkerman, O. S.; Bickelhaupt, 
F.; Organometallics 1990,  9, 2243-2247. 
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ligands.2  Coordination of a ligand to the dialkylzinc center would increase the Lewis 
acidity of the Zn and cause the alkyl groups to bear more negative charge, hence 
increasing the nucleophilicity of the alkyl groups.  This type of activation could be more 
pronounced for Et2Zn because it already has longer C-Zn bonds and weaker bond 
strengths.  
The seemingly minor change from a Me-group to an Et-group causes a significant 
change the nucleophilicity of the alkylzinc reagents, which is apparent for the additions 
of Me2Zn to pyridyl-ynones.  The chiral ligand identified for the addition of Et2Zn to 
pyridyl-ynones (see Chapter 2) proved to be far less effective for Me2Zn and therefore 
required the development of a new catalytic system for the addition of Me2Zn to pyridyl 
ynones.  Our goal was to utilize our previous strategy to identify an amino acid-based ligand, 
which promoted this important transformation. 
 
II. Initial Studies 
We began investigations for the additions of Me2Zn to pyridyl-ynone 1a (Scheme 
1).  Our initial studies were conducted based on conditions developed for alkylation of α-
ketoesters 3 and pyridyl-ynones.  To our surprise, the use of the catalytic system for the 
addition of dialkylzinc reagents to α-ketoesters3 afforded no desired product ( 4a) at -78 
oC. 
                                                 
2 Denmark, S. E.; Beutner, G. L.; Wynn, T. Eastgate, M. D. J. Am. Chem. Soc. 2005, 127, 3774-3789 and 
references cited therein. 
3 Wieland, L. C.; Deng, H.; Snapper, M. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2005, 127, 15453–15456. 
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Ph
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Scheme 1. Preliminary Screening for Me2Zn Additions to Alkynyl-Pyridyl Ketones
1a 4a
2
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60% conv, <2% ee
N
- 78 oC:
- 30 oC:
Ph
O
10 mol % Al(Oi-Pr)3,
5 equiv Me2Zn
50 mol % H2NP(O)(OEt)2 (3)
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N
Ph
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1a 11a
 Me2Zn Addition Using Optimal Condit ions f or Et2Zn Addition to Py ridyl-Ynones
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O
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MeMe CF3
5
10 mol %
<2% conv
53% conv, <2% ee
 Me2Zn Addition Using Optimal Condit ions f or (alky l)2Zn Addition to α -Ketoester s
- 78 oC:
- 30 oC:
 
At -30 oC, in the presence of amino acid based ligand 2 the desired alcohol 4a was 
delivered in 53% conv and <2% ee (Scheme 1, eq 1).   The catalytic system developed 
for the addition of Et2Zn to pyridyl-ynones also was not efficient; as illustrated in Scheme 
1 eq 2.  Reactivity was achieved at -30 oC (60% conv), but the tertiary alcohol was 
obtained in <2% ee.  
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III. Ligand Screening Strategies:  Site Selective Screening 
X
N
H
N
O
AA1 O
C-Terminus
AA2
N-T erminus
Figure 1. Modular Peptide Ligand Structure  
Figure 1 defines the moieties of the ligand that were modified to identify the 
optimal ligand.   Ligand screening for the addition of Me2Zn to 1a was carried out at 5 
mol % ligand, 5 mol % Al(Oi-Pr)3, 50 mol % 3 in toluene at -30 oC for 12 h.  Our initial  
L-PheL-Val
L-Phe
L-Val
72
71
77
67
AA1 conv. (%)b
<10
<10
65
14
ee (%)c
D-Val 56 <104
3
5
2
1
entry
a All reactions perfomed under an N2 atmosphere. b Conversions
determined by 400MHz 1H NMR analysis. c Enantioselectivities
determined by chiral HPLC analysis.
-
-
D-Phe
L-Phe
L-Val
73 <10
L-Val 68 <106
7 L-Phe
Gly
Gly
L1c
L1e
L1b
L1a
L1d
L1g
L1f
AA2
N
AA1
O
H
N
AA2
O
NHn-Bu
OH
L1
Table 1. Site Selective Positional Screening for Me2Zn Addition to 1aa
N
Ph
O 5 mol % ligand
5 mol % Al(Oi -Pr)3
10 equiv Me2Zn
50 mol % 3
toluene, -30 oC, 12 h
N
HO Me
Ph
1a 4a
 
screening temperature was -30 oC because there is <2% background reaction (only 
Me2Zn and 1a). Initial experiments included single amino acid ligands (L1a, and L1b), 
diamino acid ligands (L1c, L1d, and L1e), as well as ligands with Gly- as AA1 or AA2 
(L1f and L1g, Table 1).  We found that single amino acid ligands provided 4a in superior 
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selectivities than dipeptide ligands (77% conv, 65% ee with L1b vs. 72% conv, <2% ee 
with L1c, entries 2 and 3, Table 1).   
 
IV. Ligand Screening Strategies:  N-Terminus and the Amino Acid Moiety 
N
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Chart 1. Schiff Base Modifications for Catalytic Enantioselective Me2Zn Additions to Ynone 1a
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Modification of the N-terminus of ligand L1b was performed (see Chart 1) and 
results indicated that a 3,5-dichlorosalicyl Schiff base moiety for phenylalanine mono-
amino acid ligand was optimal for the alkylation of 1a, affording tertiary alcohol 4a in 
92% conv and 79% ee.   There is a distinct trend of decreasing enantioselectivity when 
N
AA
NHn-Bu
O
OH
Chart 2. Amino Acid Modif icaitons for Catalytic Enantioselective Me2Zn Additions to Ynone 1a
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the salicyl Schiff based is changed form 3,5-Cl2 (79% ee) to 3,5-Br2 (65% ee) to 3,5-I2   
(15% ee).  Also evident from this screen is that strongly electron rich Schiff bases deliver 
poor selectivities (4-OH 16% ee, 3-OMe 10% ee, and 5-OH <2% ee). 
N
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O
OH
R
1
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4
5
6
Chart 3. Schiff Base Modificaitons of Cys(Bn) Amino Acid Ligand
for Catalytic Enantioselective Me2Zn Additions to Ynone 1a
9 2
8 6
4 6
7 3
8 9
7 3
9 1
8 8
7 6
6 9
8 3
7 5
5 5
5 9
3 6
7 2
7 9
6 5
1 4
5 7
6 8
5
7 3
5 9
1 6
2 0
5 3
1 2
00
5
1 1
0
1 0
2 0
3 0
4 0
5 0
6 0
7 0
8 0
9 0
un
su
bs
titu
ted
4-O
Me
5-O
H
3-M
e
5-N
O23,5
-I
3,5
-C
l
5-B
r-3
-N
O2
3-O
Me
3,5
-t-
Bu
5-N
O2
-3-
OM
e
5-B
r-3
-O
Me
4-O
H
3,5
-N
O2
4-N
Et
2
3-O
H
Pe
rce
nt 
(%
)
%  c o n v
%  e e
 
Chapter 3, Page 163 
Concurrent modification of the amino acid portion of the ligand indicated 
Cys(Bn) as a complementary amino acid to Phe, affording 4a in 93% conv and 79% ee 
(see Chart 2). Empirical data indicates a need for an aromatic group as the part of the 
amino acid, which could be important for mechanistic consideration (Phe 63%ee, 
Cys(Bn) 79% ee, Tyr( Bn) 68% ee, Thr(Bn) 59% ee, and Glu(Bn) 61% ee). 
Further modification of the Cys(Bn) ligand showed that the unsubstituted salicyl 
Schiff base was most selective; comparable results are obtained with functionalized 
salicyl Schiff base, but are more costly (3,5-Cl2 73% ee, 4-OMe 65% ee and 5-NO2 
68%ee, Chart 3).  Ligands, 6 and 7 (Figure 2), perform in a similar manner for the 
addition of Me2Zn to 1a, affording 4a in 93% conv and 79% ee.   
N
O
NHn-Bu
OH
Cl
Cl
Ph
N
O
NHn-Bu
OH
BnS
76
Figure 2. Optimal Mono Amino-Acid Ligands for the addition of
Me2Zn to Pyridyl-Ynones  
 
V. Ligand Screening Strategies:  C-Terminus and Lewis Basic Additive Studies 
Exploration of the C-terminus was carried out with two ligands. No improvement 
in overall reactivity or selectivity compared to ligand 7 was observed (92% conv, 79% 
ee).  Several C-termini performed in an equivalent manner to that of ligand 7, they,  
however, proved to be more costly (i.e., Table 2, entries 3 and 9, NHBn L2c 71% ee and  
NHC12H25 L3c 75% ee). 
Chapter 3, Page 164 
5 mol % ligandO HO Me5 mol % Al(Oi -Pr)3
50 mol % 3
10 equiv Me2Zn
toluene, -30 oC, 24 h
N
Ph
N
Ph1a 4a
63
47
87
73
conv. (%)b
10
<2
71
<2
ee (%)c
74 <25
4
10
3
2
entry
a All reactions perfomed under a N2 atmosphere. b Conversions determined
by 400 MHz 1H NMR analysis. c Enantioselectivities determined by chiral
HPLC analysis.
NR'R"
NHt-Bu
NMorph
95 46
62 2911
12
Table 2. C-Terminus Modifications for Me2Zn Addition to Ynone 1aa
L2d
L3d
L2c
L2b
L2e
L3f
L3e
N
O
BnS
BnS
NR'R''
OH
Cl
Cl
N
O
NR'R''
OH
L2 L3
64 426 NH(p-CF3)Ph
93 75
51 -38
9
NH(p-OMe)Ph
L2f
L3c
L3b
NHC12H25
Gly-OMe
NHPh
NEt2
NHBn
NHMe
89 707 L3a
91 731 L2a
NHn-Bu
NHn-Bu
 
After identification of optimal ligands 6 and 7 for asymmetric addition of Me2Zn 
to 1a, we investigated the role of the Lewis basic phosphoramidate additive 3.  We found 
that the addition of additive 3 increased the efficiency of the uncatalyzed reaction (see 
Scheme 2, eqs 3 and 4).  Data from equation 5 showed that an efficient reaction was 
achieved in the absence of the aluminum salt; in order to achieve selectivity, however, 
aluminum was required (eq 6, Scheme 2). Comparison of the data illustrated by equations 
6 and 7, showed that the phosporamidate additive 3 was detrimental to the Al-catalyzed 
enantioselective addition of Me2Zn to 1a, 50mol % 3 afforded 4a in 65% ee, 50 mol % 3 
afforded 4a in 79% ee (Scheme 2).   
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Scheme 2. Condition Screening of Uncatalyzed Reactions for the Addition of Me2Zn to 1a
N
Ph
O
5 equiv Me2Zn
toluene, -30 oC, 24 h
N
Ph
MeHO
1a 4a
<2% conv
N
Ph
O
50 mol % H2NP(O)(OEt)2 (3)
5 equiv Me2Zn
toluene, -30 oC, 24 h
N
Ph
MeHO
1a 4a
69% conv
O
N
Ph
5 mol % 7
50 mol % H2NP(O)(OEt)2 (3)
5 equiv Me2Zn
toluene, -30 oC, 24 h
N
HO Me
Ph
1a 4a
92% conv
<2% ee
N
Ph
O 5 mol % 7
5 mol % Al(O i-Pr)3
5 equiv Et2Zn
toluene, -30 oC, 24 h
N
Ph
MeHO
1a 4a
70% conv,
79% ee
5 mol % 7
5 mol % Al(O i-Pr)3
50 mol % H2NP(O)(OEt)2 (3)
5 equiv Me2Zn
toluene, -30 oC, 24 h
N
O HO Me
N
Ph Ph
1a 4a
(3)
(4)
(5)
(7)
(6)
95% conv,
65% ee
 
Catalyst loading studies were conducted for the asymmetric addition of Me2Zn to 
1a and results indicted that 15 mol % catalyst is beneficial to the reaction >98 % conv, 
74% yield and 95% ee (see Table 3).  The need for increased catalyst loading became 
more evident upon investigations of other substrates. Background reactivity varies 
depending on the substrate and higher catalyst loadings allows the catalytic reaction to 
more efficiently compete with the background reactions.  
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N
Ph
O
N
Ph
MeHO
entry
ee
(%)d
conv
(%)b
7
mol %
yield
(%)c
Al(Oi-Pr)3
mol %
1 89 7964
2
3
92
>98
82
95
60
74
5
10
15
5
10
15
a All reactions perfomed using glovebox techniques.
b Conversions determined by 400 MHz 1H NMR analysis. c Yields of
isolated products, d Enantioselectivity determined by chiral HPLC analysis.
T able 3. Investigation of Catalyst Loading for Me2Zn Additions to 1aa
4a1a
X
X
mol % 7
mol % Al(O i-Pr)3
5 equiv Me2Zn,
toluene, -30 oC, 12 h
                                                
 
VI. Examination of Substrate Scope 
As illustrated in Table 4, substrates bearing aromatic (entries 1-6), heteroaromatic 
(entry 7) and aliphatic (entry 8) substituents on the alkyne proved to be suitable.  Moreover, 
pyridyl-ynones that contain electron withdrawing groups on the aryl ring show in increase in 
background reactivity and require lower temperatures (Table 4 entries 3 and 5).  Lower 
enantioselectivity is observed for the addition of Me2Zn to substrate 1g  because the reaction 
is performed at -30 oC; when this reaction is performed at -50 oC, there is no conversion to 
desired product.  Substitution on the pyridyl-ring was also tolerated for the addition of Me2Zn 
to afford tertiary alcohol products 8 and 9 with 77% and 63% ee respectively; lower yields 
for isolated products, however, were observed (45-57%).  Ynones which deliver alcohols 8 
and 9 contain electron donating groups on the pyridyl ring, this increase in electron density 
could have a negative affect on catalytic turnover, which could be the cause of  lower yields.4   
 
4 Placement of a bromine at the ortho position of the pyridyl ring underwent >98% conv, however we were 
unable to identify HPLC or GC separation condition to determine enantioselectivity.  Modifications of the 
tertiary alcohol product were also attempted yet separation was not achieved. 
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O
entry
1
2
3
4
5
6
7
8
9
N
R
HO
N
R
Me
15 mol % Al(Oi-Pr)3, 5 equiv Me2Zn,
toluene, –30 °C, 12 h
1 4
R
C6H5
p-OMeC6H4
p-CF3C6H4
p-IC6H4
p,m-Cl2C6H3
o-BrC6H4
3-thiophene
n-hex
(i-Pr)3Si
conv
(%)b
yield
(%)c
ee
(%)d
>98
>98
>98
>98
>98
>98
>98
>98
>98
74
77
70
58
53
57
74
59
65
95
96
87f
79
95f
96
91
89
57e
a
e
f
g
h
i
j
k
m
Table 4. Al-Catalyzed AA Reactions with Me2Zna
N
NHn-Bu
O
OH 7
SBn15 mol %
a All reactions performed under N2 atm; see the
experimental section for details. b Determined through
analysis of 400 MHz 1H NMR spectra. c Yields of products
after silica gel purification. d Enantioselectivities were
determined by chiral HPLC analysis. e Reaction performed at
-50 °C with ligand 6. f Reaction performed at -50 °C.
N
Ph
MeHO
N
Ph
MeHO
8
77% ee, 53% yield
9
63% ee, 45% yield
OMe
 
 
VII. Cross Examination of Optimal Condition for Me2Zn and Et2Zn 
  The conditions identified for the asymmetric addition of Et2Zn to 1a (10 mol % 5, 
10 mol % Al(Oi-Pr)3, 50 mol % 3 in toluene at  -78 or -30 oC for 12 h, Scheme 3, eq 8) 
are not sufficient enough to afford 4a in reasonable selectivity for the asymmetric 
addition of Me2Zn. When these conditions were applied in the absence of Lewis basic 
additive 3 only 23% ee could be achieved (Scheme 3 eq 8).  Furthermore, the optimal 
conditions that were identified for Me2Zn addition to 1a (15 mol % 7, 15 mol % Al(Oi-
Chapter 3, Page 168 
Pr)3, 50 mol % 3 in toluene at -78 oC for 20 min) were screened for Et2Zn addition 
(Scheme 3 eq 9); a significant decrease in enantioselectivity, chemoselectivity and 
efficiency were observed. 
Scheme 3. Cross Examination of Optimal Conditions for Me2Zn vs. Et2Zn
<2% conv
60% conv, <2% ee
59% conv, 23% ee
N
N
Ph
O 15 mol % 7
15 mol % Al(O i-Pr)3
3 equiv Et2Zn
+/- 50 mol % 3
toluene, -78 oC, 20 min
1a
N
Ph
EtHO
10
With 3:
Without 3:
 Et2Zn Addition Using Optimal Condit ions f or Me2Zn Addit ion
conv (%) 10:11 10yield (%)
10
ee (%)
82 1:1 24 <20
92 1:1 27 <27
- 78 oC with 3:
- 30 oC with 3:
- 30 oC without 3:
Ph
O
10 mol % Al(O i-Pr)3
5 equiv Me2Zn, +/- 50 mol% 3
toluene, 24 h
N
Ph
MeHO
1a 4a
 Me2Zn Addition Using Optimal Condit ions for Et 2Zn Addit ion to Py ridy l-Ynones
(8)
N
O
H
N
Ph
O
N
H
MeMe CF3
OH
5
10 mol %
(9)
N
rac-11
OH
Ph
aAll reactions performed under N2 atm; see the
experimental section for details. b Determined through analysis
of 400 MHz 1H NMR spectra. c Yields of products after silica gel
purification. d Enantioselectivities were determined by chiral
HPLC analysis  
As illustrated in Scheme 3, cross examination of the optimal catalyst systems did not 
improve selectivities or yields for either Me2Zn or Et2Zn addition. Secondary alcohol 
product 11 was also formed for Et2Zn addition under Me2Zn conditions; once again 
indicating how differently various dialkylzinc reagents can behave.  
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VIII. Mechanistic Consideration 
The proposed models that account for catalytic enantioselective additions using 
Me2Zn are illustrated in Scheme 4 (I-II).  Catalyst screening indicated a requirement for 
the presence of an aryl-containing amino acid side change (see Chart 2), most likely due 
to the structural organization gained through a π-stacking interaction involving the 
electron deficient pyridine ring of the Al-bound substrate.5  The aryl–aryl association 
inhibits nucleophilic addition from one face of the activated ketone, leading to selective 
generation of one enantiomer. This is supported by minimization of energies for 
transition states proposed in complexes I and/or II and the proposed scenario is 
consistent with the absolute stereochemistry for Me2Zn addition product 4a, determined 
by X-ray crystallography.6  
The adverse effect of 3 in reactions with Me2Zn may be attributed to the 
facilitation of the non-catalyzed process by this additive (see Scheme 2, comparison of eq 
3 and 4), where one equivalent of Me2Zn acts as an achiral Lewis acid, activating a 
substrate molecule, followed by a phosphoramidate-activated equivalent of Me2Zn 
adding to this Zn-bound substrate.  This process competes efficiently with the chiral Al-
Lewis acid catalyzed process.  Such an effect maybe absent in the reactions of Et2Zn, as 
such transformations are performed at –78 °C (vs. –30 °C for Me2Zn); at lower reaction 
temperatures, there may be minimal activation of Et2Zn by 3.  
                                                 
5 (a) Tucker, J. A.; Houk, K. N.; Trost, B. M. J. Am. Chem. Soc. 1990, 112, 5465-5471. (b) Lewis, F. D.; 
Simpson, J. T. J. Am. Chem. Soc. 1980, 102, 7595-7596. (c) Alvaro, G.; Boga, C.; Savoia, D.; Umani-
Ronchi, A. J. Chem. Soc., Perkin Trans. I. 1996, 875-882.  (d) Otera, J.; Yoshinaga, Y.; Yamaji, T.; 
Yoshioka, T.; Kawasaki, Y. Organometallics 1985, 4, 1213-1218.  (e) Jones, G. B.; Chapman, B. J. 
Synthesis, 1995, 475-497. (f) Ito, Y.; Amino, Y.; Nakatsuka, M.; Saegusa, T.  J. Am. Chem. Soc. 1983, 105, 
1586-1890. (g) Mezrhab, B.; Dumas, F.; d’Angelo, J.; Riche, C. J. Org. Chem. 1994, 59, 500-503. 
6 All structures were minimized using MMFF94 method as supplied by Spartan ’04, Wavefuncton, Inc. 
Irvine, CA, performed by Adil Zhugralin. 
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The L,D-ligand 5, effective for enantioselective additions with Et2Zn, only 
promotes asymmetric alkylations for Me2Zn in the absence of Lewis basic additive 3, 
albeit with lower selectivity (23% ee).  This could be due to weaker π-stacking 
interactions between AA2 of dipeptide ligand 5 and the Al-bound substrate.  When 
phosphoramidate additive 3 is used in conjunction with L,D-ligand 5, the aforementioned 
Zn-catalyzed process competes more efficiently, affording racemic 4a.  
π -Stacking Int eract ion Hinder s Appr oach f rom One F ace of Ketone
Scheme 4. Mechanistic Models for Al-Catalyzed AA Reactions with Me2Zn
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IX. Conclusion for Me2Zn Additions to Pyridyl-Ynones 
 We have developed an Al-catalyzed enantioselective method for the addition of 
Me2Zn to pyridyl-ynones.  Chiral ligands can be easily prepared in gram quantities and 
substrates are prepared in, at most, four steps.  At this point in time, we have yet to 
develop a general method for catalytic enantioselective formation of tertiary alcohols.  
We have illustrated the versatility of amino acid-based ligands, which are easily 
modifiable, cost efficient  and can be quickly optimized to promote a desired alkylation 
process.  This class of ligands  could be the key to a general method for the formation of 
enantiomerically enriched tertiary alcohols.  
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The protocols outlined in both Chapter 2 and 3 illustrate the formation of 
quaternary carbon centers bearing three modular substituents: a pyridine, and alkyne and 
an alcohol.  In the following section modification of these three moieties will be 
discussed.  
 
X.  Functionalization of Tertiary Alcohol Products Flanked by a Pyridyl-Ring and 
an Alkyne. 
a) Functionalizations of  the pyridyl group of the catalytic asymmetric 
alkylation products.  
 A number of recent disclosures have involved catalytic (non-asymmetric) 
transformations of pyridyl-substituted propargyl alcohols to the corresponding N-fused 
bicyclic structures (Scheme 5).  Various Au-,7 Cu-8 and Pt-based9 catalysts have been 
reported to promote such processes with various levels of efficiency, the majority of 
cases involving reactions of secondary alcohols.  Pyridyl-substituted tertiary alcohols, 
available for the first time in high enantiomeric purity can be easily converted to 
synthetically versatile bicyclic systems that contain a quaternary α-amino carbonyl group 
through a subsequent and facile Cu-catalyzed transformation.10  Representative examples 
are illustrated in Scheme 5. 
                                                 
7 Seregin, I. V.; Gevorgyan, V. J. Am. Chem. Soc. 2006, 128, 12050–12051. 
8 (a) Jansen, A.; Krause, N. Synthesis 2002, 1987–1992. (b) Jansen, A.; Krause, N. Inorg. Chim. Acta 2006, 
359, 1761–1766. (c) Yan, B.; Zhou, Y.; Zhang, H.; Chen, J.; Liu, Y. J. Org. Chem. 2007, 72, 7783-7786. 
9 Smith, C.; Bynnelle, E. M.; Rhodes, A. J.; Sarpong, R. Org. Lett. 2007, 9, 1169–1171. 
10 Attempts to promote similar cyclizations with a number of alkylation products (including alkyl-
substituted 14) in the presence of 15–30 mol % PtCl2 (see ref 9) resulted in generation of complex mixtures 
of products.   
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HO
N
Ph
Et
10
( >98% ee)
Scheme 5. Functionalization of Pyridyl-Substituted Tertiary Carbinols.
Application to Cu-Catalyzed Enantioselective Synthesis of Indolizinones
5 mol % CuI
1.0 equiv Et3N, CH3CN,
82 °C, 2 h
N
Ph
O
Et
12
>98% ee, 80% yield
N
Ph
O
Et
13
>98% ee, 78% yield
( >98% conv, 2 h)
f rom alcohol of >98% ee
OMe
N
O
Et
14
96% ee, 56% yield
( 85% conv, 2h)
fr om alcohol of >98% ee
N
O
Me
15
80% ee, 60% yield
(85% conv, 12 h)
f rom alcohol of 89% ee
n-hex
 
 Treatment of enantiomerically pure tertiary propargyl alcohol 10 with 5 mol % 
CuI (82 °C) results in complete conversion (>98%) within two hours, allowing 12 to be 
isolated in 80% yield.  Synthesis of bicycle 13 (78% yield after purification) represents a 
reaction of an enantiomerically pure substrate that bears a modified pyridyl group.  
Catalytic cyclization of a terminal alkyne affords 14 at a slower rate compared to the 
aforementioned two processes, presumably because the developing positive charge β to 
the developing carbonyl unit is less stabilized due to lower degree of substitution.  
Nonetheless, the desired bicycle is obtained in 56% yield after silica gel 
chromatography.11  Cu-catalyzed reaction of alkyl-substituted tertiary propargyl alcohol 
4k (see entry 8, Table 4) also proceeds less readily, as the cyclization requires 12 hours to 
proceed to 85% conversion; bicyclic amide 15 is isolated in 60% yield. 
With the availability of enantiomerically enriched tertiary propargyl alcohols, the 
retention of the stereochemical integrity of the tertiary carbinol site during the Cu-
                                                 
11 Even though 85% conv is achieved the yield of the isolated product is moderate due decomposition  of 
the substrate and product. 
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catalyzed cyclization process was investigated.  In cases where catalytic cyclization 
proceeds to >98% conversion within 2 hours, such as formation of 12 and 13, complete 
retention of stereochemistry is achieved.  When the Cu-catalyzed process is relatively 
sluggish, however, some enantiomeric purity is lost.  Bicyclic amide 14 is thus obtained 
in 96% ee from a sample of alcohol that is isolated in >98% ee, and the slowest forming 
alkyl-substituted 15 is obtained in 80% ee from a substrate which is prepared in 89% ee.  
It is plausible that with the slower cyclizations, the Cu-alkyne complex, which likely 
serves as an intermediate in the catalytic cycle, coordinates to the neighboring Lewis 
basic hydroxyl group and facilitates epimerization at the carbinol center through a C–O 
bond dissociation/reformation process. 
b) Functionalizations involving the alkyne groups of AA products.  
The alkyne unit of the enantiomerically enriched products can be readily 
hydrogenated to afford the corresponding alkyl-substituted tertiary alcohols without 
complications from the relatively sensitive tertiary benzylic alcohol; synthesis of 16 in 
84% yield through a simple Pd-catalyzed hydrogenation is representative (Scheme 6).  
Similarly, hydrogenation of ethyl-substituted tertiary carbinol 10 in the presence of 15 
mol % Pd(CaCO3) results in stereoselective reduction of the alkyne, furnishing allylic 
alcohol 17 as a 10:1 mixture of cis:trans isomers and in 87% yield (Scheme 6).  Through 
treatment of 4a with Red-Al ®,12 the derived trans tertiary alcohol 18 is obtained as a 
single alkene isomer (>98% E) in 71% yield after silica gel chromatography.  
                                                 
12 Corey, E. J.; Katzellenbogen, J. A.; Posner, G. H. J. Am. Chem. Soc. 1967, 89, 4245–4247. 
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N
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Scheme 6. Representative Functionalizations of Alkyne Group of
the Catalytic AA Products
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THF, 22 °C, 30 min
2. 2.2 equiv n-BuLi,
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56% over all y ield
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N
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It was mentioned previously that silyl-substituted AA products offer access to 
enantiomerically enriched terminal alkynes, which can undergo alkylation for installation 
of other functionality. 13   The transformation of 19 through a desilylation/alkylation 
sequence (Scheme 6), provides 20, which is a potential substrate for enyne cyclization 
reactions. 14
                                                 
13 Negishi, E.-i.; Holmes, S. J.; Tour, J. M.; Miller, J. A.; Cederbaum, F. E.; Swanson, D. R.; Takahashi, T.  
J. Am. Chem. Soc.  1989, 11, 3336-3346. 
14 For recent examples of enyne cyclization reactions, see: (a) Pearson, A. J.; Dubbert, R. A. 
Organometallics 1994, 13, 1656–1661. (b) Negishi, E-i.; Holmes, S. J.; Tour, J. M.; Miller, J. A.; 
Cederbaum, F. E.; Swanson, D. R.; Takahashi, T. J. Am. Chem. Soc. 1989, 111, 3336–3346. (c) Mamane, 
V.; Gress, T.; Krause, H.; Fürstner, A. J. Am. Chem. Soc. 2004, 126, 8654–8655. (d) Kim, H.; Lee, C. J. 
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Scheme 7. Application to Enantioselective Synthesis of
Tetrasubstituted Allenes
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 The stereochemically defined tertiary propargyl alcohol offers numerous 
opportunities for conversion of the AA products to a wide variety of compounds that are 
otherwise difficult to access in high enantiomeric purity.  A representative case is 
illustrated in Scheme 7.  Treatment of acetate 21, obtained in quantitative yield for 
enantiomerically enriched 10, with cyclopentylmagnesium chloride in the presence of 
CuCN at –40 °C leads to the formation of enantiomerically pure tetrasubstituted allene 22 
in 74% yield;8a-b, 15  synthesis of 23, involving the reaction of tert-butyllithium and 
methyl-substituted tertiary carbinol provides an additional example.16  In both examples 
there is minimal loss of enantiopurity.  Similar observations have been disclosed for 
transformations that involve enantiomerically enriched secondary propargyl alcohols; 
electron transfer processes involving the allene product and the cuprate reagents have 
                                                                                                                                                 
Am. Chem. Soc. 2005, 127, 10180–10181. (e) Jiménez-Núñez, E.; Echevarren, A. M. Chem. Commun. 2007, 
333–346. 
15 For other methods that furnish enantiomerically enriched tetrasubstituted allenes, see: (a) Hayashi, T.; 
Tokunaga, N.; Inoue, K. Org. Lett. 2003, 6, 305–307. (b) Miura, T.; Shimada, M.; Ku, S-Y.; Tamai, T.; 
Murakami, M. Angew. Chem., Int. Ed. 2007, 46, 7101–7103.  For a protocol for synthesis of Ti-substituted 
tetrasubstituted allenes, see: (c) Okamoto, S.; An, D. K.; Sato, F. Tetrahedron Lett. 1998, 39, 4551–4554. 
16  Allene 23 was afforded in 89% ee from the requisite alcohol 4a with 95% ee. 
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been suggested to rationalize such observations.8a-b  The availability of non-racemic 
tertiary propargyl alcohols gives access to allenes in high enantiomeric purity.17
 
XI. X-ray Crystallography and Absolute Stereochemistry 
 
Table 5.  Crystal data and structure refinement. 
Identification code  d08004 
Empirical formula  C15 H13 N O 
Formula weight  223.26 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  P 21 21 21 
Unit cell dimensions a = 9.3494(2) Å α= 90°. 
 b = 9.6354(2) Å β= 90°. 
                                                 
17 For reviews on stereoselective synthesis of allenes, see: (a) Krause, N.; Hoffman-Röder, A. Tetrahedron 
2004, 60, 11671–11694. (b) Miesch, M. Synthesis 2004, 746–752. (c) Brummond, K. M.; DeForrest, J. 
Synthesis 2007, 795–818.  For allene-containing natural products or biologically active molecules, see: (c) 
Hoffman-Röder, A.; Krause, N. Angew. Chem., Int. Ed. 2004, 43, 1196–1216. 
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 c = 13.2387(3) Å γ = 90°. 
Volume 1192.61(4) Å3 
Z 4 
Density (calculated) 1.243 Mg/m3 
Absorption coefficient 0.615 mm-1 
F(000) 472 
Crystal size 0.40 x 0.30 x 0.25 mm3 
Theta range for data collection 5.68 to 67.70°. 
Index ranges -11<=h<=11, -11<=k<=11, -15<=l<=15 
Reflections collected 22516 
Independent reflections 2158 [R(int) = 0.0185] 
Completeness to theta = 67.70° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.8614 and 0.7910 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2158 / 1 / 158 
Goodness-of-fit on F2 1.085 
Final R indices [I>2sigma(I)] R1 = 0.0260, wR2 = 0.0663 
R indices (all data) R1 = 0.0262, wR2 = 0.0666 
Absolute structure parameter 0.0(2) 
Largest diff. peak and hole 0.155 and -0.197 e.Å-3 
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Table 6.  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 
103).  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
O(1) 9554(1) -1434(1) 3266(1) 19(1) 
N(1) 11068(1) 1978(1) 3567(1) 20(1) 
C(1) 7679(1) 1207(1) 2101(1) 19(1) 
C(2) 8693(1) 607(1) 2446(1) 18(1) 
C(3) 9950(1) -103(1) 2892(1) 17(1) 
C(4) 11155(1) -234(1) 2107(1) 19(1) 
C(5) 10472(1) 750(1) 3796(1) 17(1) 
C(6) 10345(1) 272(1) 4781(1) 20(1) 
C(7) 10885(1) 1084(1) 5556(1) 24(1) 
C(8) 11549(1) 2331(1) 5327(1) 25(1) 
C(9) 11607(1) 2734(1) 4327(1) 23(1) 
C(11) 6485(1) 1990(1) 1723(1) 18(1) 
C(12) 5139(1) 1884(1) 2181(1) 21(1) 
C(13) 4013(1) 2690(1) 1840(1) 24(1) 
C(14) 4199(1) 3599(1) 1040(1) 26(1) 
C(15) 5527(1) 3707(1) 576(1) 27(1) 
C(16) 6668(1) 2909(1) 913(1) 22(1) 
________________________________________________________________________________
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Table 7.   Bond lengths [Å] and angles [°]. 
_____________________________________________________ 
O(1)-C(3)  1.4235(13) 
N(1)-C(9)  1.3409(15) 
N(1)-C(5)  1.3420(14) 
C(1)-C(2)  1.2012(17) 
C(1)-C(11)  1.4369(16) 
C(2)-C(3)  1.4822(15) 
C(3)-C(5)  1.5326(15) 
C(3)-C(4)  1.5373(15) 
C(5)-C(6)  1.3884(16) 
C(6)-C(7)  1.3855(17) 
C(7)-C(8)  1.3865(17) 
C(8)-C(9)  1.3809(17) 
C(11)-C(12)  1.4007(16) 
C(11)-C(16)  1.4018(16) 
C(12)-C(13)  1.3831(17) 
C(13)-C(14)  1.3855(18) 
C(14)-C(15)  1.3891(19) 
C(15)-C(16)  1.3888(18) 
 
C(9)-N(1)-C(5) 117.73(10) 
C(2)-C(1)-C(11) 176.82(12) 
C(1)-C(2)-C(3) 178.47(11) 
O(1)-C(3)-C(2) 110.34(9) 
O(1)-C(3)-C(5) 107.13(9) 
C(2)-C(3)-C(5) 108.40(9) 
O(1)-C(3)-C(4) 110.60(8) 
C(2)-C(3)-C(4) 110.53(9) 
C(5)-C(3)-C(4) 109.75(9) 
N(1)-C(5)-C(6) 122.71(10) 
N(1)-C(5)-C(3) 115.38(9) 
C(6)-C(5)-C(3) 121.91(9) 
C(7)-C(6)-C(5) 118.52(10) 
C(6)-C(7)-C(8) 119.35(11) 
C(9)-C(8)-C(7) 118.12(11) 
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N(1)-C(9)-C(8) 123.50(11) 
C(12)-C(11)-C(16) 119.15(10) 
C(12)-C(11)-C(1) 120.62(10) 
C(16)-C(11)-C(1) 120.20(10) 
C(13)-C(12)-C(11) 120.10(11) 
C(12)-C(13)-C(14) 120.61(11) 
C(13)-C(14)-C(15) 119.81(11) 
C(16)-C(15)-C(14) 120.24(11) 
C(15)-C(16)-C(11) 120.09(11) 
_____________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
  
Table 8.   Anisotropic displacement parameters (Å2x 103).  The anisotropic displacement factor 
exponent takes the form: -2π2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
O(1) 26(1)  14(1) 18(1)  -1(1) 0(1)  -3(1) 
N(1) 23(1)  17(1) 20(1)  1(1) -3(1)  -1(1) 
C(1) 20(1)  18(1) 19(1)  -4(1) 0(1)  -2(1) 
C(2) 20(1)  16(1) 17(1)  -2(1) 1(1)  -3(1) 
C(3) 18(1)  14(1) 18(1)  1(1) 1(1)  0(1) 
C(4) 21(1)  19(1) 17(1)  0(1) 1(1)  0(1) 
C(5) 14(1)  16(1) 19(1)  1(1) 0(1)  3(1) 
C(6) 22(1)  18(1) 21(1)  0(1) 2(1)  0(1) 
C(7) 29(1)  25(1) 17(1)  2(1) -2(1)  2(1) 
C(8) 30(1)  23(1) 22(1)  -4(1) -6(1)  0(1) 
C(9) 28(1)  17(1) 24(1)  1(1) -5(1)  -3(1) 
C(11) 19(1)  16(1) 18(1)  -6(1) -3(1)  0(1) 
C(12) 22(1)  20(1) 21(1)  -1(1) -1(1)  -3(1) 
C(13) 19(1)  26(1) 29(1)  -6(1) 0(1)  0(1) 
C(14) 26(1)  24(1) 28(1)  -4(1) -9(1)  7(1) 
C(15) 36(1)  24(1) 22(1)  3(1) -3(1)  3(1) 
C(16) 23(1)  22(1) 21(1)  -2(1) 1(1)  -2(1) 
______________________________________________________________________________
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Table 9.   Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103). 
________________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________________ 
 
H(1) 9403(15) -1960(14) 2763(10) 23 
H(4A) 10835 -825 1549 29 
H(4B) 11999 -649 2426 29 
H(4C) 11400 688 1848 29 
H(6) 9898 -592 4921 24 
H(7) 10801 788 6239 28 
H(8) 11953 2892 5844 30 
H(9) 12052 3594 4169 28 
H(12) 4998 1258 2726 25 
H(13) 3105 2619 2157 29 
H(14) 3420 4148 809 31 
H(15) 5655 4329 26 32 
H(16) 7575 2986 593 27 
 
Table 10.  Hydrogen bonds [Å and °]. 
____________________________________________________________________________ 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________ 
 O(1)-H(1)...N(1)#1 0.848(12) 2.084(13) 2.9265(12) 172.5(13) 
____________________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
#1 -x+2,y-1/2,-z+1/2      
 
XII. Experimental 
GENERAL: Infrared (IR) spectra were recorded on a Perkin Elmer 781 
spectrophotometer, νmax in cm-1. Bands are characterized as broad (br), strong (s), 
medium (m) or weak (w). 1H NMR spectra were recorded on a Varian Unity INOVA 400 
(400 MHz) spectrometer. Chemical shifts are reported in ppm from tetramethylsilane 
with the solvent resonance resulting from incomplete deuteration as the internal standard 
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(CDCl3: δ 7.26). Data are reported as follows: chemical shift, integration, multiplicity (s 
= singlet, d = doublet, t = triplet, q = quartet, br = broad, m = multiplet), coupling 
constants, and assignment. 13C NMR spectra are recorded on a Varian Unity INOVA 400 
(100 MHz) with complete proton decoupling. Chemical shifts are reported in ppm from 
tetramethylsilane with the solvent resonance as the internal standard (CDCl3: δ 77.16). 
Enantiomeric ratios were determined by chiral HPLC analysis (Chiral Technologies 
Chiralpak OD column (0.46 cm x 25 cm), OJ (0.46 cm x 0.25cm), AS (0.46 cm x 25 cm) 
AD (0.46 cm x 25 cm) and OB-H (0.46 cm x 25 cm) in comparison with authentic 
racemic materials. Elemental analyses were performed by Robertson Microlit 
Laboratories (Madison, New Jersey). High resolution mass spectrometry was performed 
at the Mass Spectrometry Facility at Boston College by Mr. Marek Domin (on a 
Micromass LCT ESI-MS (positive mode)) or at the University of Illinois Mass 
Spectrometry Laboratories (Urbana, Illinois). Optical rotation values were recorded on a 
Rudolph Research Analytical Autopol IV polarimeter. 
 
MATERIALS: Unless otherwise stated, all reactions were conducted in oven- (135 °C) 
and flame-dried glassware under an inert atmosphere of nitrogen.  
Acetic anhydride: Purchased from Aldrich and used as received. 
Acetylenes: C6H5, o-Me-C6H4, m-Me-C6H4, p-Me-C6H4, p-OMe-C6H4, p-CF3-C6H4, o-
Br-C6H4, Si(i-Pr)2, 3-thiophene, C6H13, cyclohexyl, (4-iodophenyl)ethynyl-
trimethylsilane and 3,5-Cl2-C6H3 were purchased from Aldrich and distilled from CaH2 
under vacuum prior to use. 
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Aluminum tri-iso-propoxide: Purchased from Strem and distilled (under vacuum, air-
cooled condenser) immediately prior to use.18  
Aluminum tri-sec-butoxide: Purchased from Aldrich and used without purification. 
Benzoic acid: Purchased from Aldrich and used as received. 
Boc-protected amino acids: Purchased from Advanced ChemTech or NovaBioChem 
and used as received. 
3-Bromopyridine: Purchased from Aldrich and used as received. 
2-Butanol: Purchased form Aldrich in a sure-seal bottle and used as received. 
n-Butylamine: Purchased from Aldrich and used as received. 
n-Butyllithium: Purchased from Strem and titrated prior to use with 2-butanol and 1,10-
phenanthrolene (indicator).  
t-Butyllithium: Purchased from Strem and titrated prior to use with 2-butanol and 1,10-
phenanthrolene (indicator).  
3-Chloroperbenzoic acid: Purchased form Aldrich and recrystallized from reagent grade 
CH2Cl2.  
Copper cyanide:  Purchased from Strem and used as received. 
Copper Iodide: Purchased from Strem and purified by recrystallization from water and 
potassium iodide. 
Dichloromethane: Purchased from Doe & Ingalls and purified through two alumina 
columns under a positive pressure of dry argon by a modified Advanced ChemTech 
purification system. 
                                                 
18 Al(Oi-Pr)3 is a white powder prior to distillation and insoluble in toluene; it exists as a clear liquid after 
distillation and is highly soluble in toluene. For details, see: Shiner, V. J. Jr.; Whittaker, D.; Fernandez, V. 
P. J. Am. Chem.Soc. 1963, 85, 2318–2322. 
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Diethyl ether: Purchased from Doe & Ingalls and purified through two alumina columns 
under a positive pressure of dry argon by a modified Advanced ChemTech purification 
system. 
Diethylphosphoramidate: Purchased from Aldrich or synthesized using a known 
procedure19 and distilled (under vacuum, air-cooled condenser).20  
Diethylzinc: Purchased from Aldrich (neat) and used without purification. 
Diisopropyl amine: Purchased from Aldrich and distilled from CaH2 prior to use. 
4-Dimethylaminopyridine: Purchased from Advanced ChemTech and used as received. 
Dimethylcarbamyl chloride: Purchased from Aldrich and distilled from CaH2 prior to 
use. 
N,O-dimethylhydroxylamine hydrochloride: Purchased from Aldrich and used as 
received. 
Dimethylzinc: Purchased from Strem (neat) and used without purification.  
EDC•HCl: Purchased from Advanced ChemTech and used as received. 
Ethanol: ASC Reagent Grade, Purchased from Doe & Ingalls and used as received. 
1-ethynyl-4-iodobenzene: Prepared according to literature procedure.21
Fmoc-protected amino acids: Purchased from Advanced ChemTech or NovoBioChem 
and used as received. 
Furanoic acid: Purchased from Aldrich and used as received. 
HOBt•H2O: Purchased from Advanced ChemTech and used as received. 
HCl (4.0 M in 1,4-dioxane): Purchased from Aldrich and used as received. 
                                                 
19 Zwierzac, A.; Koziara, A. Tetrahedron 1970, 26, 3521–3525. 
20 Diethylphosphoramidate only needs to be distilled from CaCl2 the first time it is used. As long as the 
material is stored under nitrogen in a desiccator or glovebox it can be used for up to 2 months without 
needing to be redistilled. 
21 Holmes, B. T.; Pennington, W. T.; Hanks, T. W. Synth. Commun.,  2003, 33, 2447-2461. 
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Hydrogen: Ultra High Purity, compressed gas purchased from Air Gas, Boston, MA. 
Isoquinoic acid: Purchased from Aldrich and used as received. 
Lindlars Catalyst: Pd/CaCO3 poisoned with lead, 10 mol % w/w, purchased from 
Aldrich and used as received. 
Methanol: Purchased from Aldrich in a sure-seal bottle and used as received. 
4-Methoxypyridine N-oxide: Purchased from Aldrich and used as received. 
Palladium on Carbon:  Purchased from Strem and used as received. 
1,10-Phenanthrolene:  Purchased from Aldrich and used as received. 
Picolinic acid: Purchased from Acros and used as received. 
Piperidine:  Purchased from Advanced ChemTech and used as received, 
Pyridine: Purchased from Aldrich in a sure-seal bottle and used as received. 
Red-Al ®:  Purchased from Aldrich as a 60% w/w in a solution of toluene and used as 
received. 
Salicylaldehydes: Purchased from Acros or Aldrich and used as received. 
Tetrabutyl ammonium fluoride (1 M solution in THF): Purchased from Acros and 
used as received. 
Tetrahydrofuran: Purchased from Aldrich and purified by distillation from sodium 
benzophenone ketal immediately prior to use unless otherwise specified.  
Toluene: Purchased from Doe & Ingalls and purified through Cu and alumina columns 
under a positive pressure of dry argon by a modified Innovative Technologies 
purification system. 
Triethylamine: Purchased from Aldrich and distilled over CaH2.  
Trifluoroacetic acid: Purchased from Acros and used as received. 
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4-(Trifluoromethyl)aniline: Purchased from Aldrich and used as received. 
Trimethylsilyl cyanide: Purchased from Aldrich and used as received. 
Unless otherwise noted, all work-up and purification procedures were carried out with 
reagent grade solvents (purchased from Doe & Ingalls) under an atmosphere of air. 
 
Representative Experimental Procedure for Enantioselective Additions of Me2Zn 
Pyridyl-Substituted Ynones: A 13 x 100 mm test tube was charged with Al(Oi-Pr)3 
(3.80 mg in 250 μL toluene, 18.5 μmol), 7 (6.80 mg in 1.45 mL toluene, 18.5  μmol) 
under an atmosphere of N2 in a glove box.  Ketone 1a (50.0 mg in 500 μL toluene, 
0.245  mmol) was added to this solution.  The test tube was sealed with a septum, 
electrical tape, and Teflon® tape and removed from the glove box.  The mixture was 
allowed to cool to -78 oC (dry ice/acetone) and Me2Zn (CAUTION, PYROPHORIC! 
USE EXTREME CAUTION!, 80.0  μL, 0.736 mmol) was added with continued 
stirring.22 The test tube was transferred to a cryocool maintaining a constant temperature 
of -30 oC stirring was allowed to continue for 12 h before addition of a saturated solution 
of aqueous NaHCO3 (1 mL).  After removal of the organic layer, the aqueous layer was 
washed with EtOAc (3 x 2 mL).  Combined organic layers were dried over MgSO4, 
filtered and concentrated under reduced pressure and loaded onto silica gel with toluene 
and eluted with pet. ether, followed by pet. ether:Et2O (20:1), pet. ether:Et2O (7:3), pet. 
ether:Et2O (1:1) to afford  4a as a white solid (41.0 mg, 0.184 mmol, 75.0% yield). 
  
                                                 
22 It is imperative that the dialkylzinc reagent is introduced into the reaction vessel last; the order of 
addition for other reagents and the catalyst is less critical. 
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(S)-4-Phenyl-2-pyridin-2-yl-but-3-yn-2-ol (4a): mp: 123-125 oC. IR (neat): 3383 (b), 
2993 (w), 1589 (m), 1432 (m), 1356 (w), 1136 (w), 752 (s), 689 (s) cm-1.  1H NMR (400 
MHz, CDCl3): δ  8.54 (1H, d, J = 2.8 Hz, Ar-H), 7.77 (1H, t, J = 8.0 Hz, Ar-H), 7.67 
(1H, d, J = 7.2 Hz, Ar-H), 7.44-7.42 (2H, m, Ar-H), 7.29-7.25 (4H, m, Ar-H), 5.61 (1H, 
s, OH), 1.86 (3H, s, CH3 ).  13C NMR (100 MHz, CDCl3): δ 162.0, 147.5, 137.6, 131.8, 
128.5, 128.3, 122.9, 122.7, 120.2, 92.3, 83.8, 69.0, 32.6.  Elemental Analysis: Anal 
Calcd for C15H13NO: C, 80.69; H, 5.87; N, 6.27. Found: C, 80.89; H, 6.16; N, 6.15. 
Optical Rotation: [α]20D +31.1 (c = 0.500 in CHCl3) for a >98% ee sample.  
Enantiomeric purity of the compound was determined by chiral HPLC analysis (Chiralcel 
OD, 99.4:0.6 hexanes:i-PrOH eluent 0.500 mL/min and a lamp setting of 220 nm) tr = 
114 min. (minor) and tr = 75 min. (major). 
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(S)-4-(4-Methoxy-phenyl)-2-pyridin-2-yl-but-3-yn-2-ol (4e):  IR (neat): 3370 (b), 
2989 (w), 2193 (s), 1639 (m), 1595 (m), 1513 (m), 1255 (m), 1174 (w), 1029 (m), 834 
(m) cm-1.  1H NMR (400 MHz, CDCl3): δ 8.53 (1H, d, J = 4.8 Hz, Ar-H), 7.78 (1H, t, J 
= 8.0 Hz, Ar-H), 7.68 (1H, d, J = 8.0 Hz, Ar-H), 7.36 (2H, d, J = 8.8 Hz, Ar-H), 7.26 (1H, 
t, J = 5.2 Hz, Ar-H), 6.80 (2H, d, J = 8.8 Hz, Ar-H), 5.60 (1H, s, OH), 3.79 (3H, s, 
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OCH3), 1.86 (3H, s, CH3).  13C NMR (100 MHz, CDCl3): δ 162.2, 159.7, 147.5, 137.5, 
133.3, 122.8, 120.2, 114.8, 113.9, 90.9, 83.7, 69.0, 55.4, 32.5. HRMS (ES+): Calcd for 
C16H16NO2 [M+1] 254.1181; Found 254.1188.  Optical Rotation: [α]20D  +39.0 (c = 
1.00 in CHCl3) for a 96% ee sample.  Enantiomeric purity of the compound was 
determined by chiral HPLC analysis (Chiralcel OJ, 98.0:2.0 hexanes:i-PrOH eluent 1.00 
mL/min and a lamp setting of 220 nm) tr = 80 min. (minor) and tr = 59 min. (major). 
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(S)-2-Pyridin-2-yl-4-(4-trifluoromethyl-phenyl)-but-3-yn-2-ol (4f): IR (neat): 3364 
(b), 2986 (w), 2936 (w), 1633 (m), 1608 (m), 1325 (s), 1161 (s), 1123 (s), 1079 (s), 853 
(m) cm-1.  1H NMR (400 MHz, CDCl3): δ 8.55 (1H, d, J = 4.8 Hz, Ar-H), 7.78 (1H, dt, J 
= 7.2, 1.2 Hz, Ar-H), 7.66 (1H, d, J = 8.4 Hz, Ar-H), 7.54 (4H, s, Ar-H), 7.66 (1H, t, J = 
5.2 Hz, Ar-H), 5.71 (1H, s, OH), 1.88 (3H, s, CH3).  13C NMR (100 MHz, 
CDCl3): δ 161.6, 147.6, 137.7, 132.2, 130.3 (q, J = 32.6 Hz), 126.6, 125.2 (q, J = 3.4 Hz), 
123.6 (q, J = 271.4 Hz), 123.1, 120.6, 94.8, 82.4, 68.9, 32.1.  Elemental Analysis: Anal 
Calcd for C16H12NOF3: C, 65.98; H, 4.15; N, 4.81. Found: C, 65.76; H, 4.25; N, 4.58. 
Optical Rotation: [α]20D +24.1 (c = 1.00 in CHCl3) for a 87% ee sample.  Enantiomeric 
purity of the compound was determined by chiral HPLC analysis (Chiralcel OD, 99.5:0.5 
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hexanes:i-PrOH eluent 0.500 mL/min and a lamp setting of 220 nm) tr = 57 min. (minor) 
and tr =41 min. (major). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area %
1 57.81 203633700 49.374 1 48.17 39053300 93.121
2 2 70.40 208798600 50.626 68.89 2884957 6.879
 
(S)-4-(4-Iodophenyl)-2-(pyridin-2-yl)but-3-yn-2-ol (4g): IR (neat): 3351 (b), 3052 (w), 
2969 (w), 2912 (w), 2834 (w), 1677 (w), 1591 (m), 1482 (m), 1431 (m), 1388 (m), 1264 
(m), 1058 (m), 1005 (m), 819 (m)  cm-1.  1H NMR (400 MHz, CDCl3): δ 8.54 (1H, d, J 
= 4.4 Hz, Ar-H), 7.77 (1H, dt, J = 7.6, 1.6 Hz, Ar-H), 7.63 (3H, t, J = 8.4 Hz, Ar-H), 
7.29-7.25 (1H, m, Ar-H), 7.15 (2H, d, J = 8.4 Hz, Ar-H), 5.64 (1H, s, OH), 1.86 (3H, s, 
CH3).  13C NMR (100 MHz, CDCl3): δ 161.8, 147.6, 137.7, 137.6, 133.5, 123.1, 122.4, 
120.3, 94.5, 93.9, 82.9, 69.1, 32.3. HRMS (ESI+): Calcd for C15H13NOI [M+1] 
350.0042; Found 350.0035.  Optical Rotation: [α]20D +23.9 (c = 0.480 in CHCl3) for a 
79% ee sample.  Enantiomeric purity of the compound was determined by chiral HPLC 
analysis (Chiralcel AS, 99.5:0.5 hexanes:i-PrOH eluent 0.500 mL/min and a lamp setting 
of  254 nm) tr = 74 min. (minor) and tr = 83 min. (major). 
Chapter 3, Page 190 
 7
7.
47
 
 9
1.
12
 
0 20 40 60 80 100 120 140 160 180
Time - Minutes
-5
0
5
10
15
20
25
30
35
40
45
50
55
R
es
po
ns
e 
- M
ill
iV
ol
ts
 7
4.
96
 
 8
3.
00
 
0 20 40 60 80 100 120 140 160 180
700
600
500
Time - Minutes
0
100
200
300
400
R
es
po
ns
e 
- M
ill
iV
ol
ts
 
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area %
1 77.47 17124790 47.753 1 74.96 35953640 10.132 
2 2 91.12 18736710 52.247 83.00 318906400 89.868 
 
(S)-4-(3,4-Dichlorophenyl)-2-(pyridin-2-yl)-but-3-yn-2-ol (4h): IR (neat): 3375 (b), 
3043 (w), 2982 (w), 2929 (w), 2842 (w), 1660 (m), 1592 (m), 1467 (m), 1376 (m), 1265 
(s), 1135 (m), 1035 (w), 791 (m), 738 (s) cm-1.  1H NMR (400 MHz, CDCl3): δ 8.55 (1H, 
d, J = 4.8 Hz, Ar-H), 7.79 (1H, dt, J = 7.6, 1.6 Hz, Ar-H), 7.63 (1H, d, J = 8.0 Hz, Ar-H), 
7.51 (1H, s, Ar-H), 7.33 (1H, d, J = 8.0 Hz, Ar-H), 7.29-7.24 (2H, m, Ar-H), 5.66 (1H, s, 
OH), 1.86 (3H, s, CH3).  13C NMR (100 MHz, CDCl3): δ 161.5, 147.6, 137.3, 133.5, 
132.9, 132.5, 131.1, 130.4, 123.1, 122.7, 120.1, 94.4, 81.5, 68.9, 32.1.  HRMS (ES+): 
Calcd for C15H12NOCl2 [M+1] 292.0296; Found 292.0305. Optical Rotation: [α]20D 
+22.7 (c = 0.350 in CHCl3) for a 79% ee sample.  Enantiomeric purity of the compound 
was determined by chiral HPLC analysis (Chiralcel OD, 99.5:0.5 hexanes:i-PrOH eluent 
0.500 mL/min and a lamp setting of 220 nm) tr = 73 min. (minor) and tr = 108 min. 
(major). 
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(S)-4-(2-Bromo-phenyl)-2-pyridin-2-yl-but-3-yn-2-ol (4i): IR (neat): 3370 (b), 2999 
(w), 2396 (w), 1589 (m), 1463 (s), 1432 (s), 1385 (m), 1148 (m), 1067 (m), 765 (s) cm-1.  
1H NMR (400 MHz, CDCl3): δ 8.54 (1H, d, J = 4.8 Hz, Ar-H), 7.78 (2H, d, J = 4.0 Hz, 
Ar-H), 7.56 (1H, d, J = 8.0 Hz, Ar-H), 7.47 (1H, d, J = 7.6 Hz, Ar-H), 7.29-7.22 (2H, m, 
Ar-H), 7.15 (1H, t, J = 7.6 Hz, Ar-H), 5.70 (1H, s, OH), 1.90 (3H, s, CH3).  13C NMR 
(100 MHz, CDCl3): δ 161.6, 147.5, 137.6, 133.5, 132.4, 129.7, 127.1, 125.9, 125.8, 
123.0, 120.6, 96.9, 82.6, 69.2, 32.4. HRMS (ES+): Calcd for C15H12NOBrNa [M+Na] 
224.0000; Found 224.0010. Optical Rotation: [α]20D +53.4 (c = 2.30 in CHCl3) for a 
96% ee sample.  Enantiomeric purity of the compound was determined by chiral HPLC 
analysis (Chiralcel OD, 99.4:0.6 hexanes:i-PrOH eluent 0.500 mL/min and a lamp setting 
of 220 nm) tr = 80 min. (minor) and tr = 109 min. (major). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area %
1 76.58 254317200 50.937 1 103.13 263060 1.386 
2 109.58 2 244960000 49.063 109.75 18721470 98.614 
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(S)-2-Pyridin-2-yl-4-thiophen-2-yl-but-3-yn-2-ol (4j): IR (neat): 3376 (b), 2993 (w), 
1583 (w), 1425 (m), 1369 (m), 1136 (m), 790 (s), 620 (s) cm-1.  1H NMR (400 MHz, 
CDCl3): δ 8.54 (1H, d, J = 4.8 Hz, Ar-H), 7.77 (1H, t, J = 8.0 Hz, Ar-H), 7.66 (1H, d, J = 
8.0 Hz, Ar-H), 7.44 (1H, s, Ar-H), 7.29-7.22 (2H, m, Ar-H), 7.10 (1H, d, J = 5.2 Hz, Ar-
H), 5.63 (1H, s, OH), 1.86 (3H, s, CH3).  13C NMR (100 MHz, CDCl3): δ 161.9, 147.5, 
137.6, 130.0, 129.2, 125.3, 122.9, 121.7, 120.2, 91.9, 79.0, 69.0, 32.3. HRMS (ES+): 
Calcd for C13H12NOS [M+1] 230.0640; Found 230.0643.  Optical Rotation: [α]20D 
+28.5 (c = 1.00 in CHCl3) for a 92% ee sample.  Enantiomeric purity of the compound 
was determined by chiral HPLC analysis (Chiralcel OD, 99.4:0.6 hexanes:i-PrOH eluent 
0.550 mL/min and a lamp setting of 220 nm) tr = 150 min. (minor) and tr = 102 min. 
(major). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area %
1 110.04 91832800 51.487 1 102.56 252851700 96.713 
2 138.05 86528080 48.513 2 150.18 8593296 3.287 
 
(S)-2-Pyridin-2-yl-dec-3-yn-2-ol (4k): IR (neat): 3408 (b), 2936 (w), 2867 (w), 1589 
(m), 1438 (m), 1394 (m), 1199 (m), 1067 (m), 783 (s), 746 (m) cm-1.  1H NMR (400 
MHz, CDCl3): δ 8.50 (1H, d, J = 4.8 Hz, Ar-H), 7.73 (1H, t, J = 1.2 Hz, Ar-H), 7.60 (1H, 
d, J = 7.6 Hz, Ar-H), 7.37 (1H, t, J = 1.6 Hz, Ar-H), 5.38 (1H, s, OH), 2.22 (2H, t, J = 
6.8 Hz, CH2CH2alkyne), 1.74 (3H, s, CH3), 1.49 (2H, ddd, J = 7.6, 7.4, 7.2 Hz, 
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CH2CH2CH2,) 1.40-1.24 (6H, m, CH2CH2CH2), 0.87 (3H, t, J = 6.4 Hz, CH2CH3).  13C 
NMR (100 MHz, CDCl3): δ 162.7, 147.4, 137.4, 122.6, 120.0, 84.8, 83.4, 68.7, 32.8, 
31.4, 28.7, 22.7, 18.9, 18.7, 14.1.  HRMS (+TOF): Calcd for C15H22NO [M+1] 
232.1701; Found 232.1689.  Optical Rotation: [α]20D +8.49 (c = 1.00 in CHCl3) for a 
89% ee sample.  Enantiomeric purity of the compound was determined by chiral HPLC 
analysis (Chiralcel OB-H, 95.0:5.0 hexanes:i-PrOH eluent 0.700 mL/min and a lamp 
setting of 254 nm) tr = 11 min. (minor) and tr = 9 min. (major). 
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1 9.21 1135003 50.067 1 9.13 6930746 94.812 
2 11.33 1131952 49.933 2 11.24 379230 5.188 
 
(S)-2-Pyridin-2-yl-4-triisopropylsilanyl-but-3-yn-2-ol (4m): IR (neat): 3402 (b), 2995 
(s), 2867 (s), 2174 (m), 1589 (m), 1463 (m), 1438 (m), 1381 (m), 1174 (m), 1067 (m), 
1004 (m), 953 (m), 884 (m), 790 (s), 765 (s), 670 (s) cm-1.  1H NMR (400 MHz, 
CDCl3): δ  8.50 (1H, d, J = 4.8 Hz, Ar-H), 7.73 (1H, dt, J = 8.0, 1.6 Hz, Ar-H), 7.63 (1H, 
d, J = 8.6 Hz, Ar-H), 7.24 (1H, t, J = 6.4 Hz, Ar-H), 5.47 (1H, s, OH), 1.77 (3H, s, CH3), 
1.05 (21H, s, SiCH(CH3)2).  13C NMR (100 MHz, CDCl3): δ 162.1, 147.4, 137.4, 122.8, 
120.2, 110.8, 84.7, 69.0, 32.9, 18.7, 11.3.  HRMS (ESI+) Calcd for C18H30NOSi [M+1] 
304.2096; Found 304.2091. Optical Rotation: [α]20D +1.07 (c = 2.42 in CHCl3) for a 
53% ee sample.  
Chapter 3, Page 194 
 (S)-2-(Pyridin-2-yl)-but-3-yn-2-ol: IR (neat): 3297 (b), 2982 (w), 
2924 (w), 2815 (w), 1592 (w), 1469 (w), 1432 (m), 1366 (w), 1164 
(m), 1107 (w), 1069 (m), 939 (m), 786 (m), 750 (m) cm-1.  1H NMR (400 MHz, 
CDCl3): δ 8.53 (1H, d, J = 4.0 Hz, Ar-H), 7.76 (1H, t, J = 8.0 Hz, Ar-H), 7.62 (1H, d, J = 
8.0 Hz, Ar-H), 7.29-7.24 (1H, m, Ar-H), 5.44 (1H, s, OH), 2.54 (1H, s, alkyne-H), 1.79 
(3H, s, CH3).  13C NMR (100 MHz, CDCl3): δ 161.6, 147.7, 137.7, 123.1, 120.1, 87.3, 
72.0, 68.6, 32.1.  HRMS (ESI+): Calcd for C9H10NO [M+1] 148.0762; Found 148.0764. 
Optical Rotation: [α]20D +22.1 (c = 0.160 in CHCl3) for a 57% ee sample.  Enantiomeric 
purity of the compound was determined by chiral HPLC analysis (Chiralcel OD, 98.0:2.0 
hexanes:i-PrOH eluent 1.00 mL/min and a lamp setting of 254 nm) tr = 20 min. (minor) 
and tr = 38 min. (major). 
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Peak # Ret. Time Area Area % Peak #
HO
Ret. Time Area Area %
1 19.18 3943825 52.395 1 20.06 1057664 21.095
2 38.15 3583215 47.605 2 38.09 3956175 78.905
 
(S)-2-(4-Methoxypyridin-2-yl)-4-phenylbut-3-yn-2-ol (8): IR (neat): 3342 (b), 2984 
(w), 2971 (w), 1598 (s), 1569 (m), 1487 (m), 1304 (m), 1141 (m), 1036 (m), 757 (s) cm-1.  
1H NMR (400 MHz, CDCl3): δ 8.36 (1H, d, J = 6.0 Hz, Ar-H), 7.46-7.42 (2H, m, Ar-H), 
7.31-7.26 (3H, m, Ar-H), 7.16 (1H, d, J = 2.8 Hz, Ar-H), 6.79 (1H, dd, J = 5.6, 2.4 Hz, 
Ar-H), 5.65 (1H, s, OH), 3.89 (3H, s, OCH3), 1.85 (3H, s, CH3).  13C NMR (100 MHz, 
H
N
Me
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CDCl3): δ 167.0, 164.1, 148.9, 132.0, 128.6, 128.4, 122.9, 109.6, 105.9, 92.4, 83.9, 69.2, 
55.6, 32.5. HRMS (ES+): Calcd for C16H16NO2 [M+1] 254.1181; Found 254.1188. 
Optical Rotation: [α]20D -39.1 (c = 0.550 in CHCl3) for a 75% ee sample.  Enantiomeric 
purity of the compound was determined by chiral HPLC analysis (Chiralcel AS, 99.5:0.5 
hexanes:i-PrOH eluent 1.00 mL/min and a lamp setting of 220 nm) tr = 40 min. (minor) 
and tr = 50 min. (major). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area %
1 44.49 14581580 50.611 1 40.67 13060820 11.48 
2 58.42 14229660 49.389 2 50.52 100709000 88.52 
 
(S)-2-(Isoquinolin-1-yl)-4-phenylbut-3-yn-2-ol (9): IR (neat): 3319 (b), 3054 (w), 2929 
(w), 2859 (w), 1665 (m), 1488 (m), 1459 (m), 1416 (m), 1265 (s), 739 (s) cm-1.  1H NMR 
(400 MHz, CDCl3): δ  8.86 (1H, d, J = 7.6 Hz, Ar-H), 8.42 (1H, d, J = 5.6 Hz, Ar-H), 
7.89 (1H, d, J = 2.0 Hz, Ar-H), 7.75-7.64 (4H, m, Ar-H), 7.34-7.39 (2H, m, Ar-H), 7.28-
7.24 (3H, m, Ar-H), 2.06 (3H, s, CH3).  13C NMR (100 MHz, CDCl3): δ  159.9, 139.0, 
137.8, 131.9, 130.6, 128.6, 128.4, 127.9, 127.3, 126.8, 124.6, 122.9, 122.3, 92.9, 84.8, 
67.8, 32.5. HRMS (ES+): Calcd for C19H16NO2 [M+1] 274.1232; Found 274.1236. 
Optical Rotation: [α]20D -23.3 (c = 0.381 in CHCl3) for a 63% ee sample.  Enantiomeric 
purity of the compound was determined by chiral HPLC analysis (Chiralcel AS, 99.5:0.5 
hexanes:i-PrOH eluent 0.500 mL/min and a lamp setting of 220 nm) tr = 43 min. (minor) 
and tr = 38 min. (major). 
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(S,E)-N-butyl-2-(3,5-dichloro-2-hydroxybenzylideneamino)-3-phenylpropanamide 
(6):  mp: 86-88 oC. IR (neat): 3261 (b), 3066 (w), 2958 (w), 2924 (m), 2870 (m), 1640 
(s), 1567 (m), 1500 (m), 1454 (m), 1378 (w), 1292 (w), 1214 (m), 1144 (m), 854 (m), 744 
(m), 699 (m), 665 (m) cm-1.  1H NMR (400 MHz, CDCl3): δ 13.22 (1H, s, OH), 7.79 
(1H, s), 7.44 (1H, d, J = 2.4 Hz), 7.26-7.18 (3H, m), 7.10 (2H, d, J = 6.3 Hz), 7.01 (1H, d, 
J = 2.4 Hz), 5.88 (1H, s), 4.05 (1H, dd, J = 3.4, 3.4 Hz), 3.46 (1H, dd, J = 3.9, 3.9 Hz), 
3.35-3.19 (2H, m), 3.03 (1H, dd, J = 9.3, 9.3 Hz), 1.46 (2H, q, J =7.3 Hz), 1.30 (2H, q, J 
= 7.8 Hz) 0.91 (3H, t, J = 7.3 Hz)  13C NMR (100 MHz, CDCl3): δ 169.9, 165.8, 155.3, 
136.7, 133.0, 129.8, 129.7, 128.8, 127.2, 123.9, 122.7, 119.5, 75.6, 41.1, 39.5, 31.7, 20.1, 
13.8. HRMS (ES+): Calcd for C20H23N2O2Cl2 [M+1] 393.1137; Found 393.1129. 
Optical Rotation: [α]20D -129.77 (c = 0.550 in CHCl3). 
 
 (R,E)-3-(benzylthio)-N-butyl-2-(2-hydroxybenzylideneamino)-propanamide (7): 
mp: 73-75 oC. IR (neat): 3307 (bs), 3062 (w), 2955 (w), 2923 (m), 2867 (m), 1658 (s), 
1627 (s), 1526 (m), 1495 (m), 1457 (m), 1281 (m), 1148 (m), 765 (s), 702 (m) cm-1.  1H 
NMR (400 MHz, CDCl3): δ  12.34 (1H, s, OH), 8.21 (1H, s), 7.39 (1H, t, J = 7.0 Hz), 
7.33-7.18 (6H, m), 7.06-6.93 (2H, m), 6.11 (1H, s), 3.86 (1H, dd, J = 5.6, 3.2 Hz), 3.69 
(2H, s), 3.33-3.17 (3H, m), 2.84 (1H, dd, J = 8.7, 4.7 Hz), 1.47 (2H, q, J = 8.0 Hz), 1.31 
(2H, q, J = 7.6 Hz) 0.90 (3H, t, J = 7.0 Hz).  13C NMR (100 MHz, CDCl3): δ  169.9, 
168.7, 160.7, 138.2, 133.6, 132.5, 129.1, 128.7, 127.3, 119.5, 118.4, 117.3, 73.6, 39.4, 
37.2, 36.7, 31.7, 20.1, 13.8. HRMS (ES+): Calcd for C21H27N2O2S [M+1] 371.1793; 
Found 371.1778. Optical Rotation: [α]20D -38.4 (c = 1.18 in CHCl3). 
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8a-Ethyl-3-phenylindolizin-1(8aH)-one (11): Compound 11 was prepared according to 
a previously reported method.8c  IR (neat): 3054 (m), 2986 (w), 2920 (w), 1676 (m), 
1538 (w), 1486 (w), 1448 (m), 1421 (m), 1265 (s), 739 (s), 704 (s) cm-1.  1H NMR (400 
MHz, CDCl3): δ  7.54-7.50 (5H, m, Ar-H), 6.52 (1H, d, J = 6.8 Hz, NCHCH), 5.95-5.88 
(2H, m), 5.33-5.30 (1H, m), 5.20 (1H, s), 1.87 (2H, q, J = 7.6 Hz), 0.92 (3H, t, J = 7.2 
Hz).  13C NMR (100 MHz, CDCl3): δ  202.8, 174.5, 131.2, 129.9, 129.2, 128.2, 124.1, 
123.8, 122.3, 109.2, 100.8, 72.2, 32.9, 7.0. HRMS (ES+): Calcd for C16H16NO [M+1] 
238.1232; Found 238.1242. Optical Rotation: [α]20D +753.4  (c = 0.243 in CHCl3)  for a 
>98% ee sample.  Enantiomeric purity of the compound was determined by chiral HPLC 
analysis (Chiralcel OD, 99.0/0.5 hexanes/i-PrOH eluent 1.00 mL/min and a lamp setting 
of 254 nm) tr = 30 min. (minor) and tr = 33 min. (major). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area %
1 29.99 649521 53.455 1 33.69 1255590 100 
2 35.04  565558 46.545    
 
8a-Ethyl-7-methoxy-3-phenylindolizin-1(8aH)-one (12): Compound 12 was prepared 
according to a previously reported method.8c  IR (neat): 3053 (m), 2929 (w), 2910 (w), 
1677 (m), 1449 (w), 1265 (s), 739 (s), 704 (s) cm-1.  1H NMR (400 MHz, CDCl3): δ  
7.50 (5H, s, Ar-H), 6.53 (1H, d, J = 7.2 Hz), 5.29 (1H, s), 5.20 (1H, dd, J = 8.0, 2.4 Hz), 
4.85 (1H, d, J = 1.6 Hz), 3.57 (3H, s), 1.87 (2H, q, J = 7.6 Hz), 0.91 (3H, t, J = 7.6 Hz).  
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13C NMR (100 MHz, CDCl3): δ  203.9, 174.1, 152.9, 131.3, 129.7, 129.3, 128.1, 125.5, 
108.1, 102.3, 91.7, 72.6, 55.0, 33.9, 7.3. HRMS (ES+): Calcd for C17H18NO2 [M+1] 
268.1338; Found 268.1348. Optical Rotation: [α]20D +442.5  (c = 0.380 in CHCl3) for a 
>98% ee sample.   
 
8a-Ethylindolizin-1-(8aH)-one (13): Compound 13 was prepared according to a 
previously reported method.8c  IR (neat): 3054 (m), 2982 (w), 2927 (w), 2893 (w), 1665 
(m), 1519 (w), 1265 (s), 738 (s), 705 (s) cm-1.  1H NMR (400 MHz, CDCl3): δ  7.81 (1H, 
d, J = 3.6 Hz), 6.35 (1H, d, J = 6.8 Hz), 5.93-5.89 (1H, m), 5.80-5.77 (1H, m), 5.36 (1H, 
dt, J = 6.8, 1.2 Hz), 5.07 (1H, d, J = 3.6 Hz), 1.79 (1H, dq, J = 13.6,  7.6 Hz), 1.72 (1H, 
dq, J = 13.6,  6.0 Hz), 0.82 (3H, t, J = 7.2 Hz).  13C NMR (100 MHz, CDCl3): δ  204.5, 
161.0, 125.5, 123.0, 122.5, 108.9, 99.3, 76.9, 32.2, 6.8. HRMS (ES+): Calcd for 
C10H12NO [M+1] 162.0919; Found 162.0924. Optical Rotation: [α]20D +873.3  (c = 
0.077 in CHCl3) for a 96% ee sample.  Enantiomeric purity of the compound was 
determined by chiral HPLC analysis (Chiralcel OD, 99.4/0.6 hexanes/i-PrOH eluent 1.00 
mL/min and a lamp setting of 220 nm) tr = 49 min. (minor) and tr = 42 min. (major). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area %
1 42.95 5989025 49.951 1 42.12 2540205 98.236
2 49.93 6000707 50.049 2 49.43 45619 1.764
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3-Hexyl-8a-methylindolizin-1-(8aH)-one (14): Compound 14 was prepared a according 
to a previously reported method.8c  IR (neat): 3472 (b), 2929 (m), 2908 (m), 1677 (s), 
1531 (w), 1433 (w) cm-1. 1H NMR (400 Mz, CDCl3): δ  6.42 (1H, d, J = 7.2 Hz), 5.88 
(2H, dd, J = 2.4, 0.4 Hz), 5.46-5.42 (1H, m), 4.92 (1H, s),  2.46 (2H, t, J = 7.2 Hz), 1.66-
1.62 (2H, m), 1.41-1.29 (9H, m), 0.90 (3H, t, J = 6.8 Hz).  13C NMR (100 MHz, CDCl3): 
δ  203.4, 175.4, 124.6, 122.1, 121.8, 109.1, 96.9, 67.9, 31.6, 29.1, 27.3, 26.7, 24.5, 22.7, 
14.2. HRMS (ES+): Calcd for C15H22NO [M+1] 232.1701; Found 232.1707. Optical 
Rotation: [α]20D +342.8  (c = 0.360 in CHCl3) for a 53% ee sample.   
 
1-Phenyl-3-(pyridin-2-yl)-pentan-3-ol (15): Alcohol 10 (24.0 mg, 0.110 mmol) and 
Pd/C (12.0 mg, 0.0110 mmol) were weighed into a flame-dried round bottom flask, with 
stir bar and dissolved in anhydrous EtOH (1.1 mL).  The vessel was fitted with a 
hydrogen balloon and allowed to purge for 1 min.  Stirring was allowed to continue at 22 
oC for 14 h. (The starting material and product co-elute on TLC). After 14 h, the mixture 
was passed through a pad of celite with EtOAc and concentrated under reduced pressure. 
The resulting yellow oil was purified by silica gel chromatography.  A solvent gradient of 
pet. ether:Et2O (20:1), pet. ether:Et2O (9:1), pet. ether:Et2O (4:1), pet. ether:Et2O (7:3), 
pet. ether:Et2O (1:1), 100% Et2O allowed for the isolation of 15 as a white solid (22.0 mg, 
0.0910 mmol, 84.0% yield).  mp: 115-118 oC. IR (neat): 3402 (b), 3084 (w), 2964 (m), 
2934 (m), 2876 (m), 1593 (s), 1569 (m), 1454 (s), 1433 (s), 1396 (s), 1287 (w), 1140 (s), 
998 (m), 749 (s), 699 (s), 665 (s) cm-1.  1H NMR (400 MHz, CDCl3): δ 8.55 (1H, d, J = 
4.8 Hz, Ar-H), 7.72 (1H, dt, J = 7.6, 1.2 Hz,  Ar-H), 7.31 (1H, d, J = 7.6 Hz, Ar-H), 7.22 
(3H, d, J = 7.2 Hz, Ar-H), 7.13 (1H, d, J = 7.6 Hz, Ar-H), 7.09 (2H, d, J = 7.6 Hz, Ar-H), 
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5.48 (1H, s, OH), 2.77-2.69 (1H, m, CH2CH2), 2.25-2.17 (1H, m, CH2CH2), 2.13-2.01 
(2H, m, CH2CH2), 1.93 (1H, dq, J =14.8, 7.6 Hz, CCH2CH3), 1.83 (1H, dq, J = 14.8, 7.2 
Hz, (CCH2CH3), 0.69 (3H, t, J = 7.2 Hz, CH3CH2).  13C NMR (100 MHz, CDCl3): 
δ 163.3, 147.3, 142.8, 137.1, 136.7, 128.4, 128.3, 125.6, 121.9, 119.6, 76.2, 44.3, 35.3, 
30.1, 7.8. HRMS (ES+): Calcd for C16H20NO [M+1] 242.1545; Found 242.1555. 
Optical Rotation: [α]20D +43.1 (c = 0.230 in CHCl3) for a >98% ee sample. 
 
(Z)-1-Phenyl-3-(pyridin-2-yl)-pent-1-en-3-ol (16): Alcohol 10 (24.0 mg, 0.110 mmol) 
and Lindlar’s catalyst (Pd/CaCO3 poisoned with lead, 10 mol % w/w, 34.0 mg, 0.0110 
mmol) were weighed into a flame-dried round bottom flask, with stir bar and dissolved in 
anhydrous pyridine:MeOH (2:1, 1.5 mL).  The solution was allowed to cool to 0 oC (ice 
bath) and fitted with a H2 balloon.  The solution was purged with H2 (g) for 1 min.  The 
reaction proceeded at 0 oC for 3 h (The starting material and product co-elute on TLC). 
After 3 h,  the mixture was pushed through a pad of celite with EtOAc and concentrated 
under reduced pressure. The resulting yellow oil was purified by silica gel 
chromatography, (pet. ether:Et2O (20:1), pet. ether:Et2O (9:1), pet. ether:Et2O (4:1), pet. 
ether:Et2O (7:3), 1:1 pet. ether:Et2O, 100% Et2O) to furnish a 10:1 mixture of cis:trans 
isomers as a clear oil  (22.0 mg, 0.0960 mmol, 87.0% yield). IR (neat): 3385 (b), 3055 
(m), 3011 (m), 2966 (m), 2933 (m), 1592 (s), 1570 (m), 1493 (m), 1432 (s), 1387 (s), 
1294 (w), 1186 (w), 1138 (m), 1069 (m), 997 (m), 776 (m), 750 (m), 699 (m) cm-1.  1H 
NMR (400 MHz, CDCl3): δ 8.46 (1H, d, J = 4.4 Hz, Ar-H), 7.52 (1H, dt, J = 8.8, 0.8 Hz,  
Ar-H), 7.25 (2H, d, J = 7.6 Hz, Ar-H), 7.11-7.05 (5H, m, Ar-H), 6.59 (1H, d, J = 12.4 Hz, 
Ar-H), 6.06 (1H, d, J = 12.4 Hz, Ar-H), 4.99 (1H, s, OH), 2.02 (1H, dq, J =14.8, 7.6 Hz, 
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CCH2CH3), 1.88 (1H, dq, J = 14.8, 7.6 Hz, (CCH2CH3), 0.75 (3H, t, J = 7.2 Hz, 
CH3CH2). 13C NMR (100 MHz, CDCl3): δ 163.5, 147.3, 137.3, 136.6, 136.5, 131.6, 
129.2, 127.6, 126.8, 121.9, 120.8, 76.5, 37.6, 7.8. HRMS (ES+): Calcd for C16H18NO 
[M+1] 240.1388; Found 240.1386. Optical Rotation: [α]20D -135.2 (c = 0.230 in CHCl3)  
for a >98% ee sample.   
  
(E)-4-phenyl-2-(pyridin-2-yl)-but-3-en-2-ol (17): Alcohol 4a (25.0 mg, 0.112 mmol) 
was weighed into a flame-dried round bottom flask, with a stir bar and was dissolved in 
anhydrous Et2O (5 mL).  The solution was allowed to cool to 0 oC (ice bath) and Red-
Al® (78.0 μL, 0.258 mmol) was added through a syringe. The reaction mixture was 
allowed to warm slowly to 22 oC and was allowed to stir at this temperature for 4 h.  
After 4 h, the mixture was allowed to cool to 0 oC (ice bath) and the reaction was 
quenched by dropwise addition of MeOH (1 mL).  The mixture was allowed to warm to 
22 oC.  The mixture was diluted with EtOAc (3 mL) and washed with a saturated solution 
of Rochelle’s salt (sodium potassium tartrate, concentrated aq. solution, 3 x 3 mL). The 
organic layer was dried over MgSO4, filtered and concentrated under reduced pressure to 
yield a yellow oil, which was purified by silica gel chromatography (pet. ether:Et2O 
(20:1), pet. ether:Et2O (9:1), pet. ether:Et2O (4:1), pet. ether:Et2O (7:3), pet. ether:Et2O 
(1:1), 100% Et2O) to afford 17 as a white solid (18.0 mg, 0.0800 mmol, 71.0% yield).  
mp: 116-118 oC. IR (neat): 3389 (b), 2993 (w), 2892 (w), 1558 (w), 1394 (m), 1155 (m), 
1067 (m), 960 (m), 790 (m), 746 (s), 689 (m) cm-1.  1H NMR (400 MHz, CDCl3): δ 8.53 
(1H, d, J = 4.8 Hz, Ar-H), 7.71 (1H, t, J = 7.2 Hz, Ar-H), 7.43-7.36 (3H, m, Ar-H), 7.30-
7.26 (4H, m, Ar-H), 6.72 (1H, d, J = 16.0 Hz, Ar-H), 6.44 (1H, d, J = 16.0 Hz, Ar-H), 
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5.54 (1H, s, OH), 1.72 (3H, s, CH3).  13C NMR (100 MHz, CDCl3): δ 163.8, 147.7, 
137.3, 136.9, 135.8, 128.6, 128.1, 127.6, 126.7, 122.3, 119.9, 73.9, 28.8. HRMS (ES+): 
Calcd for C15H16NO [M+1] 226.1232; Found 226.1221. Optical Rotation: [α]20D +36.6 
(c = 0.830 in CHCl3) for a >98% ee sample.   
 
(S)-3-(Pyridin-2-yl)-dec-9-en-4-yn-3-ol (20): (S)-3-Pyridin-2-yl-undec-4-yn-3-ol (53.0 
mg, 0.330 mmol) was weighed into a flame dried round bottom flask charged with a stir 
bar and sealed with a septum. Anhydrous THF was added by syringe. The solution was 
allowed to cool to -40 oC (dry ice/CH3CN) after which n-butyllithium (1.67 M in hexanes, 
395 μL, 0.266 mmol) was added slowly by syringe.13  The mixture was allowed to stir at 
-40 oC for 10 min, and the ice bath was removed; the mixture was allowed to -15 oC.  
After the allotted time, the mixture was allowed to cool to -78 oC (dry ice/acetone) and 1-
bromo-4-pentene (35 μL, 0.300 mmol) was added.  The reaction was allowed to warm 
from -78 oC to 22 oC over 12 h, after which the reaction was quenched through the 
addition of a saturated solution of NaHCO3 (2 mL). The mixture was diluted with EtOAc 
(10 mL) and washed with a saturated solution of NaCl (2 x 25 mL). The aqueous layer 
was washed with EtOAc (2 x 15 mL) and the combined organic layers were dried over 
MgSO4, filtered and concentrated under reduced pressure.  The resulting yellow oil was 
purified by silica gel chromatography (pet. ether:Et2O (20:1), pet. ether:Et2O (9:1), pet. 
ether:Et2O (4:1), pet. ether:Et2O (7:3), pet. ether:Et2O (1:1), 100% Et2O) to provide 20 as 
a clear oil  (42.0 mg, 0.183 mmol, 56.0% yield).  IR (neat): 3384 (b), 3074 (m), 2970 
(m), 2933 (m), 2867 (m), 1640 (w), 1592 (m), 1433 (m), 1393 (m), 1143 (m), 1059 (w), 
979 (w), 912 (w) cm-1.  1H NMR (400 MHz, CDCl3): δ 8.51 (1H, d, J = 4.8 Hz, Ar-H), 
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7.72 (1H, dt, J = 9.6, 2.0 Hz,  Ar-H), 7.58 (1H, d, J = 8.0 Hz, Ar-H), 7.26-7.22 (1H, m, 
Ar-H), 5.84-5.74 (1H, m), 5.31 (1H, s), 5.04-4.95 (2H, m), 2.27 (2H, t, J = 7.2 Hz), 2.18-
2.12 (2H, m), 1.99 (1H, dq, J =14.8, 7.6 Hz), 1.88 (1H, dq, J = 14.4, 7.2 Hz), 1.63 (2H, q, 
J = 7.2 Hz), 0.95 (3H, t, J = 7.2 Hz,).  13C NMR (100 MHz, CDCl3): δ 161.7, 147.4, 
138.0, 137.2, 122.7, 120.8, 115.3, 85.1, 82.7, 72.3, 38.3, 32.9, 27.9, 18.3, 8.7.   HRMS 
(ES+): Calcd for C15H20NO [M+1] 230.1545; Found 230.1544. Optical Rotation: [α]20D 
+5.11 (c = 0.235 in CHCl3) for a 92% ee sample.   
 
4-Phenyl-2-(pyridin-2-yl)-but-3-yn-2-yl acetate: 91.0% yield. IR 
(neat): 3054 (w), 2978 (w), 2928 (w), 1745 (s), 1589 (w), 1490 (m), 
1432 (m), 1365 (m), 1265 (s), 1238 (s), 1067 (m), 742 (s), 704 (m) cm-1.  1H NMR (400 
MHz, CDCl3): δ 8.58 (1H, d, J = 4.4 Hz, Ar-H), 7.87 (1H, d, J = 8.0 Hz, Ar-H), 7.71 
(1H, dt, J = 7.6, 1.6 Hz, Ar-H), 7.54-7.50 (2H, m, Ar-H), 7.33-7.30 (3H, m, Ar-H), 7.20 
(1H, t, J = 6.4 Hz, Ar-H), 2.11 (3H, s, CH3), 2.00 (3H, s, CH3).  13C NMR (100 MHz, 
CDCl3): δ 169.0, 159.9, 149.2, 136.8, 132.1, 128.8, 128.3, 122.8, 122.4, 120.9, 88.3, 87.1, 
76.0, 30.2, 21.7. HRMS (ES+): Calcd for C17H16NO2 [M+1] 266.1181; Found 266.1188. 
Optical Rotation: [α]20D -74.9 (c = 1.40 in CHCl3) for a >98% ee sample.   
 
(S)-1-Phenyl-3-(pyridin-2-yl)pent-1-yn-3-yl acetate (21): 87.0% yield. IR (neat): 3047 
(w), 2975 (w), 2928 (w), 1740 (s), 1589 (m), 1490 (m), 1432 (m), 1366 (m), 1234 (s), 
1152 (m), 1015 (m), 756 (s), 691 (m) cm-1.  1H NMR (400 MHz, CDCl3): δ 8.58 (1H, d, 
J = 4.0 Hz, Ar-H), 7.86 (1H, d, J = 8.0 Hz, Ar-H), 7.70 (1H, t, J = 7.6 Hz, Ar-H), 7.54 
(2H, dd, J = 5.2, 2.0 Hz, Ar-H), 7.37-7.30 (3H, m, Ar-H), 7.21-7.18 (1H, m, Ar-H), 2.33 
(1H, dq, J = 14.4, 7.2 Hz, CH3CH2), 2.17 (1H, dq, J = 14.8, 7.2 Hz, CH3CH2), 2.11 (3H, 
AcO Me
Ph
N
Chapter 3, Page 204 
s, CH3), 1.04 (3H, t, J = 7.2 Hz, CH3CH2). 13C NMR (100 MHz, CDCl3): δ 169.1, 159.3, 
149.2, 126.5, 132.1, 128.7, 128.4, 122.7, 122.5, 121.9, 88.2, 87.1, 79.8, 35.9, 21.6, 8.8.  
HRMS (ES+): Calcd for C18H18NO2 [M+1] 280.1227; Found 280.1342 Optical 
Rotation: [α]20D -81.9 (c = 1.80 in CHCl3) for a >98% ee sample.   
 
Cyclopentylethylphenylpyridyl tetrasubstituted allene (22): Allene 22 was prepared 
according to a previously reported procedure,8 with modifications described below. 
Copper (I) cyanide (59.0 mg, 0.659 mmol) was weighed into an oven dried 13 x 100 mm 
test tube. The test tube was sealed with a septum, electrical tape and Teflon ® tape, and 
purged with N2 and anhydrous Et2O (0.50 mL) was added through a syringe. The solution 
was allowed to cool to -35 oC (dry ice/acetonitrile), and cyclopentyl-MgCl (0.365 mL, 
0.645 mmol, 1.76 M solution in THF was added through a syringe.  The solution was 
allowed to stir for 20 minutes followed by addition of a solution of propargyl acetate 21 
(36.0 mg, 0.129 mmol, in Et2O, 1 mL) through a syringe.  The solution was allowed to 
stir at -35 oC (CH3CN/dry ice) for an additional 35 min, after which time the reaction was 
quenched through the addition of a saturated aqueous solution of NH4Cl (1 mL). This 
mixture was allowed to warm to 22 oC with stirring, then diluted with EtOAc and washed 
with a saturated solution of NH4Cl (2 x 3 mL).  A saturated solution of NaHCO3 was 
added until pH = 7 was reached then the aqueous layer was washed with EtOAc (2 x 3 
mL).  Combined organic layers were dried over MgSO4, filtered and concentrated under 
reduced pressure. The resulting bright yellow oil was purified by silica gel 
chromatography (pet. ether:Et2O (20:1), pet. ether:Et2O (4:1), pet. ether:Et2O (1:1), 100% 
Et2O) to afford 22 as a bright yellow oil  (27.0 mg, 0.0950 mmol, 74.0% yield). IR 
(neat): 3056 (w), 2957 (s), 2867 (m), 1931 (w), 1585 (m), 1562 (m), 1467 (m), 1427 (m), 
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1254 (w), 763 (m), 741 (m), 693 (m) cm-1.  1H NMR (400 MHz, CDCl3): δ 8.58 (1H, d, 
J = 4.4 Hz, Ar-H), 7.54-7.46 (4H, m, Ar-H), 7.32 (2H, t, J = 7.6 Hz, Ar-H), 7.21 (1H, t, J 
= 7.2 Hz, Ar-H), 7.06 (1H, dt, J = 4.8, 1.2 Hz, Ar-H), 3.12 (1H, dq, J = 15.2, 8.0 Hz, 
CH3CH2), 2.75 (1H, dq, J = 7.6, 1.2 Hz, CH3CH2), 2.06-2.01 (2H, m, CH2CH2CH2), 
1.69-1.54 (7H, m, CH2CH2CH2), 1.17 (3H, t, J = 7.6 Hz, CH3CH2).  13C NMR (100 
MHz, CDCl3): δ 205.9, 156.3, 149.2, 137.0, 136.0, 128.7, 127.0, 126.7, 122.2, 121.3, 
115.9, 113.8, 40.1, 33.0, 32.8, 22.6, 12.9. HRMS (ES+): Calcd for C21H24N [M+1] 
290.1909; Found 290.1905. Optical Rotation: [α]20D -170.4 (c = 0.685 in CHCl3) for a 
97% ee sample (starting material was >98% ee). Enantiomeric purity of the compound 
was determined by chiral HPLC analysis (Chiralcel OD, 99.9:0.1 hexanes:i-PrOH eluent 
0.500 mL/min and a lamp setting of 254 nm) tr = 261 min. (minor) and tr = 23 min. 
(major). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area %
1 26.66 5123970 49.702 1 23.63 10625740 98.547 
2 29.25 5185437 50.298 2 26.21 156704 1.453 
  
tert-Butylmethylphenylpyridyl tetrasubstituted allene (23): IR (neat): 3054 (w), 2961 
(w), 2920 (w), 1946 (w), 1585 (m), 1561 (m), 1470 (m), 1428 (m), 1262 (s), 1076 (w), 
740 (s), 702 (s) cm-1.  1H NMR (400 MHz, CDCl3): δ 8.54 (1H, d, J = 4.8 Hz, Ar-H), 
7.64-7.55 (2H, m, Ar-H), 7.34-7.23 (5H, m, Ar-H), 7.04 (1H, t, J = 6.0 Hz, Ar-H), 2.02 
(3H, s, CH3). 1.21 (9H, s, C(CH3)3).  13C NMR (100 MHz, CDCl3): δ 204.3, 157.1, 
Chapter 3, Page 206 
149.0, 137.4, 135.7, 129.4, 128.0, 126.9, 121.4, 120.8, 118.4, 103.2, 35.8, 30.1, 16.5.  
HRMS (ES+): Calcd for C19H22N [M+1] 264.1752; Found 264.1743.  Optical Rotation:  
[α]20D -215.8 (c = 0.965 in CHCl3) for a 89% ee sample (starting material was >98% ee).  
Enantiomeric purity of the compound was determined by chiral HPLC analysis (Chiralcel 
OD, 99.9:0.1 hexanes:i-PrOH eluent 0.500 mL/min and a lamp setting of 254 nm) tr = 26 
min. (minor) and tr = 32 min. (major). 
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XIII. NMR Data for Me2Zn Addition Products and Functionalization Products 
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